Sentence,class,file
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.3.166 Infect Chemother 2016;48(3):166-173 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Received: May 29, 2016   Revised:  August 18, 2016  Accepted: September 2, 2016  Corresponding Author : Jin-Hong Yoo MD, PhD Division of Infectious Diseases, Department of Internal Medicine, College of Medicine,  The Catholic University of Korea, Bucheon St. Mary’s Hospital #2, 327 Sosa-ro, Won - mi-gu, Bucheon 14647, Korea Tel: +82-31-820-5217, Fax: +82-31-820-2719 E-mail: jhyoo@catholic.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/89/ic-48-166.PMC5047997.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.3.166  •  Infect Chemother 2016;48(3) :166-173 www.icjournal.org 167 Introduction Enterobacteriaceae family includes Escherichia coli, Klebsi - ella pneumoniae, Citrobacter freundii , Morganella morganii ,  Proteus mirabilis , Enterobacter species, and Serratia  species,  to name a few.",Non-OADS,/arxiv_data1/oa_pdf/30/89/ic-48-166.PMC5047997.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.166  •  Infect Chemother 2016;48(3) :166-173 www.icjournal.org 169 days) [11].,OADS,/arxiv_data1/oa_pdf/30/89/ic-48-166.PMC5047997.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.166  •  Infect Chemother 2016;48(3) :166-173 www.icjournal.org 171 prevalence of CRE.,Non-OADS,/arxiv_data1/oa_pdf/30/89/ic-48-166.PMC5047997.pdf
ORCID Jin-Hong Yoo  http://orcid.org/0000-0003-2611-3399 Hyo-Jin Lee  http://orcid.org/0000-0001-9351-0779 Sung-Yeon Cho  http://orcid.org/0000-0001-5392-3405 Su-Mi Choi  http://orcid.org/0000-0002-8187-5110 Dong-Gun Lee  http://orcid.org/0000-0003-4655-0641 References   1.,Non-OADS,/arxiv_data1/oa_pdf/30/89/ic-48-166.PMC5047997.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.166  •  Infect Chemother 2016;48(3) :166-173 www.icjournal.org 173 tensive care unit patients of a Korean Tertiary Care Hospi - tal.,Non-OADS,/arxiv_data1/oa_pdf/30/89/ic-48-166.PMC5047997.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.3.174 Infect Chemother 2016;48(3):174-180 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Received: July 28, 2016  Revised:  September 1, 2016  Accepted: September 1, 2016 Corresponding Author : Hyuck Lee Division of Infectious Diseases, Dong-A University Hospital, 26 Daesingongwon-ro, Seo- gu, Busan 49201, Korea  Tel: +82-51-240-5047, Fax: +82-51-243-5047 E-mail: hleeid@dau.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/ff/ic-48-174.PMC5047998.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.174  •  Infect Chemother 2016;48(3) :174-180 www.icjournal.org 175 Introduction  Antibiotic resistance is becoming increasingly problematic  and is a major public health threat.,Non-OADS,/arxiv_data1/oa_pdf/f1/ff/ic-48-174.PMC5047998.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.3.174  •  Infect Chemother 2016;48(3) :174-180 www.icjournal.org 177 sis, ORs were also adjusted for other significant factors that  were selected using a backward elimination method, with a  criterion to stay in the model of P <0.05.",Non-OADS,/arxiv_data1/oa_pdf/f1/ff/ic-48-174.PMC5047998.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.3.174  •  Infect Chemother 2016;48(3) :174-180 www.icjournal.org 179 jor restriction was the high cost per bed in an isolation room,  which was related to an uncompensated care burden  from the  medical insurance [14].",Non-OADS,/arxiv_data1/oa_pdf/f1/ff/ic-48-174.PMC5047998.pdf
ORCID Hojin Lee  http://orcid.org/0000-0002-2750-6285 Hyuck Lee  http://orcid.org/0000-0002-4115-0748 References     1.,Non-OADS,/arxiv_data1/oa_pdf/f1/ff/ic-48-174.PMC5047998.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.3.181 Infect Chemother 2016;48(3):181-189 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Received: May 13 , 2016   Revised:  July 28, 2016  Accepted: July 29, 2016 Corresponding Author : Seung Beom Han, MD Department of Pediatrics, Seoul St. Mary’s Hospital, College of Medicine, The Catholic  University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea Tel: +82-2-2258-6179, Fax: +82-2-537-4544 E-mail: beomsid@catholic.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/6f/ic-48-181.PMC5047999.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.181  •  Infect Chemother 2016;48(3) :181-189 www.icjournal.org 183 those infected by non-AR bacteria to determine the clinical  impact of AR bacterial infection.,OADS,/arxiv_data1/oa_pdf/a0/6f/ic-48-181.PMC5047999.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.181  •  Infect Chemother 2016;48(3) :181-189 www.icjournal.org 185 plications.,Non-OADS,/arxiv_data1/oa_pdf/a0/6f/ic-48-181.PMC5047999.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.181  •  Infect Chemother 2016;48(3) :181-189 www.icjournal.org 187 matology wards in our hospital (92.9%) [25].,Non-OADS,/arxiv_data1/oa_pdf/a0/6f/ic-48-181.PMC5047999.pdf
ORCID Joon Hee Lee  http://orcid.org/0000-0001-9530-2105 Seul-Ki Kim  http://orcid.org/0000-0002-9281-0320 Seong Koo Kim  http://orcid.org/0000-0002-1860-3067 Seung Beom Han  http://orcid.org/0000-0002-1299-2137 Jae Wook Lee  http://orcid.org/0000-0002-0735-0287 Dong-Gun Lee  http://orcid.org/0000-0003-4655-0641 Nack-Gyun Chung  http://orcid.org/0000-0003-4855-390X Bin Cho  http://orcid.org/0000-0001-6675-695X Dae Chul Jeong  http://orcid.org/0000-0003-0934-817X Jin Han Kang  http://orcid.org/0000-0003-1610-6742 Hack-Ki Kim  http://orcid.org/0000-0001-7298-4596 References   1.,Non-OADS,/arxiv_data1/oa_pdf/a0/6f/ic-48-181.PMC5047999.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.181  •  Infect Chemother 2016;48(3) :181-189 www.icjournal.org 189 20th ed.,Non-OADS,/arxiv_data1/oa_pdf/a0/6f/ic-48-181.PMC5047999.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.3.190 Infect Chemother 2016;48(3):190-198 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Received: May 27, 2016   Accepted: June 17, 2016  Corresponding Author : Sofia Maraki, MD, PhD Department of Clinical Microbiology, University Hospital of Heraklion, Heraklion, Crete,  Greece Tel: +30-2810-392598, Fax: +30-2810-392597 E-mail: sofiamaraki@in.gr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/24/ic-48-190.PMC5048000.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.190  •  Infect Chemother 2016;48(3) :190-198 www.icjournal.org 191 Introduction The emergence and spread of antibiotic-resistant bacteria is of  great concern to physicians because they can cause serious and  even fatal infections in hospitalized patients.,Non-OADS,/arxiv_data1/oa_pdf/56/24/ic-48-190.PMC5048000.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.3.190  •  Infect Chemother 2016;48(3) :190-198 www.icjournal.org 193 the ICU (n = 493), and medical (n = 252) and surgical (n = 169)  wards.",Non-OADS,/arxiv_data1/oa_pdf/56/24/ic-48-190.PMC5048000.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.190  •  Infect Chemother 2016;48(3) :190-198 www.icjournal.org 195 statistically significant differences in resistance were noted by  hospital unit origin.,Non-OADS,/arxiv_data1/oa_pdf/56/24/ic-48-190.PMC5048000.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.190  •  Infect Chemother 2016;48(3) :190-198 www.icjournal.org 197 every hospital unit.,Non-OADS,/arxiv_data1/oa_pdf/56/24/ic-48-190.PMC5048000.pdf
ORCID Sofia Maraki   http://orcid.org/0000-0002-8553-0849 Elpis Mantadakis   http://orcid.org/0000-0001-7837-9733 Viktoria Eirini Mavromanolaki  http://orcid.org/0000-0002-9373-1800 Diamantis P. Kofteridis   http://orcid.org/0000-0001-7603-2592 George Samonis   http://orcid.org/0000-0001-5857-9703 References   1.,Non-OADS,/arxiv_data1/oa_pdf/56/24/ic-48-190.PMC5048000.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.3.199 Infect Chemother 2016;48(3):199-208 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Received: March 30, 2016   Revised:  June 7, 2016  Accepted: June 7, 2016 Corresponding Author : Jun Yong Choi, MD, PhD Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro,  Seodaemun-gu, Seoul 03722, Korea  Tel: +82-2-2228-1974, Fax: +82-2-393-6884  E-mail: SERAN@yuhs.ac This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/4e/ic-48-199.PMC5048001.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.199  •  Infect Chemother 2016;48(3) :199-208 www.icjournal.org 201 hypotensive status at the time of perfusion abnormality mea - surement.,Non-OADS,/arxiv_data1/oa_pdf/ca/4e/ic-48-199.PMC5048001.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.3.199  •  Infect Chemother 2016;48(3) :199-208 www.icjournal.org 203 (SOFA) score ( P <0.001), APACHE II score ( P <0.001), low white  blood cell count ( P = 0.046), low platelet count ( P = 0.001), low  erythrocyte sedimentation rate ( P = 0.018), low estimated glo - merular filtration rate (eGFR; P <0.001), high aspartate amino - transferase (AST) concentration ( P = 0.011), low albumin con - centration ( P = 0.005), high lactate level ( P <0.001), low  antithrombin III level ( P = 0.001), hemodialysis ( P <0.001), ven - tilator care ( P <0.001), and transfusion ( P <0.001).",Non-OADS,/arxiv_data1/oa_pdf/ca/4e/ic-48-199.PMC5048001.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.3.199  •  Infect Chemother 2016;48(3) :199-208 www.icjournal.org 205 In multivariate analysis, high lactate level (OR, 1.346; 95% CI,  1.083-1.673; P = 0.008) and high APACHE II score (OR, 1.153;  95% CI, 1.029-1.293; P = 0.014) were found to be independently  related to 28-day mortality (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/ca/4e/ic-48-199.PMC5048001.pdf
ORCID Je Eun Song  http://orcid.org/0000-0001-7056-6905 Jun Yong Choi  http://orcid.org/0000-0002-2775-3315 References   1.,Non-OADS,/arxiv_data1/oa_pdf/ca/4e/ic-48-199.PMC5048001.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.3.199  •  Infect Chemother 2016;48(3) :199-208 www.icjournal.org 207 B, Peterson E, Tomlanovich M; Early Goal-Directed Thera - pyCollaborative Group.",OADS,/arxiv_data1/oa_pdf/ca/4e/ic-48-199.PMC5048001.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.3.209 Infect Chemother 2016;48(3):209-215 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Received: April 20, 2016   Revised:  June 30, 2016  Accepted: July 16, 2016 Corresponding Author : Sungmin Kiem, MD Division of Infectious Diseases, Department of Internal Medicine, Inje University Haeun - dae Paik Hospital, Inje University College of Medicine, 875 Haeun-daero, Haeundae-gu,  Busan 48108, Korea.",Non-OADS,/arxiv_data1/oa_pdf/5a/26/ic-48-209.PMC5048002.pdf
"This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/26/ic-48-209.PMC5048002.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.3.209  •  Infect Chemother 2016;48(3) :209-215 www.icjournal.org 211 50.0 µg/mL, respectively, with coefficients of determination  (R2) greater than 0.995 for all.",OADS,/arxiv_data1/oa_pdf/5a/26/ic-48-209.PMC5048002.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.3.209  •  Infect Chemother 2016;48(3) :209-215 www.icjournal.org 213 ing ethnic differences in pharmacokinetics of piperacillin and  tazobactam is available, despite several reports of the popula - tion pharmacokinetics of piperacillin and tazobactam [18].",Non-OADS,/arxiv_data1/oa_pdf/5a/26/ic-48-209.PMC5048002.pdf
ORCID Yong Kyun Kim  http://orcid.org/0000-0002-7935-6952 Jin Ah Jung  http://orcid.org/0000-0003-2439-377X Sungmin Kiem  http://orcid.org/0000-0003-3518-966X References   1.,Non-OADS,/arxiv_data1/oa_pdf/5a/26/ic-48-209.PMC5048002.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.3.209  •  Infect Chemother 2016;48(3) :209-215 www.icjournal.org 215 JA, Rodríguez A, Fleites A, Navarro V , Sirvent E, Capdevila  JA; SEMI- BLEE STUDY GROUP .",OADS,/arxiv_data1/oa_pdf/5a/26/ic-48-209.PMC5048002.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2015.48.3.216 Infect Chemother 2016;48(3):216-218 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Received: January 28, 2016   Revised: May 3, 2016   Accepted: May 4, 2016 Corresponding Author : Yu Seob Shin, MD Department of Urology, Medical School, Chonbuk National University, 20 Geonji-ro,  Deokjin-Gu, Jeonju 54907, Korea Tel: +82-63-245-8493, Fax: +82-63-250-1564 E-mail: ball1210@hanmail.net This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/65/ic-48-216.PMC5048003.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.216  •  Infect Chemother 2016;48(3) :216-218 www.icjournal.org 217 2015 (Fig.,Non-OADS,/arxiv_data1/oa_pdf/85/65/ic-48-216.PMC5048003.pdf
Conflicts of Interest No conflicts of interest.ORCID Jong Kwan Park  http://orcid.org/0000-0001-9682-2081 Yu Seob Shin  http://orcid.org/0000-0002-1126-3821 References   1.,Non-OADS,/arxiv_data1/oa_pdf/85/65/ic-48-216.PMC5048003.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2015.48.3.219 Infect Chemother 2016;48(3):219-224 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Received: May 18, 2016   Revised: July 11, 2016   Accepted: August 9, 2016 Corresponding Author : Jun Yong Choi, MD, PhD  Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro,  Seodaemun-gu, Seoul 03722, Korea  Tel: +82-2-2228-1974, Fax: +82-2-393-6884  Email: seran@yuhs.ac This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/6b/ic-48-219.PMC5048004.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.3.219  •  Infect Chemother 2016;48(3) :219-224 www.icjournal.org 221 maining on the NNRTI+ F/TDF regimen, improvement in pa - tient-reported outcomes (PROs) related to NNRTI-associated  neuropsychiatric side effects, and greater treatment satisfac - tion scores [15] .",Non-OADS,/arxiv_data1/oa_pdf/6a/6b/ic-48-219.PMC5048004.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.219  •  Infect Chemother 2016;48(3) :219-224 www.icjournal.org 223 in Asian subjects on E/C/F/TDF resulted in minimal changes  in the TC:HDL ratio and were similar to those in the overall  study population.,Non-OADS,/arxiv_data1/oa_pdf/6a/6b/ic-48-219.PMC5048004.pdf
ORCID Jun Yong Choi  http://orcid.org/0000-0002-2775-3315 References   1.,Non-OADS,/arxiv_data1/oa_pdf/6a/6b/ic-48-219.PMC5048004.pdf
"1079, Fax: +52-55-5528-7494 E- mail: joseluis_sotohernandez@yahoo.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/90/ic-48-225.PMC5048005.pdf
The findings of this case report make us consider http://dx.doi.org/10.3947/ic.2016.48.3.225 Infect Chemother 2016;48(3):225-226 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online)Correspondence 11-CO-16-591 Jose_Luis.indd   1 2016-09-29   오후 1:53:40,Non-OADS,/arxiv_data1/oa_pdf/04/90/ic-48-225.PMC5048005.pdf
ORCID José Luis Soto Hernández  http://orcid.org/0000-0002-4712-1809 References     1.,Non-OADS,/arxiv_data1/oa_pdf/04/90/ic-48-225.PMC5048005.pdf
"Infection &  Chemotherapy Corresponding Author : Hee Jung Choi, MD Department of Internal Medicine, Mokdong Hospital, Ewha Womans University School of  Medicine, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 07985, Korea  Tel: +82-2-2650-6008, Fax: +82-2-2655-2076, E-mail: heechoi@ewha.ac.kr  This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/79/ic-48-227.PMC5048006.pdf
ORCID Hee Jung Choi  http://orcid.org/0000-0002-1468-4074 References     1.,Non-OADS,/arxiv_data1/oa_pdf/ae/79/ic-48-227.PMC5048006.pdf
A case of disseminated multidrug-resistant tu -http://dx.doi.org/10.3947/ic.2016.48.3.227 Infect Chemother 2016;48(3):227-228 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online)Correspondence 12-REPLY-16-591.indd   1 2016-09-29   오후 1:54:03,Non-OADS,/arxiv_data1/oa_pdf/ae/79/ic-48-227.PMC5048006.pdf
"Infection &  Chemotherapy Received:  October 1, 2015  Revised:  October 27, 2015  Accepted:  October 30, 2015 Corresponding Author : Nam Su Ku, MD Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro,  Seodaemun-gu, Seoul 03722, Korea  Tel: +82-2-2228-2277, Fax: +82-2-393-6884 E-mail: smileboy9@yuhs.ac This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/fd/ic-48-229.PMC5048007.pdf
"Two  months previously, the patient had undergone a simple ex -http://dx.doi.org/10.3947/ic.2016.48.3.229 Infect Chemother 2016;48(3):229-233 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online)Case Report 13-증례-14-488 박서현-구남수.indd   1 2016-09-29   오후 1:54:28",Non-OADS,/arxiv_data1/oa_pdf/a8/fd/ic-48-229.PMC5048007.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.229  •  Infect Chemother 2016;48(3) :229-233 www.icjournal.org 231 ture was negatively converted at this time).,OADS,/arxiv_data1/oa_pdf/a8/fd/ic-48-229.PMC5048007.pdf
ORCID Seohyun Park  http://orcid.org/0000-0002-6169-4064 Nam Su Ku  http://orcid.org/0000-0002-9717-4327 References    1.,Non-OADS,/arxiv_data1/oa_pdf/a8/fd/ic-48-229.PMC5048007.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.3.229  •  Infect Chemother 2016;48(3) :229-233 www.icjournal.org 233 ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Taka - hashi M, Taubert KA; Committee on Rheumatic Fever, En - docarditis, and Kawasaki Disease; Council on Cardiovas - cular Disease in the Young; Councils on Clinical  Cardiology, Stroke, and Cardiovascular Surgery and Anes - thesia; American Heart Association; Infectious Diseases  Society of America.",Non-OADS,/arxiv_data1/oa_pdf/a8/fd/ic-48-229.PMC5048007.pdf
"Division of Infectious Diseases, Department of Internal Medicine, National Health Insurance  Service Ilsan Hospital, 100 Ilsan-ro Ilsan-donggu Goyang 10444, Korea Tel: +82-31-900-0500, Fax: +82-31-900-0049  E-mail: ysparkok2@gmail.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/f4/ic-48-234.PMC5048008.pdf
"In this case report, we present a rare case of olecranon os - teomyelitis caused by A. meyeri confirmed by culture, not by  pathology.http://dx.doi.org/10.3947/ic.2016.48.3.234 Infect Chemother 2016;48(3):234-238 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online)Case Report 14-증례-15-526 김지연-박윤수.indd   1 2016-09-29   오후 1:54:55",Non-OADS,/arxiv_data1/oa_pdf/85/f4/ic-48-234.PMC5048008.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.3.234  •  Infect Chemother 2016;48(3) :234-238 www.icjournal.org 235 Case Report  A 70-year-old man was referred to our hospital for severe  pain, swelling, and pus discharge in his right elbow.",Non-OADS,/arxiv_data1/oa_pdf/85/f4/ic-48-234.PMC5048008.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.234  •  Infect Chemother 2016;48(3) :234-238 www.icjournal.org 237 was not possible because specimen was discarded after iden - tification by VITEK II card.,OADS,/arxiv_data1/oa_pdf/85/f4/ic-48-234.PMC5048008.pdf
Conflicts of Interest No conflicts of interest.ORCID Ji-Yeon Kim  http://orcid.org/0000-0002-8713-1497 Yoon soo Park  http://orcid.org/0000-0003-4640-9525 References    1.,Non-OADS,/arxiv_data1/oa_pdf/85/f4/ic-48-234.PMC5048008.pdf
"Infection &  Chemotherapy Received:  July 7, 2016  Revised:  July 19, 2016  Accepted:  July 21, 2016 Corresponding Author : Hyo-Lim Hong, MD Department of Internal Medicine, Catholic University of Daegu School of Medicine,  33 Duryugongwon-ro, 17-gil Nam-gu, Daegu 42472, Korea Tel: +82-53-650-4708, Fax: +82-53-621-4106 E-mail : popear01@naver.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/2f/ic-48-239.PMC5048009.pdf
"C.  striatum  can cause pulmonary abscess, meningitis, septic ar -http://dx.doi.org/10.3947/ic.2016.48.3.239 Infect Chemother 2016;48(3):239-245 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online)Case Report 15-증례 -16-603 홍효림.indd   1 2016-09-29   오후 1:55:22",Non-OADS,/arxiv_data1/oa_pdf/a0/2f/ic-48-239.PMC5048009.pdf
The 16S rRNA  gene sequence (766 bp) was blasted with NCBI Blast website  http://blast.ncbi.nlm.nih.gov/Blast.cgi.,OADS,/arxiv_data1/oa_pdf/a0/2f/ic-48-239.PMC5048009.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.239  •  Infect Chemother 2016;48(3) :239-245 www.icjournal.org 241 tion despite administration of vancomycin for 14 days.,Non-OADS,/arxiv_data1/oa_pdf/a0/2f/ic-48-239.PMC5048009.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.239  •  Infect Chemother 2016;48(3) :239-245 www.icjournal.org 243 Table 1.,OADS,/arxiv_data1/oa_pdf/a0/2f/ic-48-239.PMC5048009.pdf
ORCID Hyo-Lim Hong  http://orcid.org/0000-0003-2147-1381 A-Jin  Lee  http://orcid.org/0000-0001-7504-0881 Hwi-In Koh  http://orcid.org/0000-0003-0238-3415 References   1.,Non-OADS,/arxiv_data1/oa_pdf/a0/2f/ic-48-239.PMC5048009.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.239  •  Infect Chemother 2016;48(3) :239-245 www.icjournal.org 245 tis by broad-range polymerase chain reaction: a 3-year ex - perience.,OADS,/arxiv_data1/oa_pdf/a0/2f/ic-48-239.PMC5048009.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.3.246 Infect Chemother 2016;48(3):246-248 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Corresponding Author : Chang-Seop Lee, MD, PhD Department of Internal Medicine, Chonbuk National University Medical School, 567  Baekje-daero, Deokjin-gu, Jeonju-si, Jeollabuk-do 54907, Korea Tel: +82-63-250-2391, Fax: +82-63-254-1609 E-mail: lcsmd@jbnu.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/3b/ic-48-246.PMC5048010.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.3.246  •  Infect Chemother 2016;48(3) :246-248 www.icjournal.org 247 high comorbidity score, and regular visits to the outpatient  clinic.",Non-OADS,/arxiv_data1/oa_pdf/01/3b/ic-48-246.PMC5048010.pdf
ORCID Chang-Seop Lee   http://orcid.org/0000-0002-2897-2202References   1.,Non-OADS,/arxiv_data1/oa_pdf/01/3b/ic-48-246.PMC5048010.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.3.249 Infect Chemother 2016;48(3):249-251 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Corresponding Author : Jina Lee, MD, PhD Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine,  88 Olympic-ro 43 gil, Songpa-gu, Seoul 05505, Korea Tel: +82-2-3010-3923, Fax: +82-2-473-3725  E-mail address: entier@amc.seoul.kr  This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/52/ic-48-249.PMC5048011.pdf
ORCID Jina Lee  http://orcid.org/0000-0002-3435-251X References     1.,Non-OADS,/arxiv_data1/oa_pdf/84/52/ic-48-249.PMC5048011.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.249  •  Infect Chemother 2016;48(3) :249-251 www.icjournal.org 251 dren with cancer.,Non-OADS,/arxiv_data1/oa_pdf/84/52/ic-48-249.PMC5048011.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.3.252 Infect Chemother 2016;48(3):252-253 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Corresponding Author : Dae Won Park, M.D., PhD.",OADS,/arxiv_data1/oa_pdf/aa/86/ic-48-252.PMC5048012.pdf
"Division of Infectious Diseases, Korea University Ansan Hospital, 123 Jeukgeum-ro, Dan - won-gu, Ansan 15355, Korea Tel:+82-31-412-4270, Fax : +82-31-412-5984 E-mail: pugae1@korea.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/86/ic-48-252.PMC5048012.pdf
  http://dx.doi.org/10.3947/ic.2016.48.3.252  •  Infect Chemother 2016;48(3) :252-253 www.icjournal.org 253 ty rate in subjects randomized to lactate clearance-guided re - suscitation versus 23% in those randomized to central venous  oxygen saturation-guided resuscitation [8].,Non-OADS,/arxiv_data1/oa_pdf/aa/86/ic-48-252.PMC5048012.pdf
ORCID Ha Eun Kang http://orcid.org/0000-0002-6404-6513 Dae Won Park  http://orcid.org/0000-0002-7653-686X References   1.,Non-OADS,/arxiv_data1/oa_pdf/aa/86/ic-48-252.PMC5048012.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2016.48.3.254 Infect Chemother 2016;48(3):254-256 ISSN 2093-2340 (Print) · ISSN 2092-6448 (Online) Corresponding Author : Seunghoon Han, MD, PhD Department of Pharmacology, College of Medicine, The Catholic University of Korea,  222 Banpo-daero, Seocho-gu, Seoul 06591, Korea  Tel: +82 2 2258 7326; Fax: +82 2 2258 7876  E-mail: waystolove@catholic.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/11/ic-48-254.PMC5048013.pdf
"  http://dx.doi.org/10.3947/ic.2016.48.3.254  •  Infect Chemother 2016;48(3) :254-256 www.icjournal.org 255 data acquisition are non-trivial challenges, study goals should  be clearly defined according to the clinical needs.",Non-OADS,/arxiv_data1/oa_pdf/0d/11/ic-48-254.PMC5048013.pdf
ORCID Seunghoon Han  http://orcid.org/0000-0002-9976-5120 References   1.,Non-OADS,/arxiv_data1/oa_pdf/0d/11/ic-48-254.PMC5048013.pdf
"3081 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/ea/btw199.PMC5048061.pdf
Availability and Implementation: The RTCR pipeline is implemented in Python (v2.7) and C and is freely available at http://uubram.github.io/RTCR/along with documentation and examples of typical usage.,OADS,/arxiv_data1/oa_pdf/99/dc/btw339.PMC5048062.pdf
"3098 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/dc/btw339.PMC5048062.pdf
Availability and implementation : Software: http://www.nd.edu/~cone/LNA_GNA Contact : tmilenko@nd.edu Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/79/3c/btw348.PMC5048063.pdf
"3155 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/3c/btw348.PMC5048063.pdf
3.6 User-friendly GUI plus source code We make publicly available our software for NA evaluation (http://www.nd.edu/~cone/LNA_GNA).,OADS,/arxiv_data1/oa_pdf/79/3c/btw348.PMC5048063.pdf
"3190 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/b1/btw368.PMC5048066.pdf
Availability and Implementation: The GPM (with LIMS) package is available at https://github.com/ Jianwei-Zhang/LIMS Contacts: jzhang@mail.hzau.edu.cn or rwing@mail.arizona.edu Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/8a/07/btw370.PMC5048067.pdf
"3058 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/07/btw370.PMC5048067.pdf
", 2013 ), or Falcon (https://github.com/PacificBiosciences/FALCON-integrate).",Non-OADS,/arxiv_data1/oa_pdf/8a/07/btw370.PMC5048067.pdf
"3193 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/4e/btw378.PMC5048069.pdf
Availability and Implementation: ABAEnrichment was implemented as an R package and is avail- able under GPL ( /C212) from the Bioconductor website (http://bioconductor.org/packages/3.3/bioc/ html/ABAEnrichment.html).,OADS,/arxiv_data1/oa_pdf/a1/9e/btw392.PMC5048072.pdf
"Brain Explorer, http://human.brain-map.org/static/brainexplorer) allow for the statistical evaluation ofgene candidates in terms of expression enrichment in specific regionsor stages using an ontology.",Non-OADS,/arxiv_data1/oa_pdf/a1/9e/btw392.PMC5048072.pdf
"3201 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/9e/btw392.PMC5048072.pdf
Theinput expression datasets were provided by the Allen Brain Atlasand the processed data are available via our data packageABAData (http://bioconductor.org/packages/3.2/data/experiment/html/ABAData.html).,OADS,/arxiv_data1/oa_pdf/a1/9e/btw392.PMC5048072.pdf
The full functionality of our package is described in our Bioconductor R vignette: https://bioconductor.org/packages/release/bioc/vignettes/ABAEnrichment/inst/doc/ABAEnrichment.html3 Evaluation To determine whether our approach accurately identifies genesthat have previously been reported to show enrichment in differentbrain regions we tested the software on two datasets ( Cahoy et al.,OADS,/arxiv_data1/oa_pdf/a1/9e/btw392.PMC5048072.pdf
"Corrigendum A statistical method for the detection of variants from next-generation resequencing of DNA pools Vikas Bansal Bioinformatics (2010) 26(12), i318–i324 doi: 10.1093/bioinformatics/btq214 Corrigendum A probabilistic method for the detection and genotyping of small indels from population-scale sequence data Vikas Bansal and Ondrej Libiger Bioinformatics , (2011) 27(15), 2047–2053 doi: 10.1093/bioinformatics/btr344 Vikas Bansal, author and co-author of the above articles, wishes to alert readers to the following availability links, as the links given in the published papers are no longer active: ForA statistical method for the detection of variants from next-generation resequencing of DNA pools implementation of this method is available at: https://sites.google.com/site/vibansal/software/crisp ForA probabilistic method for the detection and genotyping of small indels from population-scale sequence data a program implementing this method is available at: https://sites.google.com/site/vibansal/software/picall The author also wishes to notify readers that the email address listed in these articles (vbansal@scripps.edu) is no longer working.",Non-OADS,/arxiv_data1/oa_pdf/ea/4b/btw520.PMC5048073.pdf
"3213 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/4b/btw520.PMC5048073.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/b2/main.PMC5048076.pdf
Subcutaneous  enoxaparin  40  mg  twice  daily  was http://dx.doi.org/10.1016/j.ijscr.2016.09.034 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/80/b2/main.PMC5048076.pdf
"[9]  ARUP Laboratories Laboratory  Test  Directory  Heparin  Anti-Xa,  Low  Molecular Weight Heparin,  2016,  http://ltd.aruplab.com/Tests/Pub/0030144 .",Non-OADS,/arxiv_data1/oa_pdf/80/b2/main.PMC5048076.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/93/main.PMC5048077.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/93/main.PMC5048077.pdf
http://dx.doi.org/10.1016/j.eucr.2016.08.012Urology Case Reports 9 (2016) 48 e50,Non-OADS,/arxiv_data1/oa_pdf/92/93/main.PMC5048077.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/4f/main.PMC5048078.pdf
Urine  culture  grew http://dx.doi.org/10.1016/j.ijscr.2016.09.009 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/94/4f/main.PMC5048078.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/6a/main.PMC5048079.pdf
"According  to  El-Sergany  et  al.,  the  higher  percentage of  intussusception  in  adults  −  65%  −  occurs  due  to  malignant  or http://dx.doi.org/10.1016/j.ijscr.2016.09.006 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/c6/6a/main.PMC5048079.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cerebrovascular reactivityBOLD MRITransfer function analysisSickle cell diseaseHypercapnia Temporal lag 1.,Non-OADS,/arxiv_data1/oa_pdf/18/d8/main.PMC5048082.pdf
http://dx.doi.org/10.1016/j.nicl.2016.09.0092213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/18/d8/main.PMC5048082.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/d8/main.PMC5048082.pdf
http://dx.doi.org/10.1016/j.nicl.2016.09.010 2213-1582/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/e1/a4/main.PMC5048084.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/a4/main.PMC5048084.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/a6/main.PMC5048086.pdf
The  patient  received ﬂuid  resuscitation  with  no  improvement  and  was  moved  to  the http://dx.doi.org/10.1016/j.ijscr.2016.08.040 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/de/a6/main.PMC5048086.pdf
"[3]  Organization  WH,  Global  Status  Report  on  Road  Safety  2009,  World  Health Organization  [Internet],  Geneva  (CH),  2009,  Available  from:  http://www.who.",Non-OADS,/arxiv_data1/oa_pdf/de/a6/main.PMC5048086.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d3/e8/main.PMC5048103.pdf
http://dx.doi.org/10.1016/j.idcr.2016.09.005 2214-2509/ ã  2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/d3/e8/main.PMC5048103.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  6  (2016)  55–57 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/d3/e8/main.PMC5048103.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/12/main.PMC5048109.pdf
http://dx.doi.org/10.1016/j.idcr.2016.09.007 2214-2509/ ã  2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/88/12/main.PMC5048109.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  6  (2016)  52–54 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locat  e/idcr,Non-OADS,/arxiv_data1/oa_pdf/88/12/main.PMC5048109.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Diffusion tensor imaging Graph theoretical analysis Left hemispherePediatric hydrocephalusSmall-worldnessNeuroImage: Clinical 12 (2016) 631 –639 Abbreviations: DTI, diffusion tensor imaging; ROI, region of interest.",Non-OADS,/arxiv_data1/oa_pdf/de/38/main.PMC5048110.pdf
http://dx.doi.org/10.1016/j.nicl.2016.09.0032213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/de/38/main.PMC5048110.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/38/main.PMC5048110.pdf
"In subjects' native space, left brain WM ﬁber tracking was conducted using Diffusion Toolkit/TrackVis ( Wang et al., 2007 ;http://trackvis.org/ dtk/).",OADS,/arxiv_data1/oa_pdf/de/38/main.PMC5048110.pdf
"Rapamycin and its analogs have been http://dx.doi.org/10.1016/j.redox.2016.09.006 Received 21 August 2016; Received in revised form 10 September 2016; Accepted 14 September 2016⁎Corresponding author at: Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.",Non-OADS,/arxiv_data1/oa_pdf/2a/06/main.PMC5048112.pdf
This is an open access article under the  CC BY-NC-ND license (http://creativecommons.org/licenses/by/4.0/).Available online 21 September 2016 crossmark,Non-OADS,/arxiv_data1/oa_pdf/2a/06/main.PMC5048112.pdf
"Decompression stops were 1 min at the depth  of 15 m, 7 min at 12 m, 10 min at 9 m, 23 min at 6 m  and 47 min at 3 m, according to US Navy  decompression tables ( http://www.usu.edu/scuba   /navy_manual6.pdf).",OADS,/arxiv_data1/oa_pdf/0a/6e/IJBMS-19-821.PMC5048116.pdf
"Databases which are used  in this study are:     NCBI (http://www.ncbi.nlm.nih.gov), Ensembl Genome   Browser  (http:/ /www.ensembl.org/index.html ),  human genome mutation database (HGMD)  (http://www.hgmd.cf.ac.uk/ac/index.php) (7) and  human genome variation society (HGVS) guidlines in  order to nomenclature of the new identified variant  (http://www.hgvs.org/ ).",OADS,/arxiv_data1/oa_pdf/71/0f/IJBMS-19-858.PMC5048121.pdf
"There are some investig ations suggesting that  sequencing analysis of exons 73 -75 of COL7A1 gene is  able to detect approximately 75% of causative  mutations in patients who are suspicious of  DDEB (6,  9) (http://www.ncbi.nlm.nih.gov/books/NBK1304/)  and al so 95% of cases on the condition of exact  diagnosis of  DEB (10).",Non-OADS,/arxiv_data1/oa_pdf/71/0f/IJBMS-19-858.PMC5048121.pdf
National  Cancer Institute http://www.cancer.gov/cancertopics/ -  treatment/drugs/fda -temozolomide .,Non-OADS,/arxiv_data1/oa_pdf/74/7a/IJBMS-19-890.PMC5048126.pdf
Reaction-specific efficiencies were deducedusing LinRegPCR 7.4 (http://LinRegPCR.nl).,OADS,/arxiv_data1/oa_pdf/93/b2/EMBJ-35-2068.PMC5048351.pdf
e-mail: masa97oikawa@yahoo.co.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/c0/93/jes-27-081.PMC5048355.pdf
"MAEDA, M. HANADA AND M. OIKAWA 92 the interaction between horse injury and racetrack surface,  and on research of the composition, construction, and main-tenance of arenas and racing tracks, readers are referred to the recent reviews “Racing Surfaces White paper 2011” (http://grayson-jockeyclub.org/resources/White_Paper_final.pdf), “Equine Surfaces White Paper 2016” (http://www.fei.org/system/files/Equine%20Surfaces%20White%20Paper.pdf), “Modeling equine race surface vertical mechanical behav - iors in a musculoskeletal modeling environment” (2015.",Non-OADS,/arxiv_data1/oa_pdf/c0/93/jes-27-081.PMC5048355.pdf
"https://www.researchgate.net/publication/237804990_ StrathAyr_Horse_Health_Discussion_Document (accessed on 25 April, 2015).",Non-OADS,/arxiv_data1/oa_pdf/c0/93/jes-27-081.PMC5048355.pdf
"http://ojs.sagepub.com (accessed on  25 April, 2015).",Non-OADS,/arxiv_data1/oa_pdf/c0/93/jes-27-081.PMC5048355.pdf
©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/94/a7/jes-27-099.PMC5048356.pdf
e-mail: ttozaki@lrc.or.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/a7/4f/jes-27-107.PMC5048357.pdf
e-mail: kyamada@azabu-u.ac.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/88/77/jes-27-115.PMC5048358.pdf
e-mail: naoki@obihiro.ac.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/4f/5e/jes-27-119.PMC5048359.pdf
e-mail: Kanichi_Kusano@jra.go.jp ©2016 Japanese Society of Equine Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/72/49/jes-27-125.PMC5048360.pdf
from AD (https://www.cms.gov/medicare-coverage-data- base/details/ncd-details.aspx?NCDId=288&ncdver=3&bc= BAABAAAAAAAA&).,OADS,/arxiv_data1/oa_pdf/8d/fd/ACN3-3-740.PMC5048385.pdf
"WMH were automatically seg-mented for each participant using a support vectormachine classiﬁer using T 1-weighted MPRAGE and T 2- weighted FLAIR information (WMLS, SBIA [Section ofBiomedical Image Analysis], University of Pennsylvania).The total WMH volume for each participant was normal-ized by the corresponding intracranial volume (ICV) gener- ated by FreeSurfer (http://surfer.nmr.mgh.harvard.edu) based on the averaged raw T 1-weighted MPRAGE data.",OADS,/arxiv_data1/oa_pdf/96/c1/ACN3-3-791.PMC5048389.pdf
Gray matter was automatically segmented for eachparticipant using FreeSurfer (http://surfer.nmr.mgh.har-vard.edu) and the total gray matter volume also was nor-malized by the corresponding ICV generated by FreeSurfer.,OADS,/arxiv_data1/oa_pdf/96/c1/ACN3-3-791.PMC5048389.pdf
Available at: https://www.nei.nih.gov/sites/ default/ﬁles/nei-pdf/manual_cm2000.pdf (accessed March 2016).,OADS,/arxiv_data1/oa_pdf/e5/84/ACN3-3-801.PMC5048390.pdf
Available at: http://www.brainline.org/content/2013/08/new-tbi- screening-tool.html (accessed March 2016).,Non-OADS,/arxiv_data1/oa_pdf/e5/84/ACN3-3-801.PMC5048390.pdf
"The validation phase of RT-QuIC was carried out on CSF samples (20 PD, 15 controls, and 3 at-risk) obtainedfrom the Oxford Discovery cohort (http://opdc.medsci.ox.ac.uk) which is one of the largest, clinically best-characterized longitudinal PD cohorts to date.",OADS,/arxiv_data1/oa_pdf/99/87/ACN3-3-812.PMC5048391.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/a6/main.PMC5048617.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.09.025 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/18/a6/main.PMC5048617.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/ba/main.PMC5048619.pdf
She  presented http://dx.doi.org/10.1016/j.ijscr.2016.09.027 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/29/ba/main.PMC5048619.pdf
"Care guidelines statement The  authors  declare  this  case  report  is  compliant  with  the  CARE Guidelines,  available  at:  http://www.care-statement.org/ .",Non-OADS,/arxiv_data1/oa_pdf/29/ba/main.PMC5048619.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Whole genome sequencingDermabacter vaginalisVaginal ﬂuid Speci ﬁcations Organism/cell line/tissue Dermabacter vaginalis Strain AD1-86 T Sequencer or array type PacBio RS IIData format AnalyzedExperimental factors Microbial strainExperimental features Whole genome analysis and gene annotation of AD1-86 T Consent N/A Sample source location Vagina 1.,Non-OADS,/arxiv_data1/oa_pdf/d9/2c/main.PMC5048620.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/nuccore/NZ_CP012117 2.,OADS,/arxiv_data1/oa_pdf/d9/2c/main.PMC5048620.pdf
http://dx.doi.org/10.1016/j.gdata.2016.09.011 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/2c/main.PMC5048620.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/2c/main.PMC5048620.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/63/c3/main.PMC5048622.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.09.040 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/c3/main.PMC5048622.pdf
"32  (2006)  320–323,  http://dx.doi.org/10.1111/j.1524- 4725.2006.32062.x .",Non-OADS,/arxiv_data1/oa_pdf/63/c3/main.PMC5048622.pdf
"[5]  Takeno,  et  al.,  Basal  cell  carcinoma  of  the  nipple  in  male  patients  with  gastric cancer  recurrence:  report  of  a  case,  Breast  Cancer  21  (1)  (2014)  102–107, http://dx.doi.org/10.1007/s12282-010-0217-6 (Epub  2010  Aug  11).",Non-OADS,/arxiv_data1/oa_pdf/63/c3/main.PMC5048622.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/83/main.PMC5048624.pdf
"Exploring  the  abdomen,  the  gallbladder  was http://dx.doi.org/10.1016/j.ijscr.2016.09.004 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/53/83/main.PMC5048624.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/16/main.PMC5048627.pdf
"Consent Not applicable Sample source locationMünster, Germany Deposited data can be found here: http://www.ncbi.nlm.nih.gov/geo/ query/acc.cgi?acc=GSE67154 .",OADS,/arxiv_data1/oa_pdf/7d/16/main.PMC5048627.pdf
http://dx.doi.org/10.1016/j.gdata.2016.09.007 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/16/main.PMC5048627.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/16/main.PMC5048627.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/e6/main.PMC5048628.pdf
The  patient http://dx.doi.org/10.1016/j.ijscr.2016.09.039 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/00/e6/main.PMC5048628.pdf
"Sao Paulo 2016;58:59 http://dx.doi.org/10.1590/S1678-9946201658059 ORIGINAL ARTICLE DIAGNOSTIC PERFORMANCE EVALUATION OF THE SD BIOLINE MALARIA ANTIGEN AG PF/PAN  TEST (05FK60) IN A MALARIA ENDEMIC AREA OF SOUTHERN ETHIOPIA Endale TADESSE(1), Bereket WORKALEMAHU(2) & Techalew SHIMELIS(1) SUMMARY  Rapid  diagnostic tests (RDTs) capable of detecting and differentiating Plasmodium  species are needed in areas in which microscopy  is unsuitable.",Non-OADS,/arxiv_data1/oa_pdf/33/22/1678-9946-rimtsp-58-00059.PMC5048630.pdf
"Sao Paulo 2016;58:60 http://dx.doi.org/10.1590/S1678-9946201658060 ORIGINAL ARTICLE COMPARISON OF METHODS TO IDENTIFY Neisseria meningitidis  IN ASYMPTOMATIC CARRIERS Camila F. RI ZEK(1), André Machado LUIZ(2), Gracilene Ramos de ASSIS(1), Silvia Figueiredo COSTA(1), Anna Sara LEVIN(1) & Marta Heloisa LOPES(2) SUMMARY  Neisseria meningitidis  is a cause of several life-threatening diseases and can be a normal commensal in the upper respiratory  tract of healthy carriers.",Non-OADS,/arxiv_data1/oa_pdf/af/b3/1678-9946-rimtsp-58-00060.PMC5048631.pdf
Genetic sequences were compared with the BLAST  database available on http://www.ncbi.nlm.nih.gov/blast/.,OADS,/arxiv_data1/oa_pdf/af/b3/1678-9946-rimtsp-58-00060.PMC5048631.pdf
"Sao Paulo 2016;58:61 http://dx.doi.org/10.1590/S1678-9946201658061 ORIGINAL ARTICLE Trichomonas vaginalis  PREVALENCE AND RISK FACTORS FOR WOMEN IN SOUTHERN BRAZIL Cíntia Lima AMBROZIO(1), Andréia Saggin NAGEL(1), Sabrina JESKE(1), Guilherme Cassão Marques BRAGANÇA(2),   Sibele BORSUK(3) & Marcos Marreiro VILLELA(1) SUMMARY Trichomonas vaginalis  infections have been associated with other diseases so that epidemiological studies of the parasite are  important and help to prevent the spread of the disease.",Non-OADS,/arxiv_data1/oa_pdf/f9/54/1678-9946-rimtsp-58-00061.PMC5048632.pdf
Sao Paulo 2016;58:62 http://dx.doi.org/10.1590/S1678-9946201658062 ORIGINAL ARTICLE FREQUENCY OF ANTI- Toxocara spp.,Non-OADS,/arxiv_data1/oa_pdf/8f/e7/1678-9946-rimtsp-58-00062.PMC5048633.pdf
Odds ratios (OR) and 95% confidence intervals (CI) were calculated with  the free software “VassarStat available at http://vassarstats.net/textbook/ index.html .,OADS,/arxiv_data1/oa_pdf/8f/e7/1678-9946-rimtsp-58-00062.PMC5048633.pdf
Available from: http://www.ine.cl/cd2002/sintesiscensal.pdf  30.,Non-OADS,/arxiv_data1/oa_pdf/8f/e7/1678-9946-rimtsp-58-00062.PMC5048633.pdf
"Sao Paulo 2016;58:63 http://dx.doi.org/10.1590/S1678-9946201658063 ORIGINAL ARTICLE DIAGNOSIS OF Strongyloides stercoralis  INFECTION IN IMMUNOCOMPROMISED PATIENTS BY  SEROLOGICAL AND MOLECULAR METHODS Fabiana Martins de PAULA(1,2), Fernanda Mello MALTA(1,3), Marcelo Andreetta CORRAL(2), Priscilla Duarte MARQUES(1,2), Maiara GOTTARDI(2),   Dirce Mary Correia Lima MEISEL(2), Juliana YAMASHIRO(2), João Renato Rebello PINHO(1,3), Vera Lucia Pagliusi CASTILHO(4),   Elenice Messias do Nascimento GONÇALVES(4), Ronaldo César Borges GRYSCHEK(1,2) & Pedro Paulo CHIEFFI(1,5) SUMMARY Strongyloidiasis is a potentially serious infection in immunocompromised patients.",Non-OADS,/arxiv_data1/oa_pdf/9f/60/1678-9946-rimtsp-58-00063.PMC5048634.pdf
"Sao Paulo 2016;58:64 http://dx.doi.org/10.1590/S1678-9946201658064 ORIGINAL ARTICLE COMPARISON OF 16S rRNA-PCR-RFLP, LipL32-PCR AND OmpL1-PCR METHODS   IN THE DIAGNOSIS OF LEPTOSPIROSIS  Tülin GÜVEN GÖKMEN(2), Ayben SOYAL(1), Yıldız KALAYCI(1), Cansu ÖNLEN(1) & Fatih KÖKSAL(1) SUMMARY  Leptospirosis is still one of the most important health problems in developing countries located in humid tropical and subtropical  regions.",Non-OADS,/arxiv_data1/oa_pdf/e7/c4/1678-9946-rimtsp-58-00064.PMC5048635.pdf
Available  from: http://apps.who.int/iris/bitstream/10665/44588/1/9789241501521_eng.pdf  16.,OADS,/arxiv_data1/oa_pdf/e7/c4/1678-9946-rimtsp-58-00064.PMC5048635.pdf
"Sao Paulo 2016;58:65 http://dx.doi.org/10.1590/S1678-9946201658065 ORIGINAL ARTICLE ADVANCED LIVER INJURY IN PATIENTS WITH CHRONIC HEPATITIS B   AND VIRAL LOAD BELOW 2,000 IU/mL Valter Oberdan Borges de OLIVEIRA(1), Juliana Passos Rocha OLIVEIRA(1), Eloy Vianey Carvalho de FRANÇA(1),   Hugo Leite de Farias BRITO(2), Tereza Virgínia NASCIMENTO(1) & Alex FRANÇA(1) SUMMARY Introduction : According to the guidelines, the viral load of 2,000 IU/mL is considered the level to differentiate between inactive  carriers and HBeAg(-) chronic hepatitis B patients.",Non-OADS,/arxiv_data1/oa_pdf/80/a0/1678-9946-rimtsp-58-00065.PMC5048636.pdf
[cited 2016  Mar 29]; Available from: http://www.who.int/mediacentre/factsheets/fs204/en/index.,OADS,/arxiv_data1/oa_pdf/80/a0/1678-9946-rimtsp-58-00065.PMC5048636.pdf
"Sao Paulo 2016;58:66 http://dx.doi.org/10.1590/S1678-9946201658066 ORIGINAL ARTICLE POTENTIAL CROSS-CONTAMINATION OF SIMILAR Giardia duodenalis ASSEMBLAGE IN CHILDREN  AND PET DOGS IN SOUTHERN BRAZIL, AS DETERMINED BY PCR-RFLP Rosiléia Marinho de QUADROS(1), Paulo Henrique Exterchoter WEISS(2)#, Sandra Marcia Tietz MARQUES(3) & Luiz Claudio MILETTI(2) SUMMARY Giardia duodenalis  is an enteric parasite that has distinct genetic groups.",Non-OADS,/arxiv_data1/oa_pdf/5b/bf/1678-9946-rimtsp-58-00066.PMC5048637.pdf
Available from: http://www.R-project.org/  26.,Non-OADS,/arxiv_data1/oa_pdf/5b/bf/1678-9946-rimtsp-58-00066.PMC5048637.pdf
"Sao Paulo 2016;58:67 http://dx.doi.org/10.1590/S1678-9946201658067 ORIGINAL ARTICLE EVOLUTION OF AMERICAN TEGUMENTARY LEISHMANIASIS CASES REPORTED   IN PARANÁ  STATE, BRAZIL Léia Regina de Souza ALCÂNTARA, Izabel Galhardo DEMARCHI & Sandra Mara Alessi ARISTIDES SUMMARY  Leishmaniases are infectious diseases caused by protozoa of the genus Leishmania .",Non-OADS,/arxiv_data1/oa_pdf/58/8a/1678-9946-rimtsp-58-00067.PMC5048638.pdf
[cited 2014 Aug 2]  Available from: http://www2.datasus.gov.br/DATASUS/index.php?area=02  11.,OADS,/arxiv_data1/oa_pdf/58/8a/1678-9946-rimtsp-58-00067.PMC5048638.pdf
Available from: http://www.cisamusep.org.br/  13.,Non-OADS,/arxiv_data1/oa_pdf/58/8a/1678-9946-rimtsp-58-00067.PMC5048638.pdf
Available  from: http://www.ibge.gov.br/estadosat/perfil.php?sigla=pr  14.,Non-OADS,/arxiv_data1/oa_pdf/58/8a/1678-9946-rimtsp-58-00067.PMC5048638.pdf
Available from: http://sinan.saude.gov.br/sinan/login/login.jsf  15.,OADS,/arxiv_data1/oa_pdf/58/8a/1678-9946-rimtsp-58-00067.PMC5048638.pdf
"Sao Paulo 2016;58:68 http://dx.doi.org/10.1590/S1678-9946201658068 ORIGINAL ARTICLE PANCREATIC TOXICITY AS AN ADVERSE EFFECT INDUCED BY MEGLUMINE ANTIMONIATE  THERAPY IN A CLINICAL TRIAL FOR CUTANEOUS LEISHMANIASIS Marcelo Rosandiski LYRA(1), Sonia Regina Lambert PASSOS(2,5), Maria Inês Fernandes PIMENTEL(1), Sandro Javier BEDOYA-PACHECO(1),   Cláudia Maria V ALETE-ROSALINO(1,3,5), Erica Camargo Ferreira V ASCONCELLOS(1), Liliane Fatima ANTONIO(1), Mauricio Naoto SAHEKI(1),   Mariza Mattos SALGUEIRO(1), Ginelza Peres Lima SANTOS(1), Madelon Noato RIBEIRO(1), Fatima CONCEIÇÃO-SILV A(4),   Maria Fatima MADEIRA(1,5), Jorge Luiz Nunes SILV A(1), Aline FAGUNDES(1) & Armando Oliveria SCHUBACH(1,6,7) SUMMARY  American tegumentary leishmaniasis is an infectious disease caused by a protozoan of the genus Leishmania .",Non-OADS,/arxiv_data1/oa_pdf/16/dd/1678-9946-rimtsp-58-00068.PMC5048639.pdf
It was registered on http://clinicaltrials.gov -  Identifier: NCT01301924.,Non-OADS,/arxiv_data1/oa_pdf/16/dd/1678-9946-rimtsp-58-00068.PMC5048639.pdf
"Sao Paulo 2016;58:69 http://dx.doi.org/10.1590/S1678-9946201658069 ORIGINAL ARTICLE ANTIFUNGAL SUSCEPTIBILITY TESTING AND GENOTYPING CHARACTERIZATION OF   Cryptococcus  neoformans  AND gattii ISOLATES FROM HIV-INFECTED PATIENTS OF   RIBEIRÃO PRETO, SÃO PAULO, BRAZIL  Thais Pandini FIGUEIREDO(1,9), Rosymar Coutinho de LUCAS(2,3) Rodrigo Anselmo CAZZANIGA(4), Carolina Nunes FRANÇA(5,6),   Fernando SEGATO(7), Rafael TAGLIALEGNA(8) & Claudia Maria Leite MAFFEI(8) SUMMARY Cryptococcosis is a leading invasive fungal infection in immunocompromised patients .",Non-OADS,/arxiv_data1/oa_pdf/fb/cd/1678-9946-rimtsp-58-00069.PMC5048640.pdf
"Sao Paulo 2016;58:70 http://dx.doi.org/10.1590/S1678-9946201658070 ORIGINAL ARTICLE SEROPREVALENCE AND RISK FACTORS ASSOCIATED WITH Toxoplasma gondii    INFECTION AMONG RURAL COMMUNITIES IN NORTHERN IRAN Ali ROSTAMI(1), Seyyed Javad SEYYEDTABAEI(1), Somayeh AGHAMOLAIE(1), Hamed BEHNIAFAR(1), Zohreh LASJERDI(1),   Alireza ABDOLRASOULI(2,3), Saeed MEHRA V AR(4) & Cosme ALV ARADO-ESQUIVEL(5) SUMMARY Toxoplasmosis is the fourth most common cause of hospitalization and the second cause of death due to food-borne infections.",Non-OADS,/arxiv_data1/oa_pdf/56/53/1678-9946-rimtsp-58-00070.PMC5048641.pdf
"Sao Paulo 2016;58:71 http://dx.doi.org/10.1590/S1678-9946201658071 ORIGINAL ARTICLE STATUS OF THE AMERICAN TEGUMENTARY LEISHMANIASIS IN THE STATE OF RIO DE JANEIRO ,  BRAZIL, FROM 2004 TO 2013 Gilmar Ferreira VITA(1), Maria Angélica Vieira DA COSTA PEREIRA(2), Ildemar FERREIRA(3), Argemiro SANA VRIA(4), Celso Guimarães BARBOSA(5),   Rita de Cássia Martins AURNHEIMER(6), Ericson Ramos de MELLO (3), Claudia Bezerra da SILV A(4) & Rísia Brígida Gonçalves  CABRAL(3)   SUMMARY  The aim of the present study was to analyze the status of the American Tegumentary Leishmaniasis (ATL) in the state of Rio de  Janeiro , from 2004 to 2013, through its spatiotemporal distribution.",Non-OADS,/arxiv_data1/oa_pdf/7b/17/1678-9946-rimtsp-58-00071.PMC5048642.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs375/en/  2.,Non-OADS,/arxiv_data1/oa_pdf/7b/17/1678-9946-rimtsp-58-00071.PMC5048642.pdf
Available from: http://sinan.saude.gov.br/sinan/login/login.jsf  9. d’Utra e Silva O. Sobre a leishmaniose tegumentar e seu tratamento.,Non-OADS,/arxiv_data1/oa_pdf/7b/17/1678-9946-rimtsp-58-00071.PMC5048642.pdf
Available from: http://www.fesp.rj.gov.br/ceep/info_territorios/ divis_politico_administrativo.html  17.,Non-OADS,/arxiv_data1/oa_pdf/7b/17/1678-9946-rimtsp-58-00071.PMC5048642.pdf
Available  from: http://www.ibge.gov.br/estadosat/perfil.php?sigla=rj  18.,OADS,/arxiv_data1/oa_pdf/7b/17/1678-9946-rimtsp-58-00071.PMC5048642.pdf
Available from: http://downloads.ibge.gov.br/downloads_estatisticas.,OADS,/arxiv_data1/oa_pdf/7b/17/1678-9946-rimtsp-58-00071.PMC5048642.pdf
Available from: http://bvsms.saude.gov.br/bvs/publicacoes/ manual_vigilancia_leishmaniose_2ed.pdf  34.,Non-OADS,/arxiv_data1/oa_pdf/7b/17/1678-9946-rimtsp-58-00071.PMC5048642.pdf
Available from: http://www.ibge.gov.br/home/estatistica/populacao/censo2000/ populacao/cor_raca_Censo2000.pdf  46.,Non-OADS,/arxiv_data1/oa_pdf/7b/17/1678-9946-rimtsp-58-00071.PMC5048642.pdf
Available fromt: http://biblioteca.ibge.gov.br/visualizacao/periodicos/94/cd_2010_ religiao_deficiencia.pdf  48.,Non-OADS,/arxiv_data1/oa_pdf/7b/17/1678-9946-rimtsp-58-00071.PMC5048642.pdf
"Sao Paulo 2016;58:72 http://dx.doi.org/10.1590/S1678-9946201658072 BRIEF COMMUNICATION EVALUATION OF CIRCUMSPOROZOITE PROTEIN OF Plasmodium vivax TO ESTIMATE ITS  PREVALENCE IN OIAPOQUE , AMAPÁ  STATE, BRAZIL, BORDERING FRENCH GUIANA Margarete do Socorro Mendonça GOMES(1,2), José Luiz Fernandes VIEIRA(2), Gustavo Capatti CASSIANO(3), Lise MUSSET(4),   Eric LEGRAND(4), Mathieu NACHER(5), Vanja Suely Calvosa D’Almeida COUTO(6), Ricardo Luiz Dantas MACHADO(2,3,7) &   Álvaro Augusto Ribeiro D’Almeida COUTO(2) SUMMARY Malaria is a major health problem for people who live on the border between Brazil and French Guiana.",Non-OADS,/arxiv_data1/oa_pdf/55/40/1678-9946-rimtsp-58-00072.PMC5048643.pdf
"Analyses were performed using the R statistical software, version  2.4.1 (The R Foundation for Statistical Computing, Vienna, Austria  [http://www.r-project.org]).",OADS,/arxiv_data1/oa_pdf/55/40/1678-9946-rimtsp-58-00072.PMC5048643.pdf
Available  from: http://www.who.int/malaria/world_malaria_report_2011/en  2.,Non-OADS,/arxiv_data1/oa_pdf/55/40/1678-9946-rimtsp-58-00072.PMC5048643.pdf
"Sao Paulo 2016;58:73 http://dx.doi.org/10.1590/S1678-9946201658073 BRIEF COMMUNICATION SILVER NANOPARTICLES-DISK DIFFUSION TEST AGAINST Escherichia coli  ISOLATES Franci sco Afrânio CUNHA(1,2), Kamila Rocha MAIA(2), Eduardo José Jucá MALLMAN(1), Maria da Conceição dos Santos Oliveira CUNHA(2),   Antonio Auberson Martins MACIEL(1,2), Ieda Pereira de SOUZA(2), Everardo Albuquerque MENEZES(2) & Pierre Basílio Almeida FECHINE(1) SUMMARY Nanotechnology can be a valuable ally in the treatment of infections.",Non-OADS,/arxiv_data1/oa_pdf/3b/16/1678-9946-rimtsp-58-00073.PMC5048644.pdf
This  is  an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/35/main.PMC5048667.pdf
Dur- ing  the  procedure  the  aneurysm  was  identiﬁed  arising  from  the http://dx.doi.org/10.1016/j.ijscr.2016.09.035 2210-2612/Crown Copyright  ©  2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/af/35/main.PMC5048667.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/45/main.PMC5048694.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.09.042 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/52/45/main.PMC5048694.pdf
"Published with license by Taylor & Francis Group, LLC.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/3.0/ ), which permits unrestricted use, distribu- tion, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
"9, 653 –663 http://dx.doi.org/10.1080/15592294.2016.1205176",Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
"Finally, all the mapped reads were compared to the “Map of the Human Methylome ”build 2 [ http://www.biobix.be/map-of- the-human-methylome/ , BIOBIX (Lab of Bioinformatics and Computational Genomics), University of Ghent, Ghent, Bel-gium 2014], which consists of an in-house developed summaryof all experimentally assessed genomic sites of potential differ-ential methylation [called Methylation Cores (MC)] To identify a candidate set of genomic regions differentially methylated between pN0 and pN COOSCC, all MC located 2,000 bp upstream to 500 bp downstream of the transcriptionstart site (TSS) or in the ﬁrst exon of an Ensemble (v65) gene were statistically compared using R 35with R-package Bayseq.29 The sequencing experiment proved to be underpowered interms of sequencing depth and number of biological replicates,precluding any de ﬁnite conclusions.",OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
The Cancer Genome Atlas data analysis The Cancer Genome Atlas (TCGA) validation was per- formed as reported previously.18Clinical data for all HNSCC patients (n D423) was downloaded from the TCGA data portal ( https://tcga-data.nci.nih.gov/tcga/ )o n April 7th 2013.,OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
"For methylation analysis, level 3 methylation Illumina In ﬁn- ium HumanMethylation450 (450K) data was downloaded for the previously selected oral SCC (OSCC) patients from theTCGA data portal ( https://tcga-data.nci.nih.gov/tcga/ ) on April 7th 2013.",OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
"35 Putative RAB25 -regulating miRNAs were identi ﬁed using the miRDB database ( http://mirdb.org/miRDB/ ) on April 6th 2015 (n D12).36Subsequently, for all miRNAs with available data (n D6), all RNA Seq V2 RSEM (z-score threshold of §2), mutation, and gene copy number data for the miRNA andRAB25 were downloaded from the cBioportal public portal (http://www.cbioportal.org/public-portal/ )33,34on April 17th 2015.",OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Eur J Cancer 2012; 48:783-96; PMID:22051735; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Laryngoscope 2008; 118:1191-4; PMID:18391764; http://dx.doi.org/10.1097/MLG.0b013e31816e2eb7 3.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
"The in ﬂuence of lymph node metastasis in the treatment of squamous cell carcinoma of the oralcavity, oropharynx, larynx, and hypopharynx: N0 versus N C. Laryn- goscope 2005; 115:629-39; PMID:15805872; http://dx.doi.org/ 10.1097/01.mlg.0000161338.54515.b1 4.",Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
2015; Available from: http://seer.cancer.gov/archive/ csr/1975_2012/ 5.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Arch Otolaryngol Head Neck Surg 1989; 115:689-90; PMID:2655666; http://dx.doi.org/10.1001/archotol.1989.01860300043013 6.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
BMC Cancer 2012; 12:236; PMID:22691269; http://dx.doi.org/ 10.1186/1471-2407-12-236 8.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Otolaryngol Head Neck Surg 2009; 141:633-8; PMID:19861203; http://dx.doi.org/10.1016/j.otohns.2009.08.008 9.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Oral Oncol 2012; 48:337-42; PMID:22130455; http://dx.doi.org/10.1016/j.oraloncology.2011.11.007 10.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Nat Rev 2011; 11:726-34;PMID:21941284; http://dx.doi.org/10.1038/nrc3130.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Nat Rev 2012; 13:679-92; PMID:22945394;http://dx.doi.org/10.1038/nrg3270 12.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
"Roossink F, de Jong S, Wisman GB, van der Zee AG, Schuuring E. DNA hypermethylation biomarkers to predict response to cisplatin treatment, radiotherapy or chemoradiation: the present state of art.Cell Oncol (Dordr) 2012; 35:231-41; PMID:22836879; http://dx.doi.org/10.1007/s13402-012-0091-7 13.",Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
HumPathol 2013; 44:1722-9; PMID:23664538; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Mol Cancer 2004; 3:14; PMID:15125777; http://dx.doi.org/10.1186/1476-4598-3-14 15.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Clin Transl Oncol 2013; 16:410-7; PMID:23943562; http://dx.doi.org/10.1007/s12094-013-1098-x 16.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Epigenetics 2015; 10:850-60; PMID:26213212; http://dx.doi.org/10.1080/15592294.2015.1075689 18.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Gene Chromosomes Canc er 2016; 55:45-59; PMID:26391330; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Nat Genet 2005; 37:182-6; PMID:15640797; http://dx.doi.org/10.1038/ng1502 21.,OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
"Cancer Res 2006; 66:2361-6; PMID:16489042;http://dx.doi.org/10.1158/0008-5472.CAN-05-3960 22. van Hooff SR, Leusink FK, Roepman P, Baatenburg de Jong RJ, Speel EJ, van den Brekel MW, van Velthuysen ML, van Diest PJ, van Es RJ,Merkx MA, et al.",Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
J Clin Oncol 2012; 30:4104-10; PMID:23045589; http://dx.doi.org/ 10.1200/JCO.2011.40.4509 23.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Oral Oncol 2013; 49:998-1005; PMID:23953778; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Br J Can- cer 2015; 112:1349-57; PMID:25867270; http://dx.doi.org/10.1038/bjc.2015.99 2 5 .,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Cancer Epidemiol Bio- markers Prev 2009; 18:3000-7; PMID:19843677; http://dx.doi.org/10.1158/1055-9965.EPI-09-0405 26.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
"Int J cancerJournal Int du cancer2012; 130:1861-9; PMID:21796628; http://dx.doi.org/10.1002/ ijc.26326 27. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, et al.",OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Leukemia 2003; 17:2257-317; PMID:14671650; http://dx.doi.org/10.1038/sj.leu.2403202 28.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Genome Biol 2009; 10:R25; PMID:19261174; http://dx.doi.org/ 10.1186/gb-2009-10-3-r25 29.,OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
BMCBioinformatics 2010; 11:422-35; PMID:20698981; http://dx.doi.org/ 10.1186/1471-2105-11-422 30.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Nucleic Acids Res 2014; 42:D191-8; PMID:24253303; http://dx.doi.org/10.1093/nar/gkt1140 31.,OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Nucleic Acids Res 2015; 43(7):e47; PMID:25605792; http://dx.doi.org/10.1093/nar/gkv007 33.,OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Cancer Discov 2012; 2:401-4; PMID:22588877; http://dx.doi.org/10.1158/2159-8290.CD-12-0095 34.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Sci Signal 2013; 6:pl1; PMID:23550210; http://dx.doi.org/10.1126/scisignal.2004088 35.,OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Nucleic Acids Res 2015; 43:D146-52; PMID:25378301; http://dx.doi.org/10.1093/nar/ gku1104 37.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Int J cancer 2006; 118:2957-64; PMID:16395697; http://dx.doi.org/10.1002/ijc.21739 38.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Cancer Res 2012; 72:6024-35; PMID:22991305; http://dx.doi.org/10.1158/0008-5472.CAN-12-1269 39.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Cancer Med 2013; 2:950-63; PMID:24403269; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
J Cell Mol Med 2015; 19:1-10; PMID:25472813; http://dx.doi.org/ 10.1111/jcmm.12403 41.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Bio- chem Soc Trans 2012; 40:1404-8; PMID:23176489; http://dx.doi.org/10.1042/BST20120249 42.,OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Cancer Res 2005; 65:2516- 9; PMID:15805241; http://dx.doi.org/10.1158/0008-5472.CAN-05-0573 43.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Biochem Soc Trans 2012; 40:1398-403;PMID:23176488; http://dx.doi.org/10.1042/BST20120199 44.,OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
NatMed 2004; 10:1251-6; PMID:15502842; http://dx.doi.org/10.1038/ nm1125 45.,OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Carcinogenesis 2013; 34:2401-8; PMID:23722651; http://dx.doi.org/10.1093/carcin/bgt187 46.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Chin J Cancer Res 2013; 25:192-9; PMID:23592900; http://dx.doi.org/10.3978/j.issn.1000-9604.2013.03.01662 M. J.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Tumour Biol 2012; 33:1581-7; PMID:22644676; http://dx.doi.org/10.1007/s13277-012-0412-5 48.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Clin Cancer Res 2013; 19(6):1375-88; PMID:23340300; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Int J Cancer 2010; 126(12):2799-81; PMID:19795443; http://dx.doi.org/10.1002/ijc.24900 50.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
PLoS One 2011; 6:e28503; PMID:22174824; http://dx.doi.org/10.1371/journal.pone.0028503 51.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
N Engl J Med 2008; 358:1148-59; PMID:18337604; http://dx.doi.org/10.1056/NEJMra072067 52.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Nat Rev Oncol 2013;10:256-66; PMID:23546521; http://dx.doi.org/10.1038/ nrclinonc.2013.42 53.,OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Oral Oncol 2014; 50:587-92; PMID:24656975; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Lung Cancer2009; 63:360-7; PMID:18687502; http://dx.doi.org/10.1016/j.lungcan.2008.06.014 55.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
OncolRep 2011; 26:1329-35; PMID:21785829; http://dx.doi.org/10.3892/ or.2011.1401 56.,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
Epigenetics Chromatin 2013; 6:4; PMID:23452981; http://dx.doi.org/10.1186/1756-8935-6-4EPIGENETICS 663,Non-OADS,/arxiv_data1/oa_pdf/2b/e1/kepi-11-09-1205176.PMC5048719.pdf
"9, 699 –707 http://dx.doi.org/10.1080/15592294.2016.1216284",Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Metr 2012 Nov 20; 10(1):22; PMID:23167948; http://dx.doi.org/ 10.1186/1478-7954-10-22 3.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Diabetes Res Clin Pract 2014; 103(2):137-49; PMID:24630390; http://dx.doi.org/10.1016/j.diabres.2013.11.002 5.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Rev Endocr Metab Disord 2014 Dec; 15(4):243-52; http://dx.doi.org/10.1007/s11154-014-9293-9 6.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Endocr Dev 2016; 31:203-20; PMID:26824439; http://dx.doi.org/10.1159/00043941817 7.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
World J Diabetes 2013 Aug 15; 4 (4):114-23; PMID:23961321; http://dx.doi.org/10.4239/wjd.v4.i4.114 8.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
1999 Feb; 42 (2):139-45; PMID:10064092; http://dx.doi.org/10.1007/s001250051131 9.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Nat Rev Genet 2013; 14:204-20; PMID:23400093; http://dx.doi.org/10.1038/nrg3354 10.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Proc Nutr Soc 2016 Feb; 75(1):78-89;PMID:26573376; http://dx.doi.org/10.1017/S0029665115004231 11.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
BMC Med 2010; 8:87; PMID:21176133; http://dx.doi.org/10.1186/1741-7015-8-87 12.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
FASEB J 2011; 25:1378-8; PMID:21209057; http://dx.doi.org/10.1096/fj.10-170365 13.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
FASEB J 2013; 27:2504-12; PMID:23475851; http://dx.doi.org/10.1096/fj.12-215566 14.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Epigenetics 2013 Apr; 8(4):445-54; PMID:23538714; http://dx.doi.org/10.4161/epi.24362 15.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Genome Biol 2014 Apr 1; 15(4):r54;PMID:24690455; http://dx.doi.org/10.1186/gb-2014-15-4-r54 16.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Diabetes Res Clin Pract 2014 Aug; 105(2):141-50; PMID:24798950;http://dx.doi.org/10.1016/j.diabres.2014.04.006 17.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Diabetes 2014; 63:801-7; PMID:24170695; http://dx.doi.org/10.2337/db13-1100 18.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Epigenetics 2013; 8:522-33; PMID:23644594; http://dx.doi.org/10.4161/epi.24506 19.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Hum Mol Genet 2012; 21:371-83; PMID:21994764; http://dx.doi.org/10.1093/hmg/ddr472 20.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
J Clin Endocrinol Metab 2013 Aug; 98(8):3384-93; PMID:23775352;http://dx.doi.org/10.1210/jc.2013-1389 21.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
J Am Soc Hypertens 2016 Mar; 10 (3):205-6; PMID:26767415; http://dx.doi.org/10.1016/j.jash.2015.12.009 22.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Public Health 2016 Apr; 133:3-13; PMID:26774698; http://dx.doi.org/ 10.1016/j.puhe.2015.11.025 23.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Pediatr Obes 2014 Jun; 9(3):e58-62; PMID:24677702; http://dx.doi.org/10.1111/j.2047-6310.2014.218.x 24.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
http://halls.md/bodymass-index/av.htm 25.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Clin Epigenet 2015; 7 (1):12; PMID:25806089; http://dx.doi.org/10.1186/s13148-015-0048-6 26.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Am J Hum Genet 1998 May; 62(5):1198-211;PMID:9545414; http://dx.doi.org/10.1086/301844 2 7 .,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Circulation 2004 Jan 27; 109(3):433-8; PMID:14744958; http://dx.doi.org/10.1161/01.CIR.0000111245.75752.C6 28.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Nutr Metab 2010; 7:26; PMID:20374655; http://dx.doi.org/10.1186/1743-7075-7- 26 29.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Pediatrics 2005; 115(4): e500-3; PMID:15741351; http://dx.doi.org/10.1542/peds.2004-1921 30.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
J Reprod Immunol 2005; 66:175-91;PMID:16029895; http://dx.doi.org/10.1016/j.jri.2005.03.005 33.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
http://www.cdc.gov/nchs/nhanes/nhanes3.htm 35.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Epigenetics 2013; 8(3):333-46; PMID:23422812; http://dx.doi.org/10.4161/epi.24008 36.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Epigenetics 2013; 8(2):203-9; PMID:23314698; http://dx.doi.org/10.4161/epi.23470 37.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
BMC Bioinformatics 2012; 13:59; PMID:22524302; http://dx.doi.org/10.1186/1471-2105-13-59 38.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Adv Genet 2001; 42:151-81; PMID:11037320; http://dx.doi.org/10.1016/S0065-2660(01)42021-9 39.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Genome Biol 2014; 15:R31;PMID:24495553; http://dx.doi.org/10.1186/gb-2014-15-2-r31 40.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
BMC Bioinformatics 2012; 13:86; PMID:22568884; http://dx.doi.org/10.1186/1471-2105-13-86 41.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
PLoS One 2012; 7:e41361; PMID:22848472; http://dx.doi.org/10.1371/journal.pone.0041361 42.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Nat Genet 2007; 39(10):1208-1216;PMID:17873875; http://dx.doi.org/10.1038/ng2119 43.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
J Evol Biol 2005 Sep; 18(5):1368-73; PMID:16135132; http://dx.doi.org/10.1111/j.1420-9101.2005.00917.x 44.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Cell 2015 Jul 16; 162(2):425-40; PMID:26186194; http://dx.doi.org/10.1016/j.cell.2015.06.043 45.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
C ancer Res 2014 Mar 1; 74(5):1390-403; PMID:24590809; http://dx.doi.org/10.1158/0008-5472.CAN-13-1275 46.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Genes Cells 1999 Jun; 4(6):339-51; PMID:10421843; http://dx.doi.org/10.1046/j.1365-2443.1999.00263.x 48.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Biochem J 2014 Aug 15; 462(1):1-13; PMID:25057888; http://dx.doi.org/10.1042/BJ20140712 49.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Growth Factors 2012; 30:207-219;PMID:22574771; http://dx.doi.org/10.3109/08977194.2012.687375 50.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Neuron 2004; 42:983-991; PMID:15207242; http://dx.doi.org/10.1016/j.neuron.2004.06.00451.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
J Endocrinol 2014 Oct; 223(1):T25-35;PMID:25232147; http://dx.doi.org/10.1530/JOE-14-0404 52.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
J Mol Endocrinol 2012 May 29; 49(1):R9-17; PMID:22448029; http://dx.doi.org/10.1530/JME-12-0025 53.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Trends Mol Med 2016 Feb; 22(2):88-98; PMID:26776093; http://dx.doi.org/10.1016/j.molmed.2015.12.001 54.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Horm Behav 2013 Jul; 64(2):187-94; PMID:23998663; http://dx.doi.org/10.1016/j.yhbeh.2013.01.014 55.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Front Physiol 2015 Nov 3; 6:304; PMID:26578976; http://dx.doi.org/10.3389/fphys.2015.00304 56.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Life Sci 2015 Nov 1; 140:4-9; PMID:25744051; http://dx.doi.org/10.1016/j.lfs.2015.02.008 57.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Nature Medicine 2004; 10:739-743; PMID:15208705; http://dx.doi.org/10.1038/nm1071 59.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Cell Metab 2006; 4:123-132; PMID:16890540; http://dx.doi.org/10.1016/j.cmet.2006.06.010 60.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Interleukin-6 and its signalling in atherosclerosis.Thromb Haemost 2009; 102:215-222; PMID:19652871; http://dx.doi.org/10.1160/TH09-05-0297 61.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Am J Hum Genet 2012 Nov 2; 91(5):823-38;PMID:23063622; http://dx.doi.org/10.1016/j.ajhg.2012.08.032 63.,OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
"Zheng YY, Wang LF, Fan XH, Wu CH, Huo N, Lu HY, Xu XY, Wei L. Association of suppressor of cytokine signalling 3 polymorphisms with insulin resistance in patients with chronic hepatitis C. J ViralHepat 2013 Apr; 20(4):273-80; PMID:23490372; http://dx.doi.org/10.1111/j.1365-2893.2012.01644.x 64.",OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
Lancet Diabetes Endocrinol 2015 Jul; 3(7):526-34;PMID:26095709; http://dx.doi.org/10.1016/S2213-8587(15)00127-8 65.,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
ClinEpigenetics 2016 Jan 28; 8:13; PMID:26823690; http://dx.doi.org/10.1186/s13148-016-0177-6EPIGENETICS 707,Non-OADS,/arxiv_data1/oa_pdf/80/a3/kepi-11-09-1216284.PMC5048720.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
"9, 637 –642 http://dx.doi.org/10.1080/15592294.2016.1214783",Non-OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Images from the UCSC genome browser ( http://genome.ucsc.edu/ ) for the 10 kb region surrounding Dube3a inﬂies (A) and 1 Mb surrounding UBE3A in humans (B; note: the SNORD cluster has been truncated).,OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Materials and methods Drosophila stocks Allﬂies were maintained at 25/C14C on a 12-hour light/dark cycle and raised on standard corn meal media (Bloomington StockCenter: http://tinyurl.com/zs5tpbf ).Dube3a 15bis a null LOF allele that produces a truncated transcript that does not makefunctional Dube3a protein.,Non-OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Genome comparisons Genomic regions surrounding Dube3a inDrosophila mela- nogaster were compared to human UBE3A using the UCSC genome browser ( http://genome.ucsc.edu/ ).18We used ﬂy BDGP Release 6 CISO1 MT/dm6 assembly and human GRCh38/hg38 assembly for comparisons.,OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Nat Genet 1997; 15:70-3; PMID:8988171;http://dx.doi.org/10.1038/ng0197-70 2.,Non-OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Epigenomics 2015;7:1213-28; PMID:26585570; http://dx.doi.org/10.2217/epi.15.70 3.,Non-OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Am JMed Genet 1989; 32:285-90; PMID:2564739; http://dx.doi.org/ 10.1002/ajmg.1320320235 4.,OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Nat Genet 1997;17:14-15; PMID:9288088; http://dx.doi.org/10.1038/ng0997-14 5.,Non-OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Hum Mol Genet 2008; 17:111-8; PMID:17940072; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
J Comp Neurol 2014; 522:1874-96; PMID:24254964; http://dx.doi.org/10.1002/cne.23507 8.,Non-OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Philos Trans R Soc Lond B Biol Sci 2013; 368:20110336; PMID:23166397; http://dx.doi.org/ 10.1098/rstb.2011.0336 11.,Non-OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Hum Mol Genet 2006; 15:2825-35; PMID:16905559; http://dx.doi.org/10.1093/hmg/ddl225 12.,OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Proc Natl Acad Sci U S A 2008; 105:12399-404; PMID:18701717; http://dx.doi.org/10.1073/ pnas.0805291105 13.,OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Biol Open 2015; 4:776-82; PMID:25948754; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Dis Model Mech 2016; 9:235-44; PMID:26935102; http://dx.doi.org/10.1242/dmm.023762 16.,OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Nature 2012; 482:173-8; PMID:22318601; http://dx.doi.org/10.1038/nature10811 17.,Non-OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Synapse 2009; 63:1100-21; PMID:19650116; http://dx.doi.org/10.1002/syn.20695 18.,OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Article published online before print in May 2002 ;PMID:12045153; http://dx.doi.org/10.1101/gr.229102.,Non-OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
Sci Rep 2015; 5:9676; PMID:25866192; http://dx.doi.org/10.1038/srep09676 20.,Non-OADS,/arxiv_data1/oa_pdf/cc/60/kepi-11-09-1214783.PMC5048722.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
"9, 674 –689 http://dx.doi.org/10.1080/15592294.2016.1208891",Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
"Disclosure of potential con ﬂicts of interest No potential con ﬂicts of interest were disclosed.Acknowledgments The results published here are in whole or in part based upon data gener- ated by the TCGA Research Network: http://cancergenome.nih.gov/ .W e thank The Genomics, Epigenomics, and Sequencing Core for the array ser-vice.",OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
J Steroid Biochem Mol Biol 2011; 127:27-34; PMID:21605673; http://dx.doi.org/10.1016/j.jsbmb.2011.05.002 2.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
A review of the carcinogenic potential of bisphenol A. Reprod Toxicol 2015; 59:167-82; PMID:26493093; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
EndocrRev 2009; 30:75-95; PMID:19074586; http://dx.doi.org/10.1210/er.2008-0021 4.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Development 2008; 135:541-57; PMID:18171687; http://dx.doi.org/10.1242/dev.010801 5.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Pediatric blood & cancer 2008; 51:349-55; PMID:18465804; http://dx.doi.org/ 10.1002/pbc.21595 6.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Br J Cancer 2008; 98:824-31; PMID:18268498; http://dx.doi.org/10.1038/sj.bjc.6604193 8.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Environ Health Perspect 2005;113:391-5; PMID:15811827; http://dx.doi.org/10.1289/ehp.7534 9.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Endocrinology2016; 157:207-19; PMID:26496021; http://dx.doi.org/10.1210/en.2015-1363 10.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
PloS one 2014; 9:e90332; PMID:24594937; http://dx.doi.org/ 10.1371/journal.pone.0090332 11.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
AmJObstetGynecol 2010; 202:393-7; PMID:20350650; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Environ Sci Technol 2013; 47:12477-85; PMID:23941471; http://dx.doi.org/10.1021/ es402764d 13.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
ReprodToxicol 2008; 25:413-9; PMID:18577445; http://dx.doi.org/10.1016/j.reprotox.2008.05.058 14.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
JPerinatol 2008; 28:258-63;PMID:18273031; http://dx.doi.org/10.1038/sj.jp.7211913 15.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
EnvironHealth Perspect 2009; 117:645-52; PMID:19440506; http://dx.doi.org/10.1289/ehp.0800073 16.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Reprod Toxicol 2007; 24:178-98; PMID:17628395; http://dx.doi.org/10.1016/j.reprotox.2007.05.010 17.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Endocrinology 2011; 152:2150-63; PMID:21427218; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Endocrinology 1998; 139:424-7; PMID:9421443; http://dx.doi.org/10.1210/endo.139.1.5809#sthash.rMzyrNHt.dpuf 1 9 .,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Endocrinology 2014; 155:805-17; PMID:24424067; http://dx.doi.org/10.1210/en.2013-1955 20.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Dose-response 2015; 13:1559325815610582;PMID:26740804; http://dx.doi.org/10.1177/1559325815610582 21.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
J Clin Endocrinol Metab 2002; 87:5185-90; PMID:12414890; http://dx.doi.org/10.1210/ jc.2002-020209 22.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
J Anim Sci 1998; 76:1662-70; PMID:9655587;http://dx.doi.org/10.2527/1998.7661662x 23.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
"Matthews J, Celius T, Halgren R, Zacharewski T. Differential estro- gen receptor binding of estrogenic substances: a species comparison.J Steroid Biochem Mol Biol 2000; 74:223-34; PMID:11162928; http://dx.doi.org/10.1016/S0960-0760(00)00126-6 24.",OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Reprod Toxicol 2004; 19:181-8; PMID:15501383; http://dx.doi.org/10.1016/j.reprotox.2004.08.003 25.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
J Dev Orig Health Dis 2010; 1:365-70; PMID:24795802;http://dx.doi.org/10.1017/S2040174410000577 28.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Birth Defects Res A Clin Mol Teratol 2010; 88:938-44; PMID:20568270; http://dx.doi.org/10.1002/bdra.20685 29.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
J Steroid Biochem Mol Biol 2014; 141:160-70;PMID:24533973; http://dx.doi.org/10.1016/j.jsbmb.2014.02.002 30.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Endocrinology 2015; 156:3984-95; PMID:26248216; http://dx.doi.org/10.1210/en.2015-1067 31.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Chemosphere 2015; 124:54-60; PMID:25434263; http://dx.doi.org/ 10.1016/j.chemosphere.2014.10.071 32.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Endocrinology 2012; 153:42-55; PMID:22109888; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Epigenetics 2015; 10:127-34; PMID:25612011; http://dx.doi.org/10.1080/15592294.2015.1009768 34.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
"Prins GS, Ye SH, Birch L, Ho SM, Kannan K. Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats.Reprod Toxicol 2011; 31:1-9; PMID:20887781; http://dx.doi.org/10.1016/j.reprotox.2010.09.009 35.",Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Aging Male 2002; 5:98-102; PMID:12198740; http://dx.doi.org/10.1080/tam.5.2.98.102 36.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Meth- ods Mol Biol 2007; 402:371-84; PMID:17951806; http://dx.doi.org/ 10.1007/978-1-59745-528-2 38.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Endocrinology 1989; 125:2719-27; PMID:2792005; http://dx.doi.org/10.1210/endo-125-5- 2719 39.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Jama 2005; 293:2095- 101; PMID:15870412; http://dx.doi.org/10.1001/jama.293.17.2095 41.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Ann N Y Acad Sci 2006; 1089:1-13; PMID:17261752; http://dx.doi.org/10.1196/annals.1386.009 42.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Signal transduction pathways in andro- gen-dependent and -independent prostate cancer cell proliferation.Endocrine-related Cancer 2005; 12:119-34; PMID:15788644; http://dx.doi.org/10.1677/erc.1.00835 43.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Int J Cancer 2003; 107:676-80; PMID:14520710; http://dx.doi.org/10.1002/ijc.11471 44.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
International Journal of Cancer 2007; 121 (7):1424-1432; PMID:17551921; http://dx.doi.org/10.1002/ijc.22862 45.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
J Urol 1999; 162:1537-42; PMID:10492251; http://dx.doi.org/10.1016/S0022-5347(05)68354-1 47.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
J Mol Cell Biol 2011; 3:230-8; PMID:21415100; http://dx.doi.org/10.1093/jmcb/mjr002 49.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
PloS one 2013; 8:e53701; PMID:23326489; http://dx.doi.org/ 10.1371/journal.pone.0053701 50.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Gen Dev 2008; 22:3121-34;PMID:19056892; http://dx.doi.org/10.1101/gad.1692808 51.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Cancer Lett 2013; 336:379-89; PMID:23545177; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
FEBS J 2008; 275:5703-13; PMID:18959755; http://dx.doi.org/10.1111/j.1742- 4658.2008.06697.x 53.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
"Int J Oncol 2014; 44:609-15; PMID:24317684; http://dx.doi.org/10.3892/ijo.2013.2200 54. van Duin M, van Marion R, Vissers K, Watson JE, van Weerden WM, Schroder FH, Hop WC, van der Kwast TH, Collins C, vanDekken H. High-resolution array comparative genomic hybridiza-tion of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.",OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Genes Chromosomes Cancer 2005; 44:438-49; PMID:16130124; http://dx.doi.org/10.1002/gcc.20259 55.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Pros- tate 2006; 66:1521-34; PMID:16921506; http://dx.doi.org/10.1002/ pros.20490 57.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
J Pathol 2003; 201:204-12; PMID:14517837; http://dx.doi.org/10.1002/path.144958.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Endocrinology 2015;156:3451-7; PMID:26241068; http://dx.doi.org/10.1210/en.2015-1357 59.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
PloS one 2012; 7:e48455; PMID:23119026; http://dx.doi.org/10.1371/journal.pone.0048455 60.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Neurosci- ence 1995; 68:65-71; PMID:7477936; http://dx.doi.org/10.1016/0306- 4522(95)00141-5 61.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Mol Cell Endocrinol 2012; 355:201-7; PMID:22227557; http://dx.doi.org/10.1016/j.mce.2011.12.012 62.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Cell Death Differ 2010; 17:1511-23; PMID:20203690; http://dx.doi.org/10.1038/ cdd.2010.20 63.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Regul Toxicol Pharmacol 2010; 58:18-24; PMID:20541576; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Endocrinol- ogy 1992; 130:3703-14; PMID:1597166; http://dx.doi.org/10.1210/ en.130.6.3703 65.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Toxicology 2015; 333:168-78; PMID:25929835; http://dx.doi.org/10.1016/j.tox.2015.04.012 66.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Cancer Res 2006; 66:7939-47; PMID:16912168; http://dx.doi.org/10.1158/0008-5472.CAN-06-1888 67.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
PloS one 2010; 5:e13100; PMID:20927350; http://dx.doi.org/10.1371/journal.pone.0013100 68.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Gen Biol 2004; 5:R80; PMID:15461798; http://dx.doi.org/10.1186/gb-2004-5-10-r80 69.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Random set methods iden- tify distinct aspects of the enrichment signal in gene-set analysis.AnnApplStat 2007; 1:85-106; http://dx.doi.org/doi:10.1214/07-AOAS104 70.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
"Bioinformatics 2005; 21:4067-8; PMID:16141249; http://dx.doi.org/10.1093/bioinformatics/bti652 71. van Belkum A, Melles DC, Nouwen J, van Leeuwen WB, van Wamel W, Vos MC, Wertheim HF, Verbrugh HA.",OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Infect Genet Evol 2009; 9:32-47; PMID:19000784; http://dx.doi.org/ 10.1016/j.meegid.2008.09.012 72.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
J Neuropathol Exp Neurol 2011; 70:736-47; PMID:21865882; http://dx.doi.org/10.1097/NEN.0b013e31822830e5 74.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Oncol Rep 2013; 29:507-14; PMID:23135473; http://dx.doi.org/10.3892/or.2012.2126 75.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Bio- chem Biophys Res Commun 2013; 438:493-9; PMID:23916705; http://dx.doi.org/10.1016/j.bbrc.2013.07.108 76.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
EMBO Mol Med 2013; 5:264-79;PMID:23307470; http://dx.doi.org/10.1002/emmm.201201320 77.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
J Cell Biochem 2011; 112:1593-600; PMID:21344486; http://dx.doi.org/10.1002/jcb.23070 78.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
PloS one 2015; 10:e0133238; PMID:26222054; http://dx.doi.org/10.1371/journal.pone.0133238 79.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Reproduction 2009; 138:151- 62; PMID:19419993; http://dx.doi.org/10.1530/REP-08-0510 80.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Mol Med 2008; 14:697-704; PMID:18769639; http://dx.doi.org/10.2119/2008-00072.Gonez 81.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Nature 2014; 511:246-50; PMID:24909994; http://dx.doi.org/10.1038/nature13305 82.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Neuron 2003; 39:749-65; PMID:12948443; http://dx.doi.org/10.1016/S0896-6273(03)00497-5 83.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Biochem Bio- phys Res Commun 2009; 383:157-62; PMID:19268426; http://dx.doi.org/10.1016/j.bbrc.2009.02.156 84.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
BMC Cancer 2015; 15:742;PMID:26482785; http://dx.doi.org/10.1186/s12885-015-1724-9 85.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Evidence that SOX2 overexpression is oncogenic in the lung.PloS one 2010; 5:e11022; PMID:20548776; http://dx.doi.org/10.1371/journal.pone.0011022 86.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
PloS one 2013; 8:e56324; PMID:23424657; http://dx.doi.org/ 10.1371/journal.pone.0056324 87.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Stem cells 2008; 26:903-11; PMID:18238855; http://dx.doi.org/ 10.1634/stemcells.2007-0951 89.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Mol Cell Biol 2011; 31:4593-608; PMID:21930787;http://dx.doi.org/10.1128/MCB.05798-11 90.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Biochem Biophys Res Com-mun 2009; 389:455-60; PMID:19732746; http://dx.doi.org/10.1016/j.bbrc.2009.08.165 91.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
J Cell Sci 2011; 124:4051-63; PMID:22159417; http://dx.doi.org/10.1242/ jcs.088120 92.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Mol Cancer Res 2007;5:133-44; PMID:17314271; http://dx.doi.org/10.1158/1541-7786.MCR-06-0245 93.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Cancer Res 2004; 64:1589-94; PMID:14996714; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Prostate 2011; 71:1568-77; PMID:21360566; http://dx.doi.org/10.1002/pros.21373 95.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Neoplasia 2006; 8:59-68;PMID:16533427; http://dx.doi.org/10.1593/neo.05664 96.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Int J Cancer 2005; 117:1049-54; PMID:15986428; http://dx.doi.org/10.1002/ijc.21250 97.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Mol Cell Endocrinol 2009; 306:75-80; PMID:19041365; http://dx.doi.org/10.1016/j.mce.2008.10.043 98.,OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
J Dental Res 2008; 87:676-81; PMID:18573990; http://dx.doi.org/ 10.1177/154405910808700716 99.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Physiol Genomics 2007; 31:295-305; PMID:17712038;http://dx.doi.org/10.1152/physiolgenomics.00097.2007 100.,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Mol Cell Biol 2005; 25:7657-64; PMID:16107712; http://dx.doi.org/10.1128/ MCB.25.17.7657-7664.2005EPIGENETICS 689,Non-OADS,/arxiv_data1/oa_pdf/3f/28/kepi-11-09-1208891.PMC5048723.pdf
Keywords Vemurafenib; TGF β; pERK; IL-8; MMP-1; Human melanoma; Murine melanoma This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/59/nihms819237.PMC5048745.pdf
"Molly.H.Jenkins@dartmouth.edu, http://dx.doi.org/10.1016/j.matbio.",OADS,/arxiv_data1/oa_pdf/46/59/nihms819237.PMC5048745.pdf
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.matbio.2015.05.007 .,OADS,/arxiv_data1/oa_pdf/46/59/nihms819237.PMC5048745.pdf
"9, e1204507 (7 pages)http://dx.doi.org/10.1080/2162402X.2016.1204507",Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
"The super-computing resource (http://sc.hgc.jp/shirokane.html ) was provided by Human Genome Center, the Institute of Medical Science, The University of Tokyo.",OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
New Engl JMed 2012; 366:2455-65; PMID:22658128; http://dx.doi.org/10.1056/NEJMoa1200694 3.,OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Annu Rev Med 2014;65:185-202; PMID:24188664; http://dx.doi.org/10.1146/annurev-med-092012-112807 4.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
New Engl J Med 2015; 372:320-30; PMID:25399552; http://dx.doi.org/10.1056/ NEJMoa1412082 5.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Oncotarget 2015; 6:3479- 92; PMID:25682878; http://dx.doi.org/10.18632/oncotarget.2980 6.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
J Clin Invest 2014; 124:2246-59; PMID:24667641; http://dx.doi.org/10.1172/ JCI73639 7.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Annu Rev Immunol 2008; 26:677-704; PMID:18173375; http://dx.doi.org/10.1146/annurev.immunol.26.021607.090331 8.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Clin Cancer Res 2014; 20:5064-74;PMID:24714771; http://dx.doi.org/10.1158/1078-0432.CCR-13-3271 9.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Nature 2014;515:568-71; PMID:25428505; http://dx.doi.org/10.1038/nature13954 10.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Cancer 1996; 77:1303-10; PMID:8608507; http://dx.doi.org/10.1002/(SICI)1097-0142(19960401)77:7%3c1303::AID-CNCR12%3e3.0.CO;2-5 12.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
J Clin Invest 1993; 91:1183-90; PMID: 8450047; http://dx.doi.org/10.1172/JCI116278 13.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Immunol Rev 2014; 257:56-71;PMID:24329789; http://dx.doi.org/10.1111/imr.12132 14.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Oncoimmunology 2014; 3:e968467; PMID:25964866; http://dx.doi.org/10.4161/21624011.2014.96846715.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Oncoimmunology 2015; 4:e1030561; PMID:26451311;http://dx.doi.org/10.1080/2162402X.2015.1030561 17.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Bone Marrow Transplant 2015; 50:1227-34;PMID:26052909; http://dx.doi.org/10.1038/bmt.2015.133 18.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Eur Urol Focus 2015; in press; http://dx.doi.org/10.1016/j.euf.2015.09.007 19.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Eur J Cancer 2009; 45:228-47; PMID:19097774; http://dx.doi.org/10.1016/j.ejca.2008.10.026 20.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Nat Immunol 2007; 8:239-45; PMID:17304234; http://dx.doi.org/10.1038/ni1443 21.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Cancer Sci 2016;107:1055-8; PMID:27420474; http://dx.doi.org/10.1111/cas.12961 2 2 .,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Adv Exp Med Biol 2007; 601:123-31; PMID:17712999; http://dx.doi.org/10.1007/978-0-387-72005-0_13 24.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Adv Cancer Res 2005; 93:189-234;PMID:15797448; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Br J Cancer 2014; 111:1391-9; PMID:25093496; http://dx.doi.org/10.1038/bjc.2014.416 27.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
PLoS Pathog 2014; 10:e1004380; PMID:25255144; http://dx.doi.org/10.1371/ journal.ppat.1004380 28.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
Science 2015; 348:124-8; PMID:25765070;http://dx.doi.org/10.1126/science.aaa1348 30.,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
J Immunol Methods 2007; 321:182-95; PMID:17337271;http://dx.doi.org/10.1016/j.jim.2007.01.019ONCOIMMUNOLOGY e1204507-7,Non-OADS,/arxiv_data1/oa_pdf/f1/da/koni-05-09-1204507.PMC5048759.pdf
"9, e1198865 (15 pages)http://dx.doi.org/10.1080/2162402X.2016.1198865",Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Nat Rev Immunol 2008; 8:607- 18; PMID:18641646; http://dx.doi.org/10.1038/nri2368 2.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Immunity 2002; 17:211-20; PMID:12196292; http://dx.doi.org/10.1016/S1074-7613(02)00365-5 3.,OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Nat Immunol 2004; 5:678-84; PMID:15224093; http://dx.doi.org/10.1038/ni1082ONCOIMMUNOLOGY e1198865-13,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Frontiers Immunol 2014; 5:586; PMID:25484884; http://dx.doi.org/10.3389/ ﬁmmu.2014.00586 5.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Nat Rev Immunol 2012; 12:557-69; PMID:22790179;http://dx.doi.org/10.1038/nri3254 6.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Springer Semin Immunopathol 2005; 26:257-71;PMID:15592842; http://dx.doi.org/10.1007/s00281-004-0176-0 7.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Nature 2003; 425:397-402; PMID:14508489; http://dx.doi.org/10.1038/nature01911 8.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Frontiers Immunol 2014; 5:30; PMID:24575091; http://dx.doi.org/10.3389/ ﬁmmu.2014.00030 9.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
PLoS Pathogens 2015; 11:e1004941;PMID:26107264; http://dx.doi.org/10.1371/journal.ppat.1004941 10.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Eur J Immunol 2014; 44:2880-92; PMID:25043392;http://dx.doi.org/10.1002/eji.201444588 11.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
PloS One 2014; 9:e89897; PMID:24587108; http://dx.doi.org/10.1371/ journal.pone.0089897 12.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Eur J Immunol 2013;43:2554-65; PMID:23836147; http://dx.doi.org/10.1002/eji.201343324 13.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Proc Natl Acad Sci U S A 1995; 92:7976-80; PMID:7644523; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
"Guilloux Y, Lucas S, Brichard VG, Van Pel A, Viret C, De Plaen E, Brasseur F, Lethe B, Jotereau F, Boon T. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene.J Exp Med 1996; 183:1173-83; PMID:8642259; http://dx.doi.org/10.1084/jem.183.3.1173 16.",Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Curr Opin Immunol 2012;24:71-6; PMID:22341517; http://dx.doi.org/10.1016/j.coi.2012.01.007 19.,OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
J Immu- nol 2004; 172:1501-7; PMID:14734727; http://dx.doi.org/10.4049/jimmunol.172.3.150121.,OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Diabetes 2012;61:2893-905; PMID:22829452; http://dx.doi.org/10.2337/db12-0006 22.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
J Immunol 2010; 185:6608-16; PMID:21048109; http://dx.doi.org/10.4049/ jimmunol.1001768 2 3 .,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Immunity 2001; 14:471- 81; PMID:11336692; http://dx.do i.org/10.1016/S1074-7613(01)00127-3 24.,OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Immunity 1997;6:613-21; PMID:9175839; http://dx.doi.org/10.1016/S1074-7613(00) 80349-0 25.,OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Nat Cell Biol 2007; 9:654-9;PMID:17486113; http://dx.doi.org/10.1038/ncb1596 29.,OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Nat Med 2001; 7:297-303; PMID:11231627; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
PeerJ 2013; 1:e201; PMID:24255815; http://dx.doi.org/10.7717/peerj.201 32.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Trends Immunol 2011; 32:548-58; PMID:21962745; http://dx.doi.org/10.1016/j.it.2011.08.001 33.,OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
J Exp Med 2001; 193:1189-98; PMID:11369790; http://dx.doi.org/10.1084/jem.193.10.1189 36.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
J Exp Med 2002; 195:353-8; PMID:11828010; http://dx.doi.org/10.1084/jem.20011399e1198865-14 E. DUVALLET ET AL.,OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
J Exp Med1996; 183:1131-40; PMID:8642255; http://dx.doi.org/10.1084/ jem.183.3.1131 38.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
J Exp Med 2000; 191:1617-24; PMID:10790436; http://dx.doi.org/10.1084/jem.191.9.1617 39.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
J Immunol 2005; 175:796-805; PMID:16002676;http://dx.doi.org/10.4049/jimmunol.175.2.796 40.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Science 1995; 267:243-6; PMID:7809629; http://dx.doi.org/10.1126/science.7809629 41.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
J Exp Med 2013; 210:1035-47;PMID:23569327; http://dx.doi.org/10.1084/jem.2012110343.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Nature 2011; 473:337-42; PMID:21593866; http://dx.doi.org/10.1038/nature10098 44.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Cancer Sci 2013; 104:15-21;PMID:23107418; http://dx.doi.org/10.1111/cas.12050 45.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Onco Immunol 2015; 4:e974411;PMID:26137405; http://dx.doi.org/:10.4161/2162402X.2014.974411 46.,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
Virol J 2010; 7:271; PMID:20950422; http://dx.doi.org/10.1186/1743-422X-7-271 48.,OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
PLoS Pathogens 2010; 6:e1001151;PMID:20976201; http://dx.doi.org/10.1371/journal.ppat.1001151ONCOIMMUNOLOGY e1198865-15,Non-OADS,/arxiv_data1/oa_pdf/c9/e0/koni-05-09-1198865.PMC5048765.pdf
"9, e1209615 (7 pages)http://dx.doi.org/10.1080/2162402X.2016.1209615",Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
J Clin Oncol 2015;33:1191-6; PMID:25713437; http://dx.doi.org/10.1200/JCO.2014.56.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
J ClinOncol 2015; 33:1889-94; PMID:25667295; http://dx.doi.org/ 10.1200/JCO.2014.56.2736 3.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
J Clin Oncol 2008; 26:5275-83; PMID:18838703; http://dx.doi.org/10.1200/JCO.2008.17.8954 4.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
Oncologist 2013; 18:733-43;PMID:23774827; http://dx.doi.org/10.1634/theoncologist.2012-0483 5.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
AmSoc Clin Oncol Educ Book 2012; 174-7; PMID:24451730; http://dx.doi.org/10.14694/EdBook_AM.2012.32.174 6.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
Autoimmun Rev 2011; 10:305-10; PMID:21224015; http://dx.doi.org/10.1016/j.autrev.2010.11.009 7.,OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
ClinCancer Res 2009; 15:5591-8; PMID:19671877; http://dx.doi.org/10.1158/1078-0432.CCR-09-1024 8.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
Clin Immunol 2008; 126:121-36;PMID:17916444; http://dx.doi.org/10.1016/j.clim.2007.08.013 10.,OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
Clin Cancer Res 2015; 21:5642-3; PMID:26672088; http://dx.doi.org/10.1158/1078-0432.CCR-15-2471 11.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
Age 2014; 36:9603; PMID:24352567; http://dx.doi.org/ 10.1007/s11357-013-9603-2 12.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
The ISME journal 2015; 10:1456-70;PMID:26613342; http://dx.doi.org/10.1038/ismej.2015.209 13.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
J Immunol 2006; 177:4376-83;PMID:16982872; http://dx.doi.org/10.4049/jimmunol.177.7.4376 14.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
Immunol Rev 2001; 182:190-200; PMID:11722634;http://dx.doi.org/10.1034/j.1600-065X.2001.1820115.x 15.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
J Clin Investig 2006; 116:1935-45;PMID:16778987; http://dx.doi.org/10.1172/JCI27745 16.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
J Exp Med 2013; 210:1695-710;PMID:23897981; http://dx.doi.org/10.1084/jem.20130579 18.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
Dig Dis Sci 2010; 55:1396-405; PMID:19507029; http://dx.doi.org/ 10.1007/s10620-009-0839-8 19.,OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
J Immunol 2005; 175:7746-54; PMID:16301685;http://dx.doi.org/10.4049/jimmunol.175.11.7746 21.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
J Exp Med 1997;185:855-66; PMID:9120391; http://dx.doi.org/10.1084/jem.185.5.855 22.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
J Pathol 2000; 190:184-9; PMID:10657017; http://dx.doi.org/10.1002/(SICI) 1096-9896(200002)190:2%3c184::AID-PATH531%3e3.0.CO;2-E23.,OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
In ﬂamm Bowel Dis 2010; 16:1299-310; PMID:20196149; http://dx.doi.org/10.1002/ibd.21229 25.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
Inﬂamm Bowel Dis 2011; 17:160-70; PMID:20848510; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
Gut 2011; 60:1345-53; PMID:21459928; http://dx.doi.org/10.1136/ gut.2010.217117 27.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
Gastroenterology 2003; 124:1774-85; PMID:12806611; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/5b/koni-05-09-1209615.PMC5048766.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
"9, e1211218 (13 pages)http://dx.doi.org/10.1080/2162402X.2016.1211218",Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
J ClinOncol 2015; 33:540-9; PMID:25154820; http://dx.doi.org/10.1200/JCO.2014.56.2025 4.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
N Eng J Med 2014; 371:1507-17; PMID:25317870; http://dx.doi.org/10.1056/ NEJMoa1407222 5.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Sci Transl Med 2011; 3:95ra73; PMID:21832238; http://dx.doi.org/10.1126/scitranslmed.3002842 6.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Lancet 2015; 385:517-28; PMID:25319501; http://dx.doi.org/ 10.1016/S0140-6736(14)61403-3 7.,OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
N Eng J Med 2013; 368:1509-18; PMID:23527958; http://dx.doi.org/10.1056/NEJMoa1215134 8.,OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Cancer Immunol Immun- other 2015; 64:123-30; PMID:25488419; http://dx.doi.org/10.1007/s00262-014-1641-9 9.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Dis Colon Rectum 1998; 41:747-54; PMID:9645743; http://dx.doi.org/10.1007/BF02236263 10.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
TumourBiol 1988; 9:145-53; PMID:3399813; http://dx.doi.org/10.1159/000217555 11.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
JBiol Chem 1997; 272:27902-7; PMID:9346938; http://dx.doi.org/ 10.1074/jbc.272.44.27902 12.,OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Cancer Met Rev 2013; 32:643-71; PMID:23903773; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Clin Cancer Res 2008; 14:8112-22; PMID:19088026; http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Mol Ther 2011; 19:620-6; PMID:21157437; http://dx.doi.org/10.1038/mt.2010.272 16.,OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Cancer Res 2008; 68:8446-55; PMID:18922918; http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Curr Immunol Rev 2013; 9:190-206; PMID:24790593; http://dx.doi.org/10.2174/ 1573395509666131126231209 18.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Int J Cancer J Int Du Cancer 1997;72:197-202; PMID:9212243; http://dx.doi.org/10.1002/(SICI)1097- 0215(19970703)72:1%3c197::AID-IJC28%3e3.0.CO;2-F 20.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
CD19-targeted chime- ric antigen receptor T-cell therapy for acute lymphoblastic leukemia.Blood 2015; 125:4017-23; PMID:25999455; http://dx.doi.org/10.1182/ blood-2014-12-580068 21.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Trends Neurosci 2002; 25:154-9; PMID:11852148; http://dx.doi.org/10.1016/S0166-2236(00)02088-9 2 2 .,OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Psycho- neuroendocrinol 2015; 51:237-52; PMID:25462897; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Appl Anim Behav Sci 2013; 143:157- 63; PMID:25210211; http://dx.doi.org/10.1016/j.applanim.2012.10.014 24.,OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Mediators Inﬂamm 2014; 2014:736563; PMID:24963216; http://dx.doi.org/ 10.1155/2014/736563 25.,OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Cancer J 2014; 20:119-22; PMID:24667956; http://dx.doi.org/10.1097/PPO.0000000000000035 26.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Mol Ther 2007; 15:825- 33; PMID:17299405; http://dx.doi.org/10.1038/sj.mt.630010428.,OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Mol Ther 2013; 21:904-12; PMID:23423337; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Clin Cancer Res 2015; 21:3149-59; PMID:25850950; http://dx.doi.org/ 10.1158/1078-0432.CCR-14-1421 31.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Blood 2011; 118:6050-6; PMID:21984804; http://dx.doi.org/10.1182/blood-2011-05-354449 32.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
M ol Ther 2009; 18:843-51; PMID:20179677; http://dx.doi.org/10.1038/mt.2010.24 33.,OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Cancer Immunol Res 2015; 3:815-26; PMID:25941351; http://dx.doi.org/10.1158/2326-6066.CIR-15-0054 34.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Nat Med2015; 21:524-9; PMID:25849134; http://dx.doi.org/10.1038/nm.3833 35.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
BMC Cancer 2014;14:30; PMID:24438073; http://dx.doi.org/10.1186/1471-2407-14-30 36.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice.Clin Cancer Res 2012; 18:1672-83; PMID:22291136; http://dx.doi.org/ 10.1158/1078-0432.CCR-11-3050 37.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Mol Ther 2011; 19:760-7; PMID:21326215; http://dx.doi.org/10.1038/mt.2011.9 38.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
J Clin Invest 2010; 120:3953-68; PMID:20978347; http://dx.doi.org/10.1172/JCI43490 39.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Cancer Res 2004; 64:4995-5003; PMID:15256474; http://dx.doi.org/10.1158/0008-5472.CAN-04-0626 40.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
J Immu- nol 2015; 195:755-61; PMID:26188068; http://dx.doi.org/10.4049/ jimmunol.1500751 41.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Mol Ther 2009; 17:1453-64; PMID:19384291; http://dx.doi.org/ 10.1038/mt.2009.83 42.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Tissue Antigens 2009; 74:277-89; PMID:19775368; http://dx.doi.org/10.1111/j.1399- 0039.2009.01336.x 43.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Gastroenterol 2012; 143:1095-107.e2;PMID:22750462; http://dx.doi.org/10.1053/j.gastro.2012.06.037 44.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Gene Ther 2013; 20:177-86; PMID:22378346; http://dx.doi.org/10.1038/gt.2012.21 45.,OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Mol Ther 2004; 9:775-85; PMID:15194045;http://dx.doi.org/10.1016/j.ymthe.2004.03.009 46.,OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Mol Ther 2014; 22:1018-28; PMID: 24686242; http://dx.doi.org/10.1038/mt.2014.41 47.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
J Immunother 2010; 33:697-705; PMID:20664357; http://dx.doi.org/10.1097/CJI.0b013e3181eb826d48.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Mol Ther Nucleic Acids 2012; 1:e63; PMID:23250361; http://dx.doi.org/10.1038/mtna.2012.52 50.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Gene Ther 2012; 19:959-66; PMID:22113316; http://dx.doi.org/10.1038/gt.2011.185 51.,OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Int J Cancer 2011; 129:1126-36; PMID:21710495; http://dx.doi.org/10.1002/ijc.25775 52.,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
Eur J Immunol 2010; 40:787-96; PMID:20017193; http://dx.doi.org/10.1002/eji.200939724ONCOIMMUNOLOGY e1211218-13,Non-OADS,/arxiv_data1/oa_pdf/e9/2b/koni-05-09-1211218.PMC5048773.pdf
"Key words: aviary, laying hen, strain, spatial distribution, litter 2016 Poultry Science 95:2489–2502 http://dx.doi.org/10.3382/ps/pew236 INTRODUCTION The distribution of laying hens within aviary housing environments is influenced by the behavior of the flock as well as by the available physical space and distribu- tion of resources (e.g., the placement of perches, litter areas, nest boxes, solid ledges, feed, and water; Appleby and Hughes, 1991 ; Hansen, 1994 ; Abrahamsson et al., 1996 ; Lentfer et al., 2013 ).",Non-OADS,/arxiv_data1/oa_pdf/ba/74/pew236.PMC5049101.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribu- tion Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/74/pew236.PMC5049101.pdf
http://uepcertified.com/wp- content/uploads/2015/08/2016-UEP-Animal-Welfare- Guidelines-2016-Cage-Free-Edit-002.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ba/74/pew236.PMC5049101.pdf
"Key words: chicken interleukin-7, eukaryotic expression, IBDV, prevention, treatment 2016 Poultry Science 95:2647–2654 http://dx.doi.org/10.3382/ps/pew251 INTRODUCTION Interleukin 7 ( IL-7), an important cytokine derived from thymic stromal cells, was first identified as a pre- B cell growth factor (Namen et al., 1988; Goodwin et al., 1989; Namen et al., 1998) ,w h i c hi se s s e n t i a l for initiating and maintaining activities of immune and hematopoietic systems (Chazen et al., 1989; Schluns and Lefran¸ cois,2003).",Non-OADS,/arxiv_data1/oa_pdf/ac/8a/pew251.PMC5049102.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribu- tion Non-Commercial License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/8a/pew251.PMC5049102.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs311/en/.,Non-OADS,/arxiv_data1/oa_pdf/a3/6d/MNFR-59-2267.PMC5049449.pdf
http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/c3/f9/JCPH-56-316.PMC5049450.pdf
Available at: url: http://sci-dok.sulb.uni-saarland.de/volltexte/2014/5940/.36.,Non-OADS,/arxiv_data1/oa_pdf/31/a7/PROT-83-1887.PMC5049452.pdf
"http://www.hosonline.org/sur-veys/hos/download/Veter-ans_RAND_12_Item_Health_Survey_VR- 12_2007.pdf (accessed November 4, 2014).",Non-OADS,/arxiv_data1/oa_pdf/22/5d/IJCP-69-1517.PMC5049491.pdf
"Declaration of Helsinki: Ethical Principles for Medical Research InvolvingHumans, 2013. http://www.wma.net/en/30publica-tions/10policies/b3/ (accessed 4 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
http://www.phrma.org/principles-and-guideli-nes (accessed 4 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
"List of Corporate Integrity Agreements, 2015. https://oig.hhs.gov/compliance/corporate-integrity-agree-ments/cia-documents.asp.",Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
http://annals.org/article.aspx?articleid=2424869 (accessed 11 August 2015).,Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
"Fair Research Contracting, 2014. http://www.-cohred.org/wp-content/uploads/2014/06/COHRED- FRC-FairResearchContracting1_WEB_EN.pdf (ac- cessed 4 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
2007. http://www.gpo.-gov/fdsys/pkg/PLAW-110publ85/pdf/PLAW-110pub-l85.pdf#page=82 (accessed 4 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
http://www.equator-network.org/reporting-guidelines/(accessed 4 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
"Code of Ethics, 2013. http://www.ismp-p.org/code-of-ethics (accessed 4 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
http://www.nejm.org/doi/full/10.1056/NEJMed010093 (accessed 4 May 2015).,OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
http://www.grassley.senate.gov/sites/de-fault/ﬁles/about/upload/Senator-Grassley-Report.pdf(accessed 4 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
http://www.plosmedicine.org/ar-ticle/info%3Adoi%2F10.1371%2Fjour- nal.pmed.100015 (accessed 4 May 2015).,OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000023 (ac-cessed 4 May 2015).,OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
http://www.plosmedicine.org/article/info%3A- doi%2F10.1371%2Fjournal.pmed.0040286 (accessed4 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
"Recommendations for the Conduct,Reporting, Editing and Publication of ScholarlyWork in Medical Journals, 2014. http://www.icmje.org/recommendations/ (accessed 4 May2015).",Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
http://www.icmje.org/recom- mendations/ (accessed 4 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
http://publicationethics.org/ (accessed 4 May2015).,Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
"ICH Harmonised Tripartite Guideline (E6) Good Clini-cal Practice, 1995. http://www.ich.org/products/guidelines/efﬁcacy/article/efﬁcacy-guidelines.htm-l6_R1_Guideline.pdf (accessed 4 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
"ICH Harmonised tripartite guideline (E3) structure andcontent of clinical study reports, 1999. http://www.ich.org/products/guidelines/efﬁcacy/article/efﬁcacy-guidelines.html (accessed 4 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
"Merck Guidelines for Publication of Clini- cal Trials and Related Works, 2013. http://www.merck.com/research/discovery-and-develop-ment/clinical-development/Merck-Guidelines-for-Publication-of-Clinical-Trials-in-the-Scientiﬁc-Lit-erature.pdf (accessed 4 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
"Guiding Principles for the Development of Policies on Sharing Clinical Trials Data, 2014.http://www.icmje.org/news-and-editorials/princi-ples_data_sharing_jan2014.html (accessed 4 May2015).29 Institutes of Medicine of the National Academies.",Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
"Sharing Clinical Trial Data: Maximizing Beneﬁts,Minimizing Risk, 2015. http://www.iom.edu/Re-ports/2015/Sharing-Clinical-Trial-Data.aspx (ac-cessed 4 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
Effective 1 January 2015. http://www.ema.eu-ropa.eu (accessed 4 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/38/30/IJCP-69-915.PMC5049493.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/41/sbw035.PMC5049524.pdf
Analyses were  performed using R ( http://cran.r-project.org/ ).,OADS,/arxiv_data1/oa_pdf/8d/41/sbw035.PMC5049524.pdf
doi:http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/41/sbw035.PMC5049524.pdf
2008;13:147– 161. doi:http://dx.doi.org/10.1038/sj.mp.4002011.,Non-OADS,/arxiv_data1/oa_pdf/8d/41/sbw035.PMC5049524.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/23/sbw069.PMC5049536.pdf
The graph metrics  used to quantify these properties are explained in detail in  the supplementary material .All topological properties were computed using Graph  Analysis Toolbox (GAT)34 (http://brainlens.org/tools.,OADS,/arxiv_data1/oa_pdf/24/23/sbw069.PMC5049536.pdf
html ) that uses computation algorithms from the Brain  Connectivity Toolbox ( https://sites.google.com/site/bct- net/).,Non-OADS,/arxiv_data1/oa_pdf/24/23/sbw069.PMC5049536.pdf
The connectomes from the 3 groups were visualized  using BrainNet Viewer35 (http://www.nitrc.org/projects/ bnv/).,OADS,/arxiv_data1/oa_pdf/24/23/sbw069.PMC5049536.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/73/sbw124.PMC5049539.pdf
"Spyridon Michopoulos, MD, PhD A ’ Vice-President Hellenic Society of GastroenterologyCharis Tzathas, MD (1954-2016)IN MEMORIAM Received 29 August 2016; accepted 29 August 2016;   published online 6 September 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0087",Non-OADS,/arxiv_data1/oa_pdf/81/7a/AnnGastroenterol-29-389.PMC5049545.pdf
": +30 210 4809000, +30 210 4807077,   e-mail: nikos.gouvas@gmail.com Received 29 June 2015; accepted 10 March 2016;   published online 3 June 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0050SPECIAL ARTICLE Abstract Introduction Factors predisposing to metastases An increased risk of metastases is anticipated in case of:  1) advanced primary disease (advanced T stage, positive  lymph nodes, presence of extramural venous invasion,  poor differentiation) [1-3]; 2) female gender [3]; 3)  location at the rectum [3]; or at left than the right colon [4];  4) increased CD-10 expression [5]; 5) KRAS  and PIK3CA",Non-OADS,/arxiv_data1/oa_pdf/b4/17/AnnGastroenterol-29-390.PMC5049546.pdf
e-mail: helmut.messmann@klinikum-augsburg.de Received 21 March 2016; accepted 17 May 2016;   published online 14 July 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0070,Non-OADS,/arxiv_data1/oa_pdf/70/5a/AnnGastroenterol-29-417.PMC5049547.pdf
": +49 641 985 42751, Fax: +49 641 985 42759,   e-mail: thomas.karrasch@innere.med.uni-giessen.de Received 19 May 2016; accepted 22 July 2016;   published online 6 September 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0077",Non-OADS,/arxiv_data1/oa_pdf/f0/24/AnnGastroenterol-29-424.PMC5049548.pdf
": +30 26510 99639, Fax: +30 26510 07016,  e-mail: dchristodoulou@gmail.com Received 29 January 2016; accepted 26 April 2016;   published online 3 June 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0051",Non-OADS,/arxiv_data1/oa_pdf/ff/9e/AnnGastroenterol-29-439.PMC5049549.pdf
From: http://www.fda.gov/forpatients/approvals/fast/ ucm20041766.htm 5.,Non-OADS,/arxiv_data1/oa_pdf/ff/9e/AnnGastroenterol-29-439.PMC5049549.pdf
http://www.fda.gov/ForPatients/ Approvals/Fast/ucm405447.htm 9.,Non-OADS,/arxiv_data1/oa_pdf/ff/9e/AnnGastroenterol-29-439.PMC5049549.pdf
Available from: http://www.cancernetwork.com/articles/fda- launches-7-initiatives-european-drug-regulators.,Non-OADS,/arxiv_data1/oa_pdf/ff/9e/AnnGastroenterol-29-439.PMC5049549.pdf
Available from:  http://www.fda.gov/BiologicsBloodVaccines/Development  ApprovalProcess/BiologicalApprovalsbyY ear 18.,Non-OADS,/arxiv_data1/oa_pdf/ff/9e/AnnGastroenterol-29-439.PMC5049549.pdf
Available from: http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatory Information/ Guidances/UCM273001.pdf 21.,Non-OADS,/arxiv_data1/oa_pdf/ff/9e/AnnGastroenterol-29-439.PMC5049549.pdf
http://www.medpace.com/Offers/GI_CentralReader/Medpace_ GI_Imaging_IBD_White_paper_May2013.pdf,Non-OADS,/arxiv_data1/oa_pdf/ff/9e/AnnGastroenterol-29-439.PMC5049549.pdf
": +44 0 191 222 8266,   Fax: +44 0 191 222 5066, e-mail: dina.tiniakos@newcastle.ac.uk Received 22 February 2016; accepted 5 May 2016; published online 27  May 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0046Abstract",Non-OADS,/arxiv_data1/oa_pdf/bc/24/AnnGastroenterol-29-445.PMC5049550.pdf
": +81 52 744 2248,   Fax: +81 52 744 1911, e-mail: horitomo@tenriyorozu.jp Received 8 March 2016; accepted 6 June 2016;   published online 8 July 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0069",Non-OADS,/arxiv_data1/oa_pdf/eb/e6/AnnGastroenterol-29-454.PMC5049551.pdf
": +39 02 81841, e-mail: gcarraf@gmail.com Received 16 February 2016; accepted 29 May 2016;   published online 24 June 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0066Abstract",Non-OADS,/arxiv_data1/oa_pdf/82/aa/AnnGastroenterol-29-460.PMC5049552.pdf
": +30 210 7700220, e-mail: fotopoulos.george1@gmail.com Received 9 March 2016; accepted 5 May 2016;   published online 10 June 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0056REVIEW ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/a8/bf/AnnGastroenterol-29-466.PMC5049553.pdf
": +44 1226 730000,   Fax: +44 1226 437215, e-mail: drsaid@doctors.org.uk Received 18 April 2016; accepted 9 May 2016;   published online 10 June 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0058",Non-OADS,/arxiv_data1/oa_pdf/3e/e0/AnnGastroenterol-29-477.PMC5049554.pdf
": +1 252 744 5681, e-mail: harving@ecu.edu Received 11 March 2016; accepted 9 May 2016;   published online 10 June 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0054",Non-OADS,/arxiv_data1/oa_pdf/1a/93/AnnGastroenterol-29-481.PMC5049555.pdf
": +30 26510 07528, Fax: +30 26510 07025,   e-mail: anthitsoumani@yahoo.gr Received 3 March 2016; accepted 5 May 2016;   published online 16 June 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0064",Non-OADS,/arxiv_data1/oa_pdf/54/82/AnnGastroenterol-29-487.PMC5049556.pdf
": +39 06 58446608, Fax: +39 06 58446533,   e-mail: angelozullo66@yahoo.it Received 20 May 2016; accepted 28 June 2016;   published online 21 July 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0073Abstract",Non-OADS,/arxiv_data1/oa_pdf/ea/b1/AnnGastroenterol-29-492.PMC5049557.pdf
http://www.quotidianosanita.it/allegati/allegato1656975.,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/AnnGastroenterol-29-492.PMC5049557.pdf
": +1 412 359 8900,  Fax: +1 412359 8974, e-mail: shail121@gmail.com Received 11 May 2016; accepted 27 July 2016;   published online 6 September 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0079",Non-OADS,/arxiv_data1/oa_pdf/9b/64/AnnGastroenterol-29-497.PMC5049558.pdf
": +1 573 882 1013,   Fax: +1 573 884 4595, e-mail: bechtoldm@health.missouri.edu Received 29 May 2016; accepted 01 July 2016;   published online 28 July 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0075Abstract",Non-OADS,/arxiv_data1/oa_pdf/2e/b1/AnnGastroenterol-29-502.PMC5049559.pdf
Available at: http://seer.cancer.gov/statfacts/html/colorect.html.,Non-OADS,/arxiv_data1/oa_pdf/2e/b1/AnnGastroenterol-29-502.PMC5049559.pdf
http://www.gradeworkinggroup.org/intro.htm#criteria.,Non-OADS,/arxiv_data1/oa_pdf/2e/b1/AnnGastroenterol-29-502.PMC5049559.pdf
"Subjective Global Assessment (SGA) uses clinical criteria Department of Gastroenterology, Government Medical College and  Super Specialty Hospital, Nagpur, Maharashtra, India Conflict of Interest: None Correspondence to: Sudhir Jagdishprasad Gupta, Professor and Head,  Department of Gastroenterology, Government Medical College and  Super Specialty Hospital, Nagpur, Maharashtra, India,   e-mail: sudhirjgupta@gmail.com Received 7 January 2016; accepted 26 March 2016;   published online 20 May 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0049ORIGINAL ARTICLE Abstract",Non-OADS,/arxiv_data1/oa_pdf/46/31/AnnGastroenterol-29-509.PMC5049560.pdf
": +1 559 459 3882,   Fax: +1 559 459 3887, e-mail: patla@fresno.ucsf.edu Received 17 May 2016; accepted 23 June 2016;   published online 21 July 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0072ORIGINAL ARTICLE Abstract",Non-OADS,/arxiv_data1/oa_pdf/5f/6e/AnnGastroenterol-29-515.PMC5049561.pdf
": +30 210 7709948,   Fax: +30 210 7709949, e-mail: georgios.sotiropoulos@uni-due.de Received 1 April 2016; accepted 30 May 2016;   published online 24 June 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0067overconsumption, metabolic disorders and a number of  other causes may lead to hepatopathy and liver cirrhosis, a  potentially precancerous condition, which may be complicated  by the development of HCC [1].",Non-OADS,/arxiv_data1/oa_pdf/cc/66/AnnGastroenterol-29-521.PMC5049562.pdf
": +212 0671195295,   e-mail: youssefmotiaa@gmail.com Received 27 March 2016; accepted 12 June 2016;   published online 14 July 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0071",Non-OADS,/arxiv_data1/oa_pdf/26/9f/AnnGastroenterol-29-530.PMC5049563.pdf
": +1 617 636 6227, Fax: +1 617 636 8538,   e-mail: WSaif@tuftsmedicalcenter.org Received 21 March 2016; accepted 17 May 2016;   published online 16 June 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0065ORIGINAL ARTICLE Abstract",Non-OADS,/arxiv_data1/oa_pdf/1a/aa/AnnGastroenterol-29-536.PMC5049564.pdf
"https://www.nami.org/Learn-More/ Treatment/Mental-Health-Medications/Methylphenidate- Dexmethylphenidate-(Concerta,-Rita).",Non-OADS,/arxiv_data1/oa_pdf/1a/aa/AnnGastroenterol-29-536.PMC5049564.pdf
http://www.consumerreports.org/cro/2012/11/where-high-drug- costs-hide/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/1a/aa/AnnGastroenterol-29-536.PMC5049564.pdf
https://www.uptodate.com/ contents/methylphenidate-drug-information?source=search_res ult&search=methylphenidate&selectedTitle=1%7E105#F195326.54.,Non-OADS,/arxiv_data1/oa_pdf/1a/aa/AnnGastroenterol-29-536.PMC5049564.pdf
"When symptomatic,  esophagogastric fistula can be treated conservatively with  anti-secretory agents or endoscopically with clip application  (either through or over the scope); for non-responding cases  laparoscopic gastroplasty or even open surgery could be an  option [3].Esophagogastric fistula: a rare complication of laparoscopic Nissen  fundoplication Paraskevas Gkolfakisa, John Katsogridakisb, Dimitrios Schizasc, Ioannis S. Papanikolaoua Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens; Gastroenterology  Unit of Athens; Laikon General Hospital, National and Kapodistrian University of Athens, Athens, GreeceIMAGE OF THE MONTH aHepatogastroenterology Unit, Second Department of Internal  Medicine – Propaedeutic, Research Institute and Diabetes Center,  Medical School, National and Kapodistrian University of Athens,  Attikon University General Hospital (Paraskevas Gkolfakis, Ioannis  S. Papanikolaou); bGastroenterology Unit of Athens, Athens (John  Katsogridakis); cFirst Department of Surgery, Laikon General Hospital,  National and Kapodistrian University of Athens (Dimitrios Schizas),  Athens, Greece Conflict of Interest: None Correspondence to: Paraskevas Gkolfakis, MD, Hepatogastroenterology  Unit, 2nd Department of Internal Medicine and Research Unit,  Attikon University General Hospital, Medical School, National and  Kapodistrian University of Athens, Rimini 1, 12462 Athens, Greece,  +30 210 5832089, e-mail: pgkolfakis@med.uoa.com Received 22 May 2016; accepted 10 June 2016;   published online 6 Sepember 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0078Figure 1  Endoscopy images during the first postoperative control.",Non-OADS,/arxiv_data1/oa_pdf/50/5b/AnnGastroenterol-29-544.PMC5049565.pdf
": +30 22510 55557, Fax: +30 22510 42290,  e-mail: mavrogenis@gmail.com Received 10 April 2016; accepted 25 April 2016;   published online 11 May 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0043IMAGE OF THE MONTH Figure 1 (A) Early gastric cancer of the angulus (Paris IIb+IIc, Tis).",Non-OADS,/arxiv_data1/oa_pdf/c8/1a/AnnGastroenterol-29-545.PMC5049566.pdf
": +81 6 6972 1181, Fax: +81 6 6981 4067,   e-mail: uedou-no@mc.pref.osaka.jp Received 9 April 2016; accepted 17 April 2016;   published online 11 May 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0044IMAGE OF THE MONTH Figure 1  (A) A whitish superficial lesion was found on the dental line.",Non-OADS,/arxiv_data1/oa_pdf/0d/67/AnnGastroenterol-29-546.PMC5049567.pdf
": +39 0382433631, Fax: +39 0382576821,   e-mail: guidopoggi64@gmail.com, guido.poggi@grupposandonato.it Received 27 May 2016; accepted 26 May 2016;   published online 24 June 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0068",Non-OADS,/arxiv_data1/oa_pdf/2f/f6/AnnGastroenterol-29-547.PMC5049568.pdf
"The study was performed after at least 6-h  fasting and according to the standard procedure based on CASE REPORT Gastroenterology Unit, Department of Medical and Surgical Sciences,  University of Bologna, Ιtaly Conflict of Interest: None Correspondence to: Dr. Daniele Mandolesi, Department of Medical  and Surgical Sciences, Policlinico S. Orsola,   Via Massarenti 9, 40138 Bologna, Italy, Tel./Fax: +39 0516363376,   e-mail: dani.mandolesi@gmail.com Received 24 March 2016; accepted 19 May 2016;   published online 10 June 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0055",Non-OADS,/arxiv_data1/oa_pdf/35/45/AnnGastroenterol-29-548.PMC5049569.pdf
": + 1 617 636 5627, Fax: +1 617 636 8538,   e-mail: wsaif@tuftsmedicalcenter.org Received 23 March 2016; accepted 12 May 2016:   published online 10 June 2016 DOI: http://dx.doi.org/10.20524/aog.2016.0053",Non-OADS,/arxiv_data1/oa_pdf/46/40/AnnGastroenterol-29-551.PMC5049570.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial reproduction and distribution of the work, in anymedium,providedtheoriginalworkis notalteredor transformedinanyway,andthattheworkis properlycited.Forcommercialre-use, please contact journals.permissions@oup.com1",Non-OADS,/arxiv_data1/oa_pdf/94/d7/fow077.PMC5049586.pdf
"Lexington, MA: Cubist Phar- maceuticals Inc. 2014. http://www.zerbaxa.com/pdf/PrescribingIn- formation.pdf 5.",Non-OADS,/arxiv_data1/oa_pdf/98/6f/JCPH-56-56.PMC5049594.pdf
"Available on http://www.ncbi.nlm.nih.gov/books/ NBK11737/pdf/Bookshelf_NBK11737.pdf (Accessed December 8, 2015).",Non-OADS,/arxiv_data1/oa_pdf/9e/6f/AIPM-14-13.PMC5049597.pdf
"AIDS, TB and Malaria, http://www.afro.",Non-OADS,/arxiv_data1/oa_pdf/d5/31/AIPM-14-21.PMC5049598.pdf
Available from: http://www.norc.org/PDFs/ Walsh%20Center/Oral_Rural%20Evaluation% 20Issue%20Brief-6pg_mm.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c3/2f/AIPM-14-35.PMC5049600.pdf
Available from: http://www.raconline.org/community health/oral-health/1/barriers.,Non-OADS,/arxiv_data1/oa_pdf/c3/2f/AIPM-14-35.PMC5049600.pdf
p.  http://www.ada.org/en/education -caree rs/  careers -in-dentistry/general -dentistry.,Non-OADS,/arxiv_data1/oa_pdf/44/3f/AIPM-14-44.PMC5049602.pdf
Available from: http://pi.lilly.com/us/strattera-pi.pdf (revised 01/2015; cited 2015 Feb 13).14.,Non-OADS,/arxiv_data1/oa_pdf/46/9f/CNS-21-936.PMC5049605.pdf
"For the Span- ish individuals, Spaniards’ growth charts were used as provided at http://www.webpediatrica.com/endocrinoped/antropometria.php.",OADS,/arxiv_data1/oa_pdf/6b/49/HUMU-36-1052.PMC5049609.pdf
"In Silico Prediction on the Mutations and their Effects on 3D Structure The following in silico prediction software programs were used to assist with interpretation of pathogenicity: SIFT (sift.jcvi.org), PolyPhen (genetics.bwh.harvard.edu/pph2), MutationTaster (http://www.mutationtaster.org), MutPred Splice 1056 HUMAN MUTATION, Vol.",OADS,/arxiv_data1/oa_pdf/6b/49/HUMU-36-1052.PMC5049609.pdf
(http://www.interactive- biosoftware.com) and CADD (cadd.gs.washington.edu).,OADS,/arxiv_data1/oa_pdf/6b/49/HUMU-36-1052.PMC5049609.pdf
"Presence or absence of the variants against large control populations was checked: 1000Genomes (http://www.1000genomes.org), the Exome Variant Server (http://evs.gs.washington.edu/EVS), and the Exome Aggregation Consortium (http://exac.broadinstitute.org).",OADS,/arxiv_data1/oa_pdf/6b/49/HUMU-36-1052.PMC5049609.pdf
Evolutionary conservation for human neuroﬁbromin NP000258.1 residues 1730–1815 was evaluated using ClustalW2 (http://www.ebi.ac.uk/T ools/msa/clustalw2).,OADS,/arxiv_data1/oa_pdf/6b/49/HUMU-36-1052.PMC5049609.pdf
"Comparison of Clinical Features in Patients Carrying Missense Mutations Affecting Codon 1809 with Patients Carrying The NF1 P.Met992del Mutation, Patients With LS and Patients with “Classic NF1” Comparison of clinical features of the p.Arg1809 cohort with individuals carrying the NF1 mutation p.Met992del [Upadhyaya et al., 2007], LS [Brems et al., 2012, and references therein and patients with “classic NF1” as previously reported in large scale NF1 patient cohorts [Huson et al., 1988; Huson et al., 1989a; T onsgard et al., 1998; McGaughran et al., 1999; Lin et al., 2000; Khosrotehrani et al., 2005] is summarized in Table 2, with sta- tistical signiﬁcance calculated using two-tailed Fisher’s exact test (http://graphpad.com/quickcalcs/contingency1/).",OADS,/arxiv_data1/oa_pdf/6b/49/HUMU-36-1052.PMC5049609.pdf
"[33] https://www.mzcloud.org/ [34] J. Agraz, A. Grunfeld, D. Li, K. Cunningham, C. Willey, R. Pozos, S. Wagner.",Non-OADS,/arxiv_data1/oa_pdf/b9/fc/RCM-29-1703.PMC5049612.pdf
Guideline on the clinical development ofproducts for speciﬁc immunotherapy for the treatment of allergic diseases; EMEA/ CHMP/EWP/18504/2006 2008 [cited; Avail-able from: http://www.emea.europa.eu/pdfs/human/ewp/1850406enﬁn.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/7d/44/ALL-70-1413.PMC5049613.pdf
Thomson Reuters Systems Biology Solutions: http://lsresearch.thomsonreuters.com/pages/solutions/1/metacore(accessed 15December 2014).,OADS,/arxiv_data1/oa_pdf/3a/97/PATH-237-447.PMC5049620.pdf
The DNAsamples were genotyped according to the GGRS protocol(http://klab.sjtu.edu.cn/GGRS/; Chen et al.,OADS,/arxiv_data1/oa_pdf/b1/a2/AGE-46-697.PMC5049631.pdf
"Among these SNPs, 29 575 (28%; submitted to dbSNP ofGenbank) were novel based on comparisons with a databaseof known SNPs that contained 28 722 391 SNPs, down-loaded from http://hgdownload.soe.ucsc.edu/goldenPath/ susScr3/database/ (updated on March 2, 2014).",OADS,/arxiv_data1/oa_pdf/b1/a2/AGE-46-697.PMC5049631.pdf
"According to the Ensembl pig gene annotation set (Ensembl release 78,ftp://ftp.ensembl.org/pub/release-78/gtf/sus_scrofa/; Fliceket al.",OADS,/arxiv_data1/oa_pdf/b1/a2/AGE-46-697.PMC5049631.pdf
The SNP datacan be downloaded from our website (http://klab.sjtu.e- du.cn/iBLUP/genotype_taihu_pigs.zip).,Non-OADS,/arxiv_data1/oa_pdf/b1/a2/AGE-46-697.PMC5049631.pdf
Available at: http://www.swgdrug.org/Mono-graphs/Ethylone.pdf [7 April 2015 ].,Non-OADS,/arxiv_data1/oa_pdf/15/09/DTA-8-847.PMC5049635.pdf
Available at: http://www.swgdrug.org/approved.htm [7 April 2015 ].,Non-OADS,/arxiv_data1/oa_pdf/15/09/DTA-8-847.PMC5049635.pdf
"https://www.glyxambi.com/ (accessed February 11, 2015).",Non-OADS,/arxiv_data1/oa_pdf/08/ec/IJCP-69-1427.PMC5049636.pdf
"http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Pres cribing+Information/PIs/ Tradjenta/Tradjenta.pdf (accessed 13 March, 2015).",Non-OADS,/arxiv_data1/oa_pdf/08/ec/IJCP-69-1427.PMC5049636.pdf
"https://www.jardiance.com(accessed 13 March, 2015).",Non-OADS,/arxiv_data1/oa_pdf/08/ec/IJCP-69-1427.PMC5049636.pdf
"Proteomics 2015, 15, 3409–3417 Correspondence concerning this and other Viewpoint articles can be accessed on the journals’ home page at: http://viewpoint.proteomics-journal.de Correspondence for posting on these pages is welcome and can also be submitted at this site.",Non-OADS,/arxiv_data1/oa_pdf/78/e5/PMIC-15-3409.PMC5049639.pdf
The NOR-SYS protocol isregistered at http://www.clinicaltrials.gov with theunique identiﬁer NCT01597453.,Non-OADS,/arxiv_data1/oa_pdf/b1/54/ENE-23-154.PMC5049640.pdf
All peptide spectra were submitted to the online MASCOT program (http://www.matrixscience.com) for data searching against the NCBI databases.,OADS,/arxiv_data1/oa_pdf/27/13/PMIC-15-3688.PMC5049642.pdf
"MS/MS spectra of peptides were matched using the Pro- teome Discoverer (Thermo Fisher Scientiﬁc, USA) against the Swiss-Prot database, including subsets Sus scrofa for pork, Bos taurus for beef, Gallus gallus for chicken, and Teleostei for ﬁsh (http://www.uniprot.org/taxonomy/complete- proteomes).",OADS,/arxiv_data1/oa_pdf/27/13/PMIC-15-3688.PMC5049642.pdf
Venn diagrams (http://bioinfogp.cnb.csic.es/tools/venny/index.html) were applied to analyze the similarity of peptides from the four types of meat.,OADS,/arxiv_data1/oa_pdf/27/13/PMIC-15-3688.PMC5049642.pdf
"In general, the pri- mary structures of porcine creatine kinase, glyceraldehyde- 3-phosphate dehydrogenase, and myosin heavy chain were similar, to a great extent, to bovine corresponding parts ac- cording to the alignment information through the Uniprot (http://www.uniprot.org/align/).",Non-OADS,/arxiv_data1/oa_pdf/27/13/PMIC-15-3688.PMC5049642.pdf
http://en.wikipedia.org/wiki/ Sensitivity_and_speci ﬁcity.,Non-OADS,/arxiv_data1/oa_pdf/3b/2c/APT-42-1082.PMC5049645.pdf
website ( http://www.gramene.org /) while insertion/deletion (InDel) markers were designed using the Primer 5.0 andDNAStar 5.0 software after comparison of the sequencesbetween the japonica cultivar Nipponbare and the indicacultivar 9311 in the public databases: RGP ( http://rgp.dna.affrc.,OADS,/arxiv_data1/oa_pdf/61/b5/JIPB-58-12.PMC5049647.pdf
"go.jp/E/toppage.html ), Gramene ( http://gramene.org/ genome_ browser/index.html ) and the Gene Research Center of the Chinese Academy of Sciences ( http://rice.genomics.org.",Non-OADS,/arxiv_data1/oa_pdf/61/b5/JIPB-58-12.PMC5049647.pdf
Accession Numbers Sequence data from this article can be found in GenBankdatabase ( http://www.ncbi.nlm.nih.gov/ ) under the following accession numbers: Genomic DNA of OsCDC48 (KP718614); CDS of OsCDC48 (KP718613).,Non-OADS,/arxiv_data1/oa_pdf/61/b5/JIPB-58-12.PMC5049647.pdf
URL: https://www.nice.org.uk/guidance/ta35/chapter/1-guidance.,Non-OADS,/arxiv_data1/oa_pdf/3b/b5/ART-67-2487.PMC5049649.pdf
Available from: http://www.austlii.edu.au/au/legis/nsw/ consol_act/la2007107/ (accessed May 2015).,Non-OADS,/arxiv_data1/oa_pdf/a2/b4/DAR-35-30.PMC5049651.pdf
Available at: http://www.abs .gov.au/AUSSTATS/abs@.nsf/allprimarymainfeatures/ 8486924370CD6CB2CA2571EF007D51B2?opendocument (accessed June 2015).,Non-OADS,/arxiv_data1/oa_pdf/a2/b4/DAR-35-30.PMC5049651.pdf
Available at: http://www.police.nsw.gov.au/__data/ assets/ﬁle/0019/111277/2006-07_Annual_Report.pdf (accessed August 2014).,OADS,/arxiv_data1/oa_pdf/a2/b4/DAR-35-30.PMC5049651.pdf
Fluorescence intensity was determined usingImageJ software ( http://rsb.info.nih.gov/ij/ ) and the back- ground was subtracted from the readings.,OADS,/arxiv_data1/oa_pdf/44/cc/JIPB-58-29.PMC5049652.pdf
"Study Design This Phase IV trial (https://clinicaltrials.gov/ct2/ show/NCT01604811) was conducted as an interna-tional, prospective, randomised, double-blind study in 2 parallel groups.",Non-OADS,/arxiv_data1/oa_pdf/33/b4/PROS-75-1857.PMC5049653.pdf
http://www.accessdata.fda.gov/ Scripts/cder/Drugs at FDA2.,Non-OADS,/arxiv_data1/oa_pdf/04/c4/JCPH-56-96.PMC5049657.pdf
"ICA Analysis A group-level ICA was performed on the all subjects’ preprocessed fMRI data using the MICA toolbox [Zhanget al., 2010, http://www.nitrc.org/projects/cogicat/].",OADS,/arxiv_data1/oa_pdf/4d/6b/HBM-36-4247.PMC5049658.pdf
"Ingenuity Path- way Analysis (Qiagen http://www.ingenuity.com), lists114 human microRNAs as having experimentally vali-dated target mRNAs, most microRNAs are linked to several mRNA targets.",OADS,/arxiv_data1/oa_pdf/63/ba/LIV-36-334.PMC5049661.pdf
Retrieved from http://www.r-project.org.,Non-OADS,/arxiv_data1/oa_pdf/63/ba/LIV-36-334.PMC5049661.pdf
"[Color ﬁgure can be seen in the online version of this article, available at http://wileyonlinelibrary.com/ journal/ajmgb]702 AMERICAN JOURNAL OF MEDICAL GENETICS PART B",Non-OADS,/arxiv_data1/oa_pdf/0f/bd/AJMG-168-697.PMC5049662.pdf
Available at: http://www.spc.int/images/ publications/ef/Corporate/ef-tahiti-nui -declaration.pdf (accessed September 2014).,Non-OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at: http://www.globalgapa.org/ Regions/Western-Paciﬁc.aspx (accessed July 2014).,Non-OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at: http://www.forumsec .org/pages.cfm/newsroom/documents-publications/forum -communiques/ (accessed July 2014).,Non-OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at: http://www.who.int/chp/steps/manual/ en/ (accessed August 2014).,Non-OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at http://www.who.int/chp/gshs/en/ (accessed September 2014).,OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at: http://nccd.cdc.gov/youthonline/App/ Default.aspx (accessed June 2014).,Non-OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at: http://www.who.int/chp/steps/reports/en/ (accessed April 2014).,OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at: http://www.who.int/chp/steps/reports/en/ (accessed February 2014).,OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at http://www.who.int/chp/steps/ reports/en/ (accessed April 2014).,OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at http://www.who.int/chp/steps/reports/en/ (accessed February 2014).,OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at http://www.who.int/chp/steps/ reports/en (accessed April 2014).,OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at http://www.who.int/chp/steps/reports/en/ (accessed Febru- ary 2014).,OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Avail- able at: http://www.who.int/chp/steps/reports/en/ (accessed April 2014).,Non-OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at http://www.who.int/chp/ steps/reports/en/ (accessed February 2014).,OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available from: http://www.ass.nc/ themes/sante-bucco-dentaire/publications/doc_download/ 630- (accessed July 2014).,Non-OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at http://www.who.int/ chp/steps/reports/en/ (accessed April 2014).,OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Avail- able at: http://www.who.int/chp/steps/reports/en/ (accessed April 2014).,Non-OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at: http://www.who.int/chp/steps/ reports/en/ (accessed April 2014).,OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at: http://www.who .int/chp/steps/reports/en/ (accessed April 2014).,OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at: http://www.spc.int/images/publications/ en/Divisions/Health/en-wallis-futuna_ncd_report.pdf (accessed April 2014).,Non-OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at http://www.who.int/chp/gshs/ factsheets/en/ (accessed June 2014).,OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at: http://www.who.int/chp/gshs/factsheets/en/ (accessed June 2014).,OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at: http://www.who.int/chp/gshs/ factsheets/en/ (accessed June 2014).,OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at: http://www.peaceguam.org/Data/docs/ statistics/EPI_proﬁle%202010_ﬁnaldraft_endorsepage.pdf (accessed January 2015).,Non-OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Available at: http://www.radioaustralia.net.au/international/ radio/onairhighlights/breathalysers-impacting-tongan-drink -driving (accessed September 2014).,Non-OADS,/arxiv_data1/oa_pdf/7f/c7/DAR-35-412.PMC5049666.pdf
Statistical analysis was performed using R and BioConductor software (http://www.bioconductor.org /).,OADS,/arxiv_data1/oa_pdf/b2/97/HEP-62-1160.PMC5049669.pdf
"Data analysis:Riksstroke,the Swedishnational quality registerfor strokecare Riksstroke (http://www.riksstroke.org/eng) is a national quality register for acute stroke, collecting data from all 90 Swedish hospitals.",OADS,/arxiv_data1/oa_pdf/ce/c3/SIM-35-227.PMC5049670.pdf
"Clark Contract grant sponsor: Energy Biosciences InstituteReceived 6 July 2015; Revision received 19 August 2015; Accepted 21 August 2015Accepted manuscript online 24 August 2015; Article ﬁrst published online 10 September 2015 in Wiley Online Library (http://onlinelibrary.wiley.com/doi/10.1002/bit.25809/abstract).DOI 10.1002/bit.25809ARTICLE 330 Biotechnology and Bioengineering, V ol.",Non-OADS,/arxiv_data1/oa_pdf/40/a6/BIT-113-330.PMC5049672.pdf
https://www.cbo.gov/publication/45477.,Non-OADS,/arxiv_data1/oa_pdf/40/a6/BIT-113-330.PMC5049672.pdf
http://www.google.com/patents/ US20140287471.,Non-OADS,/arxiv_data1/oa_pdf/40/a6/BIT-113-330.PMC5049672.pdf
"J Phys Chem B 119(29):9295 –9303 http://dx.doi.org/10.1021/jp509911m Somerville C, Bauer S, Brininstool G, Facette M, Hamann T, Milne J, Osborne E, Paredez A, Persson S, Raab T, V orwerk S, Y oungs H. 2004.",OADS,/arxiv_data1/oa_pdf/40/a6/BIT-113-330.PMC5049672.pdf
Cancer Care and Oncology Services [Online].Available at: http://www.accreditation.,Non-OADS,/arxiv_data1/oa_pdf/f2/b0/ECC-25-616.PMC5049674.pdf
Clinical Practice Guidelines in Oncology (NCCN Guidelines) Distress Management V.2.2013 [Online].Available at: http://www.nccn.org/ professionals/physician_gls/pdf/distress.,Non-OADS,/arxiv_data1/oa_pdf/f2/b0/ECC-25-616.PMC5049674.pdf
"While all the vaccine reports published to date have © SD Dowall, KR Buttigieg, SJD Findlay-Wilson, E Rayner, G Pearson, A Miloszewska, VA Graham, MW Carroll, and R Hewson *Correspondence to: SD Dowall; Email: stuart.dowall@phe.gov.ukSubmitted: 05/27/2015; Revised: 07/08/2015; Accepted: 07/26/2015 http://dx.doi.org/10.1080/21645515.2015.1078045 This is an Open Access article distributed under the terms of the Creative Co mmons Attribution-Non-Commercial License (http://creativecommons.o rg/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work i sp r o p - erly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
"Factsheet No208, 2013; http://www.who.int/mediacentre/fact sheets/fs208/en/ 2.",Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
"Lancet Infect Dis, 2006; 6(4): p:203-14; PMID:16554245; http://dx.doi.org/10.1016/S1473-3099(06)70435-2 3.",Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Antiviral Res 2003; 57(1-2): p:101-11; PMID:12615306; http://dx.doi.org/ 10.1016/S0166-3542(02)00203-6 6.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Jama 1997; 278(5): p:418-24; PMID:9244334; http://dx.doi.org/10.1001/jama.1997.03550050080037 7.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Am J Med Sci 2002; 323(6):p:316-25; PMID:12074486; http://dx.doi.org/ 10.1097/00000441-200206000-00004 8.,OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Scand J Infect Dis 2011; 43(3): p:225-9; PMID:21142621; http://dx.doi.org/10.3109/ 00365548.2010.540036 9.,OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Vaccine 2012; 30(44): p:6225-9; PMID:22902680; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Vaccine 2006; 24(21):p:4657-66; PMID:16174542; http://dx.doi.org/ 10.1016/j.vaccine.2005.08.034 11.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Clin Vaccine Immunol 2011; 18(12): p:2031-7; PMID:22012978; http://dx.doi.org/10.1128/CVI.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
PLoS One 2014; 9(3): p:e91516;PMID:24621656; http://dx.doi.org/10.1371/journal.pone.0091516 13.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Virus Res 2004; 102 (2): p:185-9; PMID:15084400; http://dx.doi.org/10.1016/j.virusres.2003.12.035 15.,OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Vaccine 2011; 29(27): p:4469-75; PMID:21549790; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
J Virol 2012; 86(22): p:12294-303; PMID:22951837; http://dx.doi.org/10.1128/ JVI.01627-12 19.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
J Biol Chem 2011; 286(5): p:3227-34; PMID:21123175; http://dx.doi.org/ 10.1074/jbc.M110.149369 20.,OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
J Virol 2001; 75(6): p:2660-4; PMID:11222689; http://dx.doi.org/10.1128/ JVI.75.6.2660-2664.2001 21.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
PLoS Negl Trop Dis 2011; 5(8): p: e1275; PMID:21858240; http://dx.doi.org/10.1371/ journal.pntd.0001275 22.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Vaccine 2005; 23(46-47): p:5404-10;PMID:16011865; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Hum Vaccin Immunother 2012; 8(4): p:425-30; PMID:22370512; http://dx.doi.org/10.4161/hv.19109 25.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Lancet 1987; 2(8552): p. 186-8; PMID:2885642; http://dx.doi.org/10.1016/ S0140-6736(87)90767-7 26.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Arch Virol 1994;139(1–2): p“23-36; PMID:7826212; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Virology 1992; 189(2): p. 795-9; PMID:1641991; http://dx.doi.org/10.1016/0042-6822(92)90609-S 30.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Curr Gene Ther 2011; 11(3): p:189-217; PMID:21453284; http://dx.doi.org/10.2174/156652311795684731 31.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Curr Opin Immunol 2011; 23(3): p:377-82; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Clin Vaccine Immunol 2010; 17(5): p:793-801; PMID:20357059; http://dx.doi.org/10.1128/CVI.00006-10 33.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
PLoS One 2013; 8(2): p:e55831; PMID:23418465; http://dx.doi.org/10.1371/journal.pone.0055831 34.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Vaccine 2013; 31(39):p:4247-51; PMID:23523407; http://dx.doi.org/ 10.1016/j.vaccine.2013.03.021 35.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
J Immunother 2010; 33(9): p:999-1005; PMID:20948436; http://dx.doi.org/10.1097/CJI.0b013e3181f5dac7 36.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
J Virol 2005; 79 (10): p. 6152-61; PMID:15858000; http://dx.doi.org/ 10.1128/JVI.79.10.6152-6161.2005 38.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
J Virol 2010; 84 (21): p:11089-100; PMID:20739514; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
J Gen Virol 2010;91(Pt 6): p:1473-7; PMID:20164263; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Stem Cells 1999; 17(3): p:138-46; PMID:10342556; http://dx.doi.org/10.1002/stem.170138 42.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
"Interferon- gamma: an overview of signals, mechanisms and functions.J Leukoc Biol 2004; 75(2): p:163-89; PMID:14525967; http://dx.doi.org/10.1189/jlb.0603252 43.",OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Annu Rev Microbiol 2001; 55: p:255-81; PMID:11544356; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
J Immunol 2010; 185(9): p:5405-16; PMID:20870934; http://dx.doi.org/10.4049/jimmunol.100170945.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
J Immunol 2009; 182(8): p:4865- 73; PMID:19342665; http://dx.doi.org/10.4049/ jimmunol.0801974 46.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
J Immunol 2012; 188(1): p:404-16; PMID:22131327; http://dx.doi.org/10.4049/ jimmunol.1102124 47.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Vaccine 2013; 31(33):p:3353-60; PMID:23727003; http://dx.doi.org/ 10.1016/j.vaccine.2013.05.059 48.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
"Ma G, Eschbaumer M, Said A, Hoffmann B, Beer M, Osterrieder N. An equine herpesvirus type 1 (EHV-1) expressing VP2 and VP5 of serotype 8 bluetongue virus (BTV-8) induces protection in a murine infection model.PLoS One 2012; 7(4): p:e34425; PMID:22511939; http://dx.doi.org/10.1371/journal.pone.0034425 49.",Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
J Infect Dis 2009; 199(1): p:39-48;PMID:19012492; http://dx.doi.org/10.1086/595565 50.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
PLoS One 2011; 6(1): p: e16503; PMID:21298069; http://dx.doi.org/10.1371/journal.pone.0016503 51.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Immunol Cell Biol 2013; 91 (2): p;184-94; PMID:23399741; http://dx.doi.org/ 10.1038/icb.2012.78 52.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
J Immunol 2008; 181(6): p:4168-76;PMID:18768874; http://dx.doi.org/10.4049/ jimmunol.181.6.4168 53.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
J Immunol 2007; 179(9): p:6153-9; PMID:17947690; http://dx.doi.org/10.4049/ jimmunol.179.9.6153 55.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Cell Immunol 2001; 211(2): p:143- 53; PMID:11591118; http://dx.doi.org/10.1006/cimm.2001.1835 56.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Lancet 1990; 335 (8692): p:791-2; PMID:1969533; http://dx.doi.org/ 10.1016/0140-6736(90)90906-L 526 Volume 12 Issue 2 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Nature 2004; 428(6982): p:561-4;PMID:15024391; http://dx.doi.org/10.1038/ nature02463 59.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
PLoS Pathog 2013; 9(10): p:e1003723; PMID:24204271; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Severe acute respira- tory syndrome coronavirus spike protein expressed byattenuated vaccinia virus protectively immunizes mice.Proc Natl Acad Sci U S A 2004; 101(17): p:6641-6; PMID:15096611; http://dx.doi.org/10.1073/ pnas.0401939101 61.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Vaccine 2010; 28 (6): p:1547-57; PMID:19969118; http://dx.doi.org/10.1016/j.vaccine.2009.11.056 62.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
J Virol Methods 2008; 154(1-2): p:121-7; PMID:18789973; http://dx.doi.org/10.1016/j.jviromet.2008.08.011 63.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Vaccine 2006; 24(37-39): p:6340-50; PMID:16781800; http://dx.doi.org/ 10.1016/j.vaccine.2006.05.025 64.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Expert Opin Drug Discov 2007 2(4): p. 571-89; PMID:23484762; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Curr Protoc Protein Sci 2001 Chapter 5: p. Unit5 13; PMID:18429179; http://www.ncbi.nlm.nih.gov/pubmed/18429179 66.,OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
Curr Protoc Protein Sci 2001 Chapter 5: p. Unit5 12; PMID:18429178; http://www.ncbi.nlm.nih.gov/ pubmed/18429178 67.,OADS,/arxiv_data1/oa_pdf/cb/d0/khvi-12-02-1078045.PMC5049717.pdf
"In addition, the observation of a net vaccineimpact on acute otitis media (AOM) and pneumonia 5in the same study alleviated similar concerns about replacement in© William P Hausdorff and William P Hanage *Correspondence to: William P Hausdorff; Email: Billhausdorff@hotmail.co.uk Submitted: 07/27/2015; Revised: 10/28/2015; Accepted: 11/06/2015http://dx.doi.org/10.1080/21645515.2015.1118593 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Expert Rev Vaccines2012; 11:841-55; PMID:22913260; http://dx.doi.org/ 10.1586/erv.12.53 2.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
The Impact Of Conjugate Vaccine On Carriage Of Haemophilus InﬂuenzaeType B. J Infect Dis 1995; 171:93-8; PMID:7798687; http://dx.doi.org/10.1093/infdis/ 171.1.93 3.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
The Lancet 1996; 348:271-2; http://dx.doi.org/ 10.1016/S0140-6736(05)65585-7 4.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Pediatr Infect Dis J 2000; 19: 187-95; PMID:10749457; http://dx.doi.org/10.1097/00006454-200003000-00003 5.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Pediatr Infect Dis J 2002; 21:810-5; PMID:12352800; http://dx.doi.org/10.1097/ 00006454-200209000-00005 6.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
N Engl J Med 2001; 344:403-9; PMID:11172176; http://dx.doi.org/ 10.1056/NEJM200102083440602 7.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
J Infect Dis 2010; 201:32-41; PMID:19947881; http://dx.doi.org/10.1086/648593 8.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Vaccine 2010; 28:3650-60; PMID:20359560; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
"Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination.The Lancet 2011; 378:1962-73; http://dx.doi.org/ 10.1016/S0140-6736(10)62225-8 10.",Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
PLoS Med 2013; 10:e1001517; PMID:24086113; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
PLoS Comput Biol 2014; 10: e1003477; PMID:24550722; http://dx.doi.org/10.1371/journal.pcbi.1003477 12.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
PLoS Comput Biol 2015; 11: e1004173; PMID:25879748; http://dx.doi.org/ 10.1371/journal.pcbi.1004173 13.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Lancet Infect Dis 2011; 11:760-8; PMID:21621466;http://dx.doi.org/10.1016/S1473-3099(11)70090-1 14.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Vaccine 2014; 32:1501- 6; PMID:24486346; http://dx.doi.org/10.1016/j.vaccine.2013.11.028 15.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Vaccine 2015; 33:2793-9; PMID:25913828; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
J Infect Dis 2015; 211:1144-53; PMID:25355940; http://dx.doi.org/10.1093/infdis/jiu576 17.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Clin Infect Dis 2013; 56:e30- 9; PMID:23118268; http://dx.doi.org/10.1093/cid/cis922 18.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
PLoS One 2015; 10:e0120290; PMID:25781031; http://dx.doi.org/10.1371/journal.pone.0120290 19.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Rev Chil Infectol 2014; 31:651-8; http://dx.doi.org/10.4067/S0716- 10182014000600002 21.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
2014 [cited 2015 Jul 22]; Available from: https://surv.esr.cri.nz/sur veillance/IPD.php?we_objectID=4081 22.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Emerg Infect Dis 2015; 21: 2040-4; Ahead – of – Print; PMID:26488415; http://dx.doi.org/ 10.3201/eid2111.14078023.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Vaccine 2015; 33:359-66;PMID:25448105; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Lancet Infect Dis 2015; 15:535-43; PMID:25801458; http://dx.doi.org/10.1016/S1473-3099(15)70044-7 25.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
"Clin Infect Dis 2014; 59:1066-73; PMID:25034421; http://dx.doi.org/ 10.1093/cid/ciu524 26. von Gottberg A, de Gouveia L, Tempia S, Quan V, Meiring S, von Mollendorf C, Madhi SA, Zell ER, Verani JR, O’Brien KL, et al.",OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
N Engl J Med 2014; 371:1889-99; PMID:25386897; http://dx.doi.org/10.1056/NEJMoa1401914 27.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
BMC Infect Dis 2015; 15:61; PMID:25885764;http://dx.doi.org/10.1186/s12879-015-0787-1 28.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Vaccine 2013; 31:6232-8; PMID:24176490; http://dx.doi.org/10.1016/j.vaccine.2013.10.032 30.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Lancet Infect Dis 2015; 15:301-9; PMID:25656600; http://dx.doi.org/10.1016/S1473- 3099(14)71081-3 31.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
"2014 32. van der Linden M, Falkenhorst G, Perniciaro S, Im €ohl M. Effects of Infant Pneumococcal Conjugate Vaccina- tion on Serotype Distribution in Invasive Pneumococ- cal Disease among Children and Adults in Germany.PLoS ONE 2015; 10:e0131494; PMID:26132078; http://dx.doi.org/10.1371/journal.pone.0131494 33.",Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
2012 [cited 2015 Jul 20]; Availablefrom: https://www.inspq.qc.ca/pdf/publications/ 1734_ProgSurvPneumoQc_RappAnnu2012.pdf 34.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
"Pneumococcal disease: guidance, data and analysis [cited 2015 Oct 26]; Available from: https://www.gov.",Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
J Infect Dis 2008; 197:1511-8; PMID:18471062; http://dx.doi.org/10.1086/ 587941 36.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
PLoS Pathog 2009; 5:e1000476; PMID:19521509; http://dx.doi.org/ 10.1371/journal.ppat.1000476 37.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Infect Immun 2013; 81:4519-24; PMID:24082068; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
J Infect Dis 2004; 190:1203-11; PMID:15346329; http://dx.doi.org/10.1086/423820 39.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
J Infect Dis 2003; 187:1424-32;PMID:12717624; http://dx.doi.org/10.1086/374624 40.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Infect Immun 2004; 72:76-81; PMID:14688083; http://dx.doi.org/10.1128/ IAI.72.1.76-81.2004 41.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
PLoS ONE 2013; 8:e72743; PMID:24009703; http://dx.doi.org/ 10.1371/journal.pone.0072743 42.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Eur Respir J 2014; 43:545-53; PMID:23845720; http://dx.doi.org/10.1183/09031936.00050413 43.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Clin Infect Dis 2007; 45:46-51; PMID:17554699; http://dx.doi.org/ 10.1086/518538 44.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Eur J Clin Microbiol Infect Dis 2014; 33:879-910; PMID:24563274; http://dx.doi.org/10.1007/s10096-014-2062-6 45.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Am Nat 1959;93:145-59; http://dx.doi.org/10.1086/282070 46.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Theor Popul Biol 1972; 3:87-112; PMID:4667078; http://dx.doi.org/10.1016/0040- 5809(72)90035-4 51.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
J R Soc Interface 2010; 7:905-19; PMID:19940002; http://dx.doi.org/10.1098/ rsif.2009.0400 52.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Epidemics 2009; 1:2-13; PMID:21352747; http://dx.doi.org/10.1016/j.epidem.2008.07.001 53.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Philos Trans R Soc B Biol Sci 2015; 370:20140342; PMID:25918447; http://dx.doi.org/ 10.1098/rstb.2014.0342 54.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
EpidemiolCamb Mass 2013; 24:522-9; http://dx.doi.org/ 10.1097/EDE.0b013e318294be89 55.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Vaccine 2007; 25:2406-12; PMID:17055620; http://dx.doi.org/10.1016/j.vaccine.2006.09.009 56.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Vaccine 2014; 32:3644-50; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
J Infect Dis 2012; 206:1020-9; PMID:22829650; http://dx.doi.org/10.1093/infdis/jis447 58.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
J Infect Dis2001; 184:861-9; PMID:11550126; http://dx.doi.org/ 10.1086/323339 59.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Scand J Infect Dis 2003; 35:452-8; PMID:14514143; http://dx.doi.org/10.1080/ 00365540310013315 60.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
J Infect Dis 2008; 198:1809-17; PMID:18959497; http://dx.doi.org/10.1086/593334 61.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
BMC Infect Dis 2015; 15:68; PMID:25887323; http://dx.doi.org/10.1186/s12879-015-0797-z 62.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
PLoS ONE 2015; 10:e0114286; PMID:25643355; http://dx.doi.org/10.1371/journal.pone.0114286 63.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
BMC Infect Dis 2015; 15:234; PMID:26088623; http://dx.doi.org/ 10.1186/s12879-015-0980-2 64.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Int J Med Microbiol IJMM 2014; 304:984-9; PMID:25023076; http://dx.doi.org/10.1016/j.ijmm.2014.06.005 65.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Science 2012; 335:1376-80;PMID:22383809; http://dx.doi.org/10.1126/ science.1215947 66.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Vaccine 2014; 32:3452-9; PMID:24690148; http://dx.doi.org/10.1016/j.vaccine.2014.03.065 67.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
GOV.UK2015 [cited 2015 Sep 29]; Available from: https://www.gov.uk/government/ publications/pneumococcal-disease-cases-caused-by- strains-covered-by-prevenar-13-vaccine/pneumococcal- disease-cases-caused-by-strains-covered-by-prevenar-13-vaccine 68.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
J Infect Dis 2015; 212:1082-92; PMID:25784729;http://dx.doi.org/10.1093/infdis/jiv167 69.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Clin Infect Dis 2010; 50:1477-86; PMID:20420501; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Vaccine 2005; 23:5464-73; PMID:16188350; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Vaccine 2015; 33:4813-9; PMID:26247901; http://dx.doi.org/10.1016/j.vaccine.2015.07.080 74.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Vaccine 2015;33:2662-9; PMID:25910923; http://dx.doi.org/ 10.1016/j.vaccine.2015.04.024 75.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
PLoS ONE 2013; 8:e72198; PMID:24086259; http://dx.doi.org/10.1371/ journal.pone.0072198 76.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
PLoS Med 2011; 8:e1001107;PMID:22028630; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
J Infect Dis 2013; 207:439-49; PMID:23175765; http://dx.doi.org/ 10.1093/infdis/jis703 78.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
mBio 2011;2:e00040-11; PMID:21693638; http://dx.doi.org/ 10.1128/mBio.00222-11 79.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Expert Rev Vaccines2015; 14:413-28; PMID:25266168; http://dx.doi.org/ 10.1586/14760584.2015.965160 80.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Clin Microbiol Rev 2015; 28:871-99; PMID:26085553; http://dx.doi.org/10.1128/CMR.00024-15 82.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
The Lancet 2006; 367:740-8;http://dx.doi.org/10.1016/S0140-6736(06)68304-9 83.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
"Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I. Clin Infect Dis 2000;30:100-21; PMID:10619740; http://dx.doi.org/ 10.1086/313608 84.",Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
J Infect Dis 1983; 148:1136-59; PMID:6361173; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Early Trends for Invasive Pneumococcal Infections in Chil- dren After the Introduction of the 13-valent Pneumo-coccal Conjugate Vaccine: Pediatr Infect Dis J 2013; 32:203-7; PMID:23558320; http://dx.doi.org/ 10.1097/INF.0b013e318275614b 88.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
[cited 2015 Jul 22]; Available from: https://www.cdc.gov.tw/professional/list.aspx?treeid=098F3B C4756F62CC&nowtreeid=90960C331E13A586 89.,OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Vaccine 2014; 32:2553-62; PMID:24674661; http://dx.doi.org/10.1016/j.vaccine.2014.03.054 90.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
Vaccine 2014; 32:5185-91; PMID:25077419; http://dx.doi.org/ 10.1016/j.vaccine.2014.07.060 91.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
2013 [cited 2015 Jul 20];Available from: https://www.wiv-isp.be/SiteCollection Documents/Maladies%20infectieuses%20p%C3%A9 diatriques%20%C3%A0%20pr%C3%A9vention%20 vaccinale.%20Rapport%20annuel%202013.pdf 374 Volume 12 Issue 2 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/48/e6/khvi-12-02-1118593.PMC5049718.pdf
"A recombinant, yellow fever-17D –dengue virus, live-atten- uated, tetravalent dengue vaccine (CYD-TDV) is in late phaseof development for the control of dengue disease with a 3dose-schedule regimen, with vaccinations given 6 months © Anand Prakash Dubey, Sharad Agarkhedkar, Jugesh Chhatwal, Arun Narayan, Satyabrata Ganguly, T Anh Wartel, Alain Bouckenooghe, and Josemund Menez es *Correspondence to: Josemund Menezes; Email: josemund.menezes@sano ﬁpasteur.com Submitted: 05/01/2015; Revised: 07/06/2015; Accepted: 07/21/2015 http://dx.doi.org/10.1080/21645515.2015.1076598 This is an Open Access article distributed under the terms of the Creative Co mmons Attribution-Non-Commercial License (http://creativecommons.o rg/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work i sp r o p - erly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
Available from: http://www.who.int/denguecontrol/9789241504034/ en/ (Accessed 7 July 2014) 2012 2.,Non-OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
Available at: http://nvbdcp.gov.in/den-cd.html(Accessed 7 July 2014) 2014 3.,Non-OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
Trans R Soc Trop Med Hyg 2012; 106:273-82.; PMID:22357401; http://dx.doi.org/ 10.1016/j.trstmh.2011.12.007 4.,OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
Available at: http://www.nvbdcp.gov.in/Doc/Clinical%20Guidelines.pdf (Accessed 7 July 2014) 2008 5.,Non-OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
Trans R Soc Trop Med Hyg 2008; 102:570-7; PMID:18402995; http://dx.doi.org/10.1016/j.trstmh.2008.02.015 6.,OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
J Clin Virol 2007; 38:269-70; PMID:17254843;http://dx.doi.org/10.1016/j.jcv.2006.12.010 7.,OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
Am J Trop Med Hyg2014;91:1235-42; PMID:25294616; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
Nature 2013; 496:504-7; PMID:23563266; http://dx.doi.org/10.1038/nature12060 10.,Non-OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
Vaccine 2011; 29:3863-72; PMID:21477675; http://dx.doi.org/ 10.1016/j.vaccine.2011.03.057 11.,Non-OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
Lancet 2012; 380:1559-67; PMID:22975340; http://dx.doi.org/ 10.1016/S0140-6736(12)61428-7 12.,Non-OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
Lancet 2014; 384:1358-65; PMID:25018116; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
N Engl J Med 2015; 372:113-23; PMID:25365753; http://dx.doi.org/10.1056/NEJMoa1411037 14.,OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
Vaccine 2013; 31:5814-21; PMID:24135573; http://dx.doi.org/ 10.1016/j.vaccine.2013.10.013 15.,Non-OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
HumVaccin Immunother 2012; 8:1259-71; PMID:22894958; http://dx.doi.org/10.4161/ hv.21224 17.,Non-OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
J Infect Dis 2014;209:360-8; PMID:23964110; http://dx.doi.org/ 10.1093/infdis/jit436 18.,OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
BMC Public Health 2015; 15:250; PMID:25886528; http://dx.doi.org/10.1186/s12889- 015-1590-z 19.,Non-OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
Rev Panam Salud Publica 2002; 11:223-7;PMID:12049030; http://dx.doi.org/10.1590/S1020- 49892002000400003 20.,Non-OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
Vaccine 2013; 31:4501-7; PMID:23896423; http://dx.doi.org/10.1016/j.vaccine.2013.06.079 21.,Non-OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
Trials in Vaccinology 2015; 4:19-23; http://dx.doi.org/ 10.1016/j.trivac.2015.03.002 22.,OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
Am J T rop Med Hyg 2011; 85:724-31; http://dx.doi.org/10.4269/ajtmh.2011.10-0436 23.,Non-OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
2015 Aug 13. pii: S0264-410X (15)01122-6; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/65/86/khvi-12-02-1076598.PMC5049724.pdf
"10Worldwide a number of countries have adopted this rec- ommendation and implemented RV vaccines in their pediatric © Antonella Mattei, Margherita Sbarbati, Fabiana Fiasca, Anna Maria Angelone, Maria Chiara Mazzei, and Ferdinando di Orio *Correspondence to: Antonella Mattei; Email: antonella.mattei@cc.univaq.itSubmitted: 05/22/2015; Revised: 07/14/2015; Accepted: 08/06/2015 http://dx.doi.org/10.1080/21645515.2015.1081726 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
Aliment Pharmacol Ther 2013; 37:289-303; PMID:23190209; http://dx.doi.org/10.1111/apt.12163 2.,Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
Expert Opin Pharmacother 2012; 13:17-26; PMID:22106840; http://dx.doi.org/10.1517/14656566.2011.634800 3.,Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
Emerg Infect Dis2006; 12: 304-6; PMID:16494759; http://dx.doi.org/ 10.3201/eid1202.050006 4.,OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
J Infect Dis 2009; 200:S9-15; PMID:19817620; http://dx.doi.org/10.1086/605025 5.,Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
Pediatr Infect Dis J 2006; 25:S7-11; http://dx.doi.org/10.1097/01.,OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
J Infect Dis 2007; 195:S4-16; PMID:17387650; http://dx.doi.org/10.1086/516714 7.,OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
Pediatrics 2009; 123:e393-400; PMID:19254975; http://dx.doi.org/10.1542/peds.2008-2088 8.,Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
Eur J Pediatr 2011; 170:213-22; PMID:20842379; http://dx.doi.org/10.1007/ s00431-010-1289-1 9.,OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
J Infect Dis 2007; 195:S26-35; PMID:17387649;http://dx.doi.org/10.1086/516717 10.,Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
Pediatr Infect Dis J 2011; 30: S21-4; PMID:21183836; http://dx.doi.org/10.1097/INF.0b013e3181fefc51 12.,Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
Lancet Infect Dis 2014; 14:416-25; PMID:24758998; http://dx.doi.org/10.1016/S1473-3099(14)70035-0 13.,Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
Vaccine 2013; 31:2686-91;PMID:23597718; http://dx.doi.org/10.1016/j.vaccine.,Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
URL:https://www.gov.uk/government/uploads/system/uploads/atta chment_data/ﬁle/193055/130429_Rotavirus_tripartite _letter_FINAL.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
URL: http://sites.path.org/rotavirusvaccine/country- introduction-maps-and-spreadsheet/ 18.,Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
Hum Vaccin 2009; 5:172-6; PMID:18802404; http://dx.doi.org/ 10.4161/hv.5.3.6764 19.,Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
BMC Public Health 2010; 10:636; PMID:20969755; http://dx.doi.org/ 10.1186/1471-2458-10-636 21.,Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
"Current immunization policies for pneumococcal, menin- gococcal C, varicella and rotavirus vaccinations in Italy.Health Policy 2011; 103:176-83; PMID:22030308; http://dx.doi.org/10.1016/j.healthpol.2011.10.002 23.",Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
Available from: http://www.etagamma.i t/wp-content/uploads/ Prato.pdf.,Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
JPediatr Gastroenterol Nutr 2008; 46:619-21; PMID:18493225; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
BMC Infect Dis 2010; 10:235; PMID:20696065; http://dx.doi.org/10.1186/1471-2334-10-235 34.,Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
Available from: http://www.crob.it/crob/ﬁles/docs/10/63/33/DOCUMENT_FILE_106333.pdf.,Non-OADS,/arxiv_data1/oa_pdf/60/88/khvi-12-02-1081726.PMC5049727.pdf
"An impor-tant component of their success is their additional ability to © 2016 GSK group of companies *Correspondence to: Cosmina Hogea; Email: cosmina.s.hogea@gsk.comSubmitted: 05/11/2015; Revised: 07/14/2015; Accepted: 08/01/2015 http://dx.doi.org/10.1080/21645515.2015.1080400 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Lancet Infect Dis 2010;10:853-61; PMID:21075057; http://dx.doi.org/ 10.1016/S1473-3099(10)70251-6 2.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Available at: http://www.ecdc.europa.eu/en/publications/Publications/Annual-Epidemiological- Report-2013.pdf [Accessed 10 February 2015].,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Hum Vaccin Immunother 2014; 10:995-1007; PMID:24500529; http://dx.doi.org/10.4161/hv.27739 5.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Expert Rev Vaccines 2013; 12:837-58; PMID:23984957;http://dx.doi.org/10.1586/14760584.2013.814862 7.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Lancet Infect Dis 2010; 10:112-24; PMID:20113980; http://dx.doi.org/ 10.1016/S1473-3099(09)70324-X 8.,OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
"Serruto D, Bottomley MJ, Ram S, Giuliani MM, Rappuoli R. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB:immunological, functional and structural characteri- z a t i o no ft h ea n t i g e n s .V a c c i n e2 0 1 2 ;3 0S u p p l2 : B87-97; PMID:22607904; http://dx.doi.org/ 10.1016/j.vaccine.2012.01.033 9.",Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Expert Rev Vaccines 2009; 8:851-61; PMID:19538112; http://dx.doi.org/10.1586/erv.09.48 10.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Lancet 2002; 359:1829-31; PMID:12044380; http://dx.doi.org/10.1016/S0140- 6736(02)08679-8 11.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Lancet 2014; 384:2123-31; PMID:25145775; http://dx.doi.org/ 10.1016/S0140-6736(14)60842-4 12.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Lancet Infect Dis2013; 13:416-25; PMID:23414709; http://dx.doi.org/ 10.1016/S1473-3099(13)70006-9 14.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
JAMA 2012; 307:573-82; PMID:22318278; http://dx.doi.org/ 10.1001/jama.2012.85 15.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Lancet 2012; 379:617-24; PMID:22260988; http://dx.doi.org/10.1016/S0140-6736(11)61713-3 16.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Lancet 2013; 381:825-35; PMID:23324563; http://dx.doi.org/10.1016/S0140-6736(12)61961-8 17.,OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Lancet Infect Dis 2011; 11:760-8; PMID:21621466; http://dx.doi.org/ 10.1016/S1473-3099(11)70090-1 19.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Expert Rev Vaccines 2006; 5: 651-67; PMID:17181439; http://dx.doi.org/10.1586/ 14760584.5.5.651 20.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Am J Epidemiol 2005; 162:89-100; PMID:15961591; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Vaccine 2013; 31:2638-46; PMID:23566946; http://dx.doi.org/ 10.1016/j.vaccine.2013.03.034 22.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
BMC Infect Dis 2010; 10:90; PMID:20377886;http://dx.doi.org/10.1186/1471-2334-10-90 23.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Vaccine 2010; 28:3650-60; PMID:20359560; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
J Infect Dis 2008; 197:737-43; PMID:18271745; http://dx.doi.org/10.1086/527401 25.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
FEMS Microbiol Rev 2007; 31:52-63; PMID:17233635; http://dx.doi.org/10.1111/j.1574-6976.2006.00052.x 26.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Math Biosci 2007; 207:58-77; PMID:17087980; http://dx.doi.org/ 10.1016/j.mbs.2006.09.010 28.,OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
BMC Infect Dis 2010; 10:175; PMID:20565757; http://dx.doi.org/10.1186/1471-2334-10-175 29.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Expert Rev Vaccines 2013; 12:505-17; PMID:23659299; http://dx.doi.org/10.1586/erv.13.30 30.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
J Clin Microbiol 2004; 42:5146-53; PMID:15528708; http://dx.doi.org/10.1128/JCM.42.11.5146-5153.2004 31.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Clin Infect Dis 2005;40:899-902; PMID:15736029; http://dx.doi.org/ 10.1086/428351 32.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
PLoS Med 2007; 4:e101; PMID:17388665; http://dx.doi.org/ 10.1371/journal.pmed.0040101 33.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
PLoS Med 2008; 5:e74; PMID:18366252; http://dx.doi.org/10.1371/journal.pmed.0050074 35.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
J Royal Statist Soc Series C: Applied Statistics 2010; 59:255-77; http://dx.doi.org/10.1111/j.1467-9876.2009.00693.x 36.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Am J Epidemiol 2006; 164:936-44; PMID:16968863;http://dx.doi.org/10.1093/aje/kwj317 37.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Epidemics 2009; 1:2- 13; PMID:21352747; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Math Biosci 2009; 218:80-7; PMID:19174173; http://dx.doi.org/10.1016/j.mbs.2008.12.009 40.,OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
J Biol Dyn 2010; 4:176- 95; PMID:22876985; http://dx.doi.org/10.1080/17513750903023715 41.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Int J Epidemiol 2000; 29:180-8; PMID:10750621; http://dx.doi.org/ 10.1093/ije/29.1.180 42.,OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
BMJ 2014; 348:g2327; PMID:24665138; http://dx.doi.org/10.1136/ bmj.g2327 43.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Avail- able at: https://www.gov.uk/government/collections/ meningococcal-disease-guidance-data-and-analysis [Accessed 10 February 2015].,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Available at: http://www.ons.,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
Available at: http://csugeo.i-server.cz/csu/2008edicniplan.nsf/engpubl/4032-08-2007 [Accessed 10 February 2015].,Non-OADS,/arxiv_data1/oa_pdf/f9/20/khvi-12-02-1080400.PMC5049729.pdf
"Introduction Streptococcus pneumoniae is the most important cause of pneu- monia and invasive bacterial infections in any age, with the great- est incidence in children and elderly.1More than 90 serotypes exist, but only a subset is associated with invasive disease.2 Since its introduction in the United States in 2000, the 7- valent conjugate pneumococcal vaccine (PCV7, including sero-types 4,6B,9V,14,18C,19F,23F) has dramatically reduced © Chiara Azzari, Martina Cortimiglia, Francesco Nieddu, Maria Moriondo, Giuseppe Indol ﬁ, Romano Mattei, Massimo Zuliani, Beatrice Adriani, Roberto Degl ’Inno- centi, Guglielmo Consales, Donatella Aquilini, Giancarlo Bini, Massimo Edoardo Di Natale, Clementina Canessa, Silvia Ricci, Elisa de Vitis, Giusi Mangone, Angela Bechini, Paolo Bonanni, Angela Pasinato, and Massimo Resti*Correspondence to: Chiara Azzari; Email: chiara.azzari@uni ﬁ.it Submitted: 07/29/2015; Revised: 09/15/2015; Accepted: 09/29/2015 http://dx.doi.org/10.1080/21645515.2015.1102811 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
Pharmacotherapy 2005; 25:1193-212; PMID:16164394; http://dx.doi.org/ 10.1592/phco.2005.25.9.1193 2.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
MBio 2011; 2(1):e00309-10; PMID:21264063;http://dx.doi.org/10.1128/mBio.00309-10 4.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
N Engl J Med 2003;348:1737-46; PMID:12724479; http://dx.doi.org/ 10.1056/NEJMoa022823 5.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
JAMA 2006; 295:1668- 74; PMID:16609088; http://dx.doi.org/10.1001/jama.295.14.1668 6.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
Clin Infect Dis 2009; 49: 205-12; PMID:19508165; http://dx.doi.org/ 10.1086/599827 7.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
N Engl J Med 2013; 369(2):155-63; PMID:23841730; http://dx.doi.org/ 10.1056/NEJMoa1209165 8.,OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
Clin Infect Dis 2009; 48: 57-64;PMID:19035779; http://dx.doi.org/10.1086/594125 9.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
"Rose M, Zielen S. Impact of infant immunization pro- grams with pneumococcal conjugate vaccine in Europe.Expert Rev Vaccines 2009; 8:1351-64; PMID:19803758; http://dx.doi.org/10.1586/erv.09.78 10.",Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
Int J Infect Dis 2010; 14:e197-209; PMID:19700359; http://dx.doi.org/ 10.1016/j.ijid.2009.05.010 11.,OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
Clin Ther 2008; 30(2):341-57; PMID:18343273; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
Vaccine 2003; 21: 1815-25; PMID:12706665; http://dx.doi.org/10.1016/S0264-410X(02)00807-1 13.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
J Infect Dis.2004; 189(5):785-96; PMID:14976594; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
Microb Drug Resist 2003; 9 Suppl 1:S61-8; PMID:14633369; http://dx.doi.org/10.1089/107662903322541919 16.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
doi:10.1371/journal.pone.00092822010; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
Lancet 2011; 378: 1962-73; PMID:21492929; http://dx.doi.org/10.1016/S0140-6736(10)62225-8 19.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
2013. http://www.epicentro.iss.it/ temi/vaccinazioni/pdf/Dati %20e%20evidenze%20vaccini% 20antipneumococcici.pdf; accessed 2015.09.07.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.Lancet Infect Dis 2011; 11: 760-8; PMID:21621466; http://dx.doi.org/10.1016/S1473-3099(11)70090-1 www.tandfonline.com 349 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
Vaccine 2012; 30 (13):2288-94; PMID:22306795; http://dx.doi.org/ 10.1016/j.vaccine.2012.01.067 22.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
Vaccine 2014; 32 (34):4349-55; PMID:24657717; http://dx.doi.org/ 10.1016/j.vaccine.2014.03.017 24.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
PLoS Med 2011; 8(4):e1001017; PMID:21483718; http://dx.doi.org/10.1371/journal.pmed.1001017 25.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
J Infect Dis 2006; 194(5):682-8; PMID:16897668; http://dx.doi.org/10.1086/505710 26.,OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
Vaccine 2007; 25 (13):2420-7; PMID:17049677; http://dx.doi.org/ 10.1016/j.vaccine.2006.09.011 27.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
Clin Infect Dis 2010; 51(9):1042-9; PMID:20883110; http://dx.doi.org/ 10.1086/656579 28.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
Vaccine 2012; 30:2701-5; PMID:22178097; http://dx.doi.org/10.1016/j.vaccine.2011.12.008 350 Volume 12 Issue 2 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/khvi-12-02-1102811.PMC5049737.pdf
"ﬁocruz.br Submitted: 05/13/2015; Revised: 07/24/2015; Accepted: 08/10/2015 http://dx.doi.org/10.1080/21645515.2015.1082693 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
Lancet Infect Dis 2001; 1:11-20; PMID:11871403; http://dx.doi.org/10.1016/S1473-3099(01)00016-0 2.,Non-OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
J Immunol 2009; 183:7919-30; PMID:19933869; http://dx.doi.org/10.4049/ jimmunol.0803903 4.,Non-OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
Vaccine 2014; 32:4977-84; PMID:25090646;http://dx.doi.org/10.1016/j.vaccine.2014.07.021 5.,Non-OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
"Am J Trop Med Hyg 2013; 89:434-44; PMID:24006295;http://dx.doi.org/10.4269/ajtmh.13-0264 6 .G a u c h e rD ,T h e r r i e nR ,K e t t a fN ,A n g e r m a n nB R , B o u c h e rG ,F i l a l i - M o u h i mA ,M o s e rJ M ,M e h t aR S ,D r a k eDR, Castro E, et al.",OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
J Exp Med 2008; 205:3119-31; PMID:19047440; http://dx.doi.org/10.1084/jem.20082292 7.,Non-OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
CD8 CT cells comple- ment antibodies in protecting against yellow fever virus.J Immunol 2015; 194: 1141-53; PMID:25539816; http://dx.doi.org/10.4049/jimmunol.1402605 8.,Non-OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
Nat Immunol 2008; 10:116-25; PMID:19029902; http://dx.doi.org/ 10.1038/ni.1688 9.,Non-OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
PLoS One 2012; 7(12): e49828; PMID:23251351; http://dx.doi.org/10.1371/ journal.pone.0049828 13.,Non-OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
Clin Exp Immunol 2007; 148:90-100; PMID:17309541; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
Science 2014; 343:313-7; PMID:24310610; http://dx.doi.org/10.1126/science.1246829 15.,Non-OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
Proc Natl Acad Sci USA 2012;109:7037-42; PMID:22509047; http://dx.doi.org/ 10.1073/pnas.1202288109 16.,OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
J Virol 2013; 87:1359-72; PMID:23175355; http://dx.doi.org/10.1128/JVI.02055-12 17.,Non-OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
J Virol 2013; 87:7805-15;PMID:23658452; http://dx.doi.org/10.1128/JVI.,OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
J Infect Dis 2013; 208:418-22; PMID:23633407; http://dx.doi.org/ 10.1093/infdis/jit180 20.,OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
J Infect Dis 2013; 208:413-7; PMID:23633404; http://dx.doi.org/10.1093/infdis/ jit178 21.,OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
Proc Natl Acad Sci USA 2012; 109:5797-802; PMID:22454499; http://dx.doi.org/10.1073/ pnas.1117208109 22.,OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
J. Immunol 2001; 166:877-84; PMID:11145663; http://dx.doi.org/ 10.4049/jimmunol.166.2.877 23.,Non-OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
Biologicals 2012; 40:399-404;PMID:23034357; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
J Med Virol 1998; 56: 159-67; PMID:9746073; http://dx.doi.org/10.1002/(SICI) 1096-9071(199810)56:2%3c159::AID-JMV10%3e3.,Non-OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
Immunity 2008; 28:710-22; PMID:18468462; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
Clin Exp Immunol 2006; 146: 124-32; PMID:16968407; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
Vaccine 2011; 29:583-92; PMID:20732465; http://dx.doi.org/10.1016/j.vaccine.2010.08.046 502 Volume 12 Issue 2 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/66/c8/khvi-12-02-1082693.PMC5049740.pdf
"IVI is a multilateral institution recognized by the Organization for Economic Co-operation and Development (OECD) therefore contribu- tions to IVI can be considered as Of ﬁcial Development Assistance © International Vaccine Institute This is an Open Access article distributed under the terms of the Creative Com-mons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/d5/khvi-12-02-1132687.PMC5049741.pdf
For more information: http://www.ivi.org/ www.tandfonline.com 555 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/82/d5/khvi-12-02-1132687.PMC5049741.pdf
"Coverage in Africa was less, © A Odutola, MO Ota, EO Ogundare, M Antonio, P Owiafe, A Worwui, B Greenwood, M Alderson, M Traskine, V Verlant, K Dobbelaere, and D Borys *Correspondence to: A Odutola; Email: aaodutola@mrc.gmSubmitted: 08/26/2015; Revised: 10/03/2015; Accepted: 10/19/2015 http://dx.doi.org/10.1080/21645515.2015.1111496 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Lancet 2009; 374:893-902;PMID:19748398; http://dx.doi.org/10.1016/S0140- 6736(09)61204-6 2.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Lancet 2005; 365:1139-46; PMID:15794968; http://dx.doi.org/10.1016/ S0140-6736(05)71876-6 3.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Lancet 2006; 368:1495-502; PMID:17071283; http://dx.doi.org/10.1016/S0140-6736(06)69637-2 4.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Pediat Infect Dis J 2004;23:485-9; PMID:15194827; http://dx.doi.org/ 10.1097/01.inf.0000129685.04847.946.,OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Clin Microbiol Infect 2008; 14:835-43; PMID:18844684; http://dx.doi.org/10.1111/j.1469- 0691.2008.02031.x 7.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Pediat Infect Dis J2009; 28:990-5; PMID:19536041; http://dx.doi.org/ 10.1097/INF.0b013e3181a78185 8.,OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
J Infect Dis 2007; 196:1346- 54; PMID:17922399; http://dx.doi.org/10.1086/ 521626 9.,OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Trends Microbiol 2012; 20:485-93; PMID:22819099; http://dx.doi.org/10.1016/j.tim.2012.06.004 12.,OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
"Microbiol Mol Biol Rev 2001; 65:187- 207; ﬁrst page, table of contents; PMID:11381099;http://dx.doi.org/10.1128/MMBR.65.2.187-207.2001 14.",Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Infect Immun 2011; 79:238-45; PMID:20956575; http://dx.doi.org/10.1128/ IAI.00378-10 15.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Infect Immun 2004; 72:4534-40; PMID:15271913; http://dx.doi.org/10.1128/IAI.72.8.4534-4540.2004 17.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Infect Immunol 2001; 69:949-58; PMID:11159990; http://dx.doi.org/10.1128/ IAI.69.2.949-958.2001 18.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Vaccine 2014; 32:6838-46; PMID:24607003; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
J Bacteriol 2001; 183:5709- 17; PMID:11544234; http://dx.doi.org/10.1128/ JB.183.19.5709-5717.2001 21.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
"Neutralizing antibodies elicited by a novel detoxiﬁed pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury.Infect Immun 2012; 80:2212-20; PMID:22473606; http://dx.doi.org/10.1128/IAI.06348-11 24.",Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Clin Infect Dis 2006; 43:673-9;PMID:16912937; http://dx.doi.org/10.1086/506941 25.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
J Infect Dis 2000; 182:1146-52; PMID:10979911; http://dx.doi.org/10.1086/315822 26.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
J Infect Dis 2001; 183:827-30; PMID:11181163; http://dx.doi.org/10.1086/318833 27.,OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Lan-cet 2006; 367:740-8; PMID:16517274; http://dx.doi.org/ 10.1016/S0140-6736(06)68304-9 29.,OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
N Engl J Med 2001; 344:403-9; PMID:11172176; http://dx.doi.org/ 10.1056/NEJM200102083440602 30.,OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Hum Vaccines Immunother 2014; 10:757-66; PMID:24356787;http://dx.doi.org/10.4161/hv.27276 31.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Hum Vaccines Immunother 2013; 9:382-8; PMID:23291945; http://dx.doi.org/10.4161/hv.22692 32.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Lancet 2013;381:214-22; PMID:23158882; http://dx.doi.org/ 10.1016/S0140-6736(12)61854-6 33.,OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
J Infect Dis 2010; 201:1570-9; PMID:20384496; http://dx.doi.org/ 10.1086/652006 35.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Pediatr Infect Dis J 2011; 30:e130-41; PMID:21540760; http://dx.doi.org/ 10.1097/INF.0b013e31821d1790 36.,OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Trop Med Int Health 2014; 19:275-83; PMID:24393095; http://dx.doi.org/ 10.1111/tmi.12245 38.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Clin Vaccine Immunol 2006; 13:356-60; PMID:16522777; http://dx.doi.org/10.1128/CVI.13.3.356-360.2006 40.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Clin Vaccine Immunol 2010; 17:134-42; PMID:19889940; http://dx.doi.org/10.1128/ CVI.00289-09 41.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
Vaccine 2007; 25:2518-27; PMID:17034907; http://dx.doi.org/ 10.1016/j.vaccine.2006.09.029 43.,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
J Pharm Biomed Analysis 2000; 21:1249-73; PMID:10708409; http://dx.doi.org/ 10.1016/S0731-7085(99)00244-7 402 Volume 12 Issue 2 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/c0/22/khvi-12-02-1111496.PMC5049746.pdf
"Exclusion criteria Have serious heart, liver, kidney and blood system diseases Inﬂiximab allergies.©Jin Wang, Qingxia Zhan, and Litao Zhang *Correspondence to: Litao Zhang; Email: zhanglitao@medmail.com.cn Submitted: 02/09/2015; Revised: 07/23/2015; Accepted: 08/04/2015http://dx.doi.org/10.1080/21645515.2015.1081322 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
ClinExp Dermatol 2001; 26(4):326-32; PMID:11422184; http://dx.doi.org/10.1046/j.1365-2230.2001.00831.x.,Non-OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
J Immunol 2009; 182(9):5836-45; PMID:19380832; http://dx.doi.org/10.4049/ jimmunol.0802999.,Non-OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
J Immunol 2010; 185(3):1887-93;PMID:20610641; http://dx.doi.org/10.4049/ jimmunol.1001227.,Non-OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
PLoS One2014; 9(11):e112408; PMID:25384035; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
J Exp Clin Cancer Res 2012 May 1; 31:40; http://dx.doi.org/10.1186/1756-9966-31-40.,Non-OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
Cytokine 2010; 52(3):225-9;PMID:20980160; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
J Invest Dermatol 1999; 113 (5):752-759;PMID:10571730; http://dx.doi.org/10.1046/j.1523- 1747.1999.00749.x.,Non-OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
J Dermatol Sci 2001; 26 (2):119-24; http://dx.doi.org/10.1016/S0923-1811(00)00167-5.,Non-OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
Br Med J 2001; 323(7 303):42-46; PMID:11440947; http://dx.doi.org/10.1136/ bmj.323.7303.42.,Non-OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
J Am Acad Dermatol 2007; 56(1):31.e1-15; PMID:17097378; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
J Dermatol Sci2010; 59(1):40-9; PMID:20547039; http://dx.doi.org/ 10.1016/j.jdermsci.2010.04.014.,OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
2011; 165(5):1109-17; PMID:21910713; http://dx.doi.org/10.1111/ j.1365-2133.2011.10615.x.,Non-OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
"Lancet 2005, Oct15-21; 366(9494):1367-74; http://dx.doi.org/10.1016/ S0140-6736(05)67566-6.",OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
"Br J Dermatol 2005, May; 152(5):954-60; http://dx.doi.org/10.1111/j.1365-2133.2005.06510.x.",Non-OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
"Lancet 2001, Jun 9; 357 (9271):1842-7; http://dx.doi.org/10.1016/S0140-6736 (00)04954-0.",Non-OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
Ann Rheum Dis 2007; 66(4):498-505; PMID:17114188; http://dx.doi.org/10.1136/ ard.2006.058339.,Non-OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
Ann Rheum Dis 2005; 64(8):1150-7; PMID:15677701; http://dx.doi.org/10.1136/ard.2004.032268.,OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
Arthritis Rheum 2005; 52(4):1227- 36; PMID:15818699; http://dx.doi.org/10.1002/ art.20967.,Non-OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
Arthritis Care Res (Hoboken) 2010; 62(7):965-9; PMID:20589696; http://dx.doi.org/ 10.1002/acr.20155.23.,Non-OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
J Eur Acad Dermatol Venereol2011; 25(12):1402-8; http://dx.doi.org/10.1111/ j.1468-3083.2011.03984.x.,Non-OADS,/arxiv_data1/oa_pdf/28/ab/khvi-12-02-1081322.PMC5049748.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: AllergyB cell epitope-based allergy vaccineHepatitis BHepatitis B surface protein preS Virus neutralization 1.,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.0232352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
"An alignment of the preS genotype A, serotype adw2 sequence and peptide sequences thereof with HBV genotypes B –Hw a sp e r f o r m e d with CLUSTAL Ωu  sing reference sequences from the HBV data base (HBVdb: https://hbvdb.ibcp.fr/HBVdb/HBVdbIndex ),(Hayer et al., 2012 ).",OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
"55, 29 –37.http://dx.doi.org/10.1016/j.jhep.2010.",OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1056/ NEJM199908123410702 .,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
FASEB J. http://dx.doi.org/10.1096/fj.,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1111/j.1365-2222.2009.03443.x .,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1097/ ACI.0b013e328357ca53 .,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1016/j.jaci.2013.08.038 .,OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
"Immunol 135, 1207 –1217, 11. http://dx.doi.org/ 10.1016/j.jaci.2014.09.012 .",OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1371/journal.pone.0117204 .,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
"204, 39 –55.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1128/JVI.77.17.9511-9521.2003 .,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1128/JVI.79.3.1613-1622.2005 .,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
"http://dx.doi.org/10.1097/ACI.0000000000000121 .Krawczyk, A., Ludwig, C., Jochum, C., Fiedler, M., Heinemann, F.M., Shouval, D., Roggendorf, M., Roggendorf, H., Lindemann, M., 2014.",Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1016/j.vaccine.2014.06.076 .,OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1038/nri1934 .,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1016/j.ymeth.2013.10.008 .,OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/ 10.4049/jimmunol.1202441 .,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1007/ s40521-013-0006-5.,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1053/j.gastro.,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1016/j.jaci.2015.,OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1016/j.jaci.2011.02.004 .,OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1038/nprot.2007.,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1016/j.vaccine.2006.01.007 .,OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1586/ 14760584.2015.1050385 .,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1111/j.1365-2893.,Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
"204, 57 –68.http://dx.doi.org/10.1007/s00430-014- 0374-x .",Non-OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
http://dx.doi.org/10.1038/nri824 .67 C. Cornelius et al.,OADS,/arxiv_data1/oa_pdf/cb/a7/main.PMC5049759.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/c0/main.PMC5049881.pdf
It concluded thatContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssmphSSM -Population Health http://dx.doi.org/10.1016/j.ssmph.2016.07.004 2352-8273/ &2016 The Authors.,OADS,/arxiv_data1/oa_pdf/68/c0/main.PMC5049881.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/c0/main.PMC5049881.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.ssmph.2016.07.004 .,OADS,/arxiv_data1/oa_pdf/68/c0/main.PMC5049881.pdf
Mplus Version 7.0 .〈http://www.statmodel.,Non-OADS,/arxiv_data1/oa_pdf/68/c0/main.PMC5049881.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Cognitive instrumentsTelemedicine Epidemiological studies Ageing 1.,Non-OADS,/arxiv_data1/oa_pdf/0e/b7/main.PMC5049917.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.001 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/b7/main.PMC5049917.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/b7/main.PMC5049917.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Acute HIV infection Art HIV DNAReservoirPersistence 1.,Non-OADS,/arxiv_data1/oa_pdf/4c/4c/main.PMC5049918.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.024 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/4c/main.PMC5049918.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/4c/main.PMC5049918.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Infectious diseaseInnate immunityLungSingle nucleotide polymorphismSNP Promoter Haplotype 1.,Non-OADS,/arxiv_data1/oa_pdf/d9/01/main.PMC5049919.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.011 2352-3964/Published by Elsevier B.V.,OADS,/arxiv_data1/oa_pdf/d9/01/main.PMC5049919.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/01/main.PMC5049919.pdf
"Relatedness of RSV dis- ease phenotypes was done using Pearson's correlation coef ﬁcients (Gene Network, http://www.genenetwork.org ).",OADS,/arxiv_data1/oa_pdf/d9/01/main.PMC5049919.pdf
Candidate gene SNP and haplotype data were obtained from the Mouse Phenome Database (MPD; Jackson Laboratory; http://phenome.jax.org ; dbSNP 138 annotation).,OADS,/arxiv_data1/oa_pdf/d9/01/main.PMC5049919.pdf
(c) Hierarchical clustering of 29 mouse strains based on 87 Marco SNPs ( http://phenome.jax.org/SNP ).,Non-OADS,/arxiv_data1/oa_pdf/d9/01/main.PMC5049919.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Foxp3+ regulatory T cells (Tregs)Cell-type-speci ﬁc epigenetic qPCR-assays Immune toleranceProspective study Cardiovascular disease risk 1.,Non-OADS,/arxiv_data1/oa_pdf/6e/3b/main.PMC5049920.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.035 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/3b/main.PMC5049920.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/3b/main.PMC5049920.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/ba/main.PMC5049921.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.028 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/ba/main.PMC5049921.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/ba/main.PMC5049921.pdf
"The minimal number of animals compatible with obtaining valid sci- entiﬁc results was calculated by a statistical design of the sample size using the software http://homepage.stat.uiowa.edu/~rlenth/Power/ , setting a variation coef ﬁcient (s) of 30%, alpha of 5%, and a power of 80% (p).",OADS,/arxiv_data1/oa_pdf/8e/ba/main.PMC5049921.pdf
"As technology becomes integrated into healthcare, further validation stud- ies will be required to ensure that the technologies used to perform rou- tine in-clinic evaluations provides the same valid and reliable data as the in-clinic, face-to-face assessment.EBioMedicine 11 (2016) 23 –24 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.08.001 .",Non-OADS,/arxiv_data1/oa_pdf/74/ee/main.PMC5049922.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.002 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/ee/main.PMC5049922.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/ee/main.PMC5049922.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Hepatitis E virusHEV infectionHEV mutationHEV variability HEV treatment failure HEV replication Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/e0/98/main.PMC5049923.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.0392352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/98/main.PMC5049923.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/98/main.PMC5049923.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Circulating tumor cell Fluidic cell microarray chipCellSearchPrognostic markerBreast cancer 1.,Non-OADS,/arxiv_data1/oa_pdf/87/13/main.PMC5049925.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.027 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/87/13/main.PMC5049925.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/13/main.PMC5049925.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Treponema pallidumDipteriaYawsNonhuman primatesTransmission 1.,Non-OADS,/arxiv_data1/oa_pdf/9d/36/main.PMC5049926.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.033 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/36/main.PMC5049926.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/36/main.PMC5049926.pdf
Sequences were compared to respective orthologous se- quences available in GenBank using the standard nucleotide (nt) BLAST search option ( http://blast.ncbi.nlm.nih.gov/Blast.cgi )a tt h e NCBI homepage.,OADS,/arxiv_data1/oa_pdf/9d/36/main.PMC5049926.pdf
Tree visualization and editing was performed in FigTree 1.4.2 ( http://tree.bio.ed.ac.uk/software/ ﬁgtree/ ).,OADS,/arxiv_data1/oa_pdf/9d/36/main.PMC5049926.pdf
Fly image source: http://www.oldskoolman.de/bilder/plog-content/images/freigestellte-bilder/natur-tiere/ ﬂiege-mit-ruessel.,Non-OADS,/arxiv_data1/oa_pdf/9d/36/main.PMC5049926.pdf
correlated the rCBF of the regions that presented signi ﬁcant perfusion differences with subjective scoresEBioMedicine 11 (2016) 29 –30 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.07.008 .,OADS,/arxiv_data1/oa_pdf/62/c2/main.PMC5049927.pdf
"URL: http://www.paininmotion.be (I. Coppieters), http://www.paininmotion.be (A. Mal ﬂiet).",Non-OADS,/arxiv_data1/oa_pdf/62/c2/main.PMC5049927.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.010 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/62/c2/main.PMC5049927.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/c2/main.PMC5049927.pdf
Though Ananworanich and colleagues did not evaluate tissue-based viral measures where most of the latent HIVEBioMedicine 11 (2016) 7 –8 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.07.024.,OADS,/arxiv_data1/oa_pdf/5e/3e/main.PMC5049928.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.009 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/3e/main.PMC5049928.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/3e/main.PMC5049928.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Diabetic retinopathy microRNA SphingolipidsDyslipidemiasVascular system injuries 1.,Non-OADS,/arxiv_data1/oa_pdf/18/39/main.PMC5049929.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.013 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/18/39/main.PMC5049929.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/39/main.PMC5049929.pdf
Data analysis was performedwith the web-based software package for the miRNA PCR array system (http://www.sabiosciences.com/pcr/arrayanalysis.php ) and TargetScan (http://www.targetscan.org /).,OADS,/arxiv_data1/oa_pdf/18/39/main.PMC5049929.pdf
"To determine if altered miRNA control could contribute to ASM upregulation in diabetes, we used Target Scan ( http://www.targetscan.org /) to identify miRNAs that have target sequence for the 3 ′UTR of ASM mRNA.",Non-OADS,/arxiv_data1/oa_pdf/18/39/main.PMC5049929.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: NAT2 reaction kinetics Isoniazid concentrationMaturationNAT2 genotypeArtiﬁcial intelligence 1.,Non-OADS,/arxiv_data1/oa_pdf/bc/c9/main.PMC5049930.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.031 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/c9/main.PMC5049930.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/c9/main.PMC5049930.pdf
"NAT2 alleles were characterized by polymorphisms located at seven positions 191, 282, 341, 481, 590, 803, and 857, as described by the Database of arylamine N-acetyltransferases (NATs) ( http://nat.mbg.duth.gr ; McDonagh et al., 2014; Sabbagh et al., 2011 ).",Non-OADS,/arxiv_data1/oa_pdf/bc/c9/main.PMC5049930.pdf
http://dx.doi.org/10.1002/psp4.17 Epub 2015 Feb 4.,Non-OADS,/arxiv_data1/oa_pdf/bc/c9/main.PMC5049930.pdf
"BMC Bioinformatics 15,92.http://dx.doi.org/10.1186/1471-2105-15-92 .",Non-OADS,/arxiv_data1/oa_pdf/bc/c9/main.PMC5049930.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Sickle cell trait Red cell storageBloodPost-transfusion survivalTransfusion practiceRBC hemolysis 1.,Non-OADS,/arxiv_data1/oa_pdf/93/e7/main.PMC5049931.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.0062352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/93/e7/main.PMC5049931.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/e7/main.PMC5049931.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: BMP4EstrogenERα White adipose tissueGlucose metabolism 1.,Non-OADS,/arxiv_data1/oa_pdf/54/e6/main.PMC5049932.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.034 2352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/54/e6/main.PMC5049932.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/e6/main.PMC5049932.pdf
"The primers were from (PrimerBank http://pga.mgh.harvard.edu/primerbank/ ), and listed in Supplementary Table 1.",Non-OADS,/arxiv_data1/oa_pdf/54/e6/main.PMC5049932.pdf
"The number of the vaccine recipients evaluat- ed is small and no titers were determined, but the data are suf ﬁcient toEBioMedicine 11 (2016) 5 –6 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.07.023 .",OADS,/arxiv_data1/oa_pdf/ad/53/main.PMC5049933.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.07.032 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/53/main.PMC5049933.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/53/main.PMC5049933.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.012 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/c3/main.PMC5049934.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/c3/main.PMC5049934.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Smoking cessationGeneticsMeta-analysisLung cancer 1.,Non-OADS,/arxiv_data1/oa_pdf/eb/c3/main.PMC5049934.pdf
"Seer Cancer Statistics Review, 1975 – 2010. http://seer.cancer.gov/csr/1975_2010/ (accessed April 2013).",Non-OADS,/arxiv_data1/oa_pdf/eb/c3/main.PMC5049934.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Progranulinβ-Glucocerebrosidase Gaucher diseaseLysosomal storage diseases 1.,Non-OADS,/arxiv_data1/oa_pdf/e8/e2/main.PMC5049935.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.004 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/e2/main.PMC5049935.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/e2/main.PMC5049935.pdf
"The sequence of each patient was sorted out by theirbarcode sequence, and full-length GRN sequence was aligned from 5 fragments using blasr from Paci ﬁc BioSciences ( https://github.com/ PaciﬁcBiosciences/blasr ,http://www.biomedcentral.com/1471-2105/ 13/238/abstract ), and then SAMtools (http://samtools.sourceforge.net/ ) were used to detect the variants in the patients samples.",OADS,/arxiv_data1/oa_pdf/e8/e2/main.PMC5049935.pdf
"FCTC article 14: tobacco dependence and cessation, evidence from the ITC project.Available at: http://www.treatobacco.net/en/uploads/documents/Other%20 Documents/ITC%20report%202010%20on%20treatment%20in%20relation %20to%20Article%2014%20of%20the%20FCTC.pdf .",Non-OADS,/arxiv_data1/oa_pdf/15/40/cej-25-556.PMC5049938.pdf
Available at: https://www.nice.org.uk/guidance/ph10/ resources/evidence-review-nhs-treatments2 .,Non-OADS,/arxiv_data1/oa_pdf/15/40/cej-25-556.PMC5049938.pdf
Available at: http://www.ncsct.co.uk/usr/pub/Briefing%208.pdf .,Non-OADS,/arxiv_data1/oa_pdf/15/40/cej-25-556.PMC5049938.pdf
Available at: http://www.who.int/classifications/apps/ icd/icd10online/Last .,Non-OADS,/arxiv_data1/oa_pdf/15/40/cej-25-556.PMC5049938.pdf
Available at: http://www.who.int/tobacco/global_ report/2015/en/ .,Non-OADS,/arxiv_data1/oa_pdf/15/40/cej-25-556.PMC5049938.pdf
https://www.healthit.gov/sites/default/ﬁles/ ONC10yearInteroperabilityConceptPaper.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1f/da/jpump-22-s44.PMC5049940.pdf
https://www.nachc.com/client/Key% 20HIT%20Terms%20Deﬁnitions%20Final April 2008.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1f/da/jpump-22-s44.PMC5049940.pdf
The online-only Data Supplement is available with this article at http://stroke.ahajournals.org/lookup/suppl/doi:10.1161/STROKEAHA.,OADS,/arxiv_data1/oa_pdf/3a/6b/str-47-2476.PMC5049943.pdf
Stroke is available at http://stroke.ahajournals.org DOI: 10.1161/STROKEAHA.116.014179,Non-OADS,/arxiv_data1/oa_pdf/3a/6b/str-47-2476.PMC5049943.pdf
Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (http://www.JPHMP.com).,Non-OADS,/arxiv_data1/oa_pdf/64/b2/jpump-22-s75.PMC5049944.pdf
"A sample of 500 LHDs was selected from the NAC- CHO 2013 National Proﬁle of Local Health Depart- ments database of approximately 2532 LHDs using a stratiﬁed sampling design based on 3 population strata(<50 000, 50 000-499 999, and 500 000 +)a n dL H DS y S status (yes, no, no response) (see the Table, Supplemen- tal Digital Content 1, available at: http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/64/b2/jpump-22-s75.PMC5049944.pdf
http://archived.naccho.org/topics/infrastructure/proﬁle/ upload/2013-national-proﬁle-of-local-health-departments- report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/64/b2/jpump-22-s75.PMC5049944.pdf
Availsble at: http://ec.europa.eu/health/files/ eudralex/vol-9/pdf/vol9a_09-2008_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2c/6d/yic-31-315.PMC5049945.pdf
Available at: http://www.ema.europa.eu/docs/en_GB/ document_library/Report/2010/04/WC500089603.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2c/6d/yic-31-315.PMC5049945.pdf
Available at: http://www.imi-protect.eu/documents/HughesetalRecommendationsforthe methodologyandvisualisationtechniquestobeusedintheassessmento.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2c/6d/yic-31-315.PMC5049945.pdf
Available at: http://www.imi.europa.eu/sites/default/files/uploads/pdfexports/project245.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2c/6d/yic-31-315.PMC5049945.pdf
Available at: http://www.fda.gov/downloads/medicaldevices/devicer egulationandguidance/guidancedocuments/ucm296379.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2c/6d/yic-31-315.PMC5049945.pdf
Available at: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/2c/6d/yic-31-315.PMC5049945.pdf
Available at: http://www.fda.gov/ downloads/medicaldevices/deviceregulationandguidance/guidancedocu ments/ucm446680.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2c/6d/yic-31-315.PMC5049945.pdf
http://www.himss.org/ library/interoperability-standards/what-is- interoperability.,Non-OADS,/arxiv_data1/oa_pdf/3a/f1/jpump-22-s34.PMC5049946.pdf
http://blog.healthlanguage.com/ understand-the-three-levels-of-interoperability.,Non-OADS,/arxiv_data1/oa_pdf/3a/f1/jpump-22-s34.PMC5049946.pdf
"Study design This was an exploratory, open-label, flexible-dose study carried out between November 2013 and October 2014 (http://www.clinicaltrials.gov ; NCT02013622).",Non-OADS,/arxiv_data1/oa_pdf/90/50/yic-31-307.PMC5049948.pdf
Available at: http://www.medical- outcomes.com .,Non-OADS,/arxiv_data1/oa_pdf/90/50/yic-31-307.PMC5049948.pdf
"A description of the short-form MEI is provided in Supplementary Table 1 (Supplemental digital content 1, http://links.lww.com/ICP/A19 ).",Non-OADS,/arxiv_data1/oa_pdf/d7/ae/yic-31-332.PMC5049949.pdf
"Functional impairment and functional health were eval- uated using the Sheehan Disab ility Scale (SDS) and SF-36, respectively (Supplementary Table 1, Supplemental digital content 1, http://links.lww.com/ICP/A19 ).",OADS,/arxiv_data1/oa_pdf/d7/ae/yic-31-332.PMC5049949.pdf
"1, Supplemental digital content 1, http://links.lww.com/ICP/A19 ).",Non-OADS,/arxiv_data1/oa_pdf/d7/ae/yic-31-332.PMC5049949.pdf
"3).Significant differences between treatment groups werealso found in the SF-36 domains of general health, socialfunctioning, and role emotional (Supplementary Table 2,Supplemental digital content 1, http://links.lww.com/ICP/ A19).",Non-OADS,/arxiv_data1/oa_pdf/d7/ae/yic-31-332.PMC5049949.pdf
"To gain an understanding of the current train- ing needs at LHDs, the National Association of City & County Health Ofﬁcials (NACCHO) con- ducted an Informatics Capacity and Needs Assess- ment Survey (http://essentialelements.naccho.org/ archives/2314).",Non-OADS,/arxiv_data1/oa_pdf/9e/49/jpump-22-s63.PMC5049951.pdf
Paper 1398. http://digitalcommons.georgiasouthern.edu/etd/1398/.,Non-OADS,/arxiv_data1/oa_pdf/9e/49/jpump-22-s63.PMC5049951.pdf
"The spectacles were then returned to the participant who was asked to wear each pair for at least 2 hours over a 2- to 3-day period, and subsequently complete a questionnaire regardingvision, comfort, fit, and how acceptable and safe they felt thespectacles were (see Appendix A, available at http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/d6/67/opx-93-1196.PMC5049952.pdf
"Primary Outcomes Participant Preference and Indication of Acceptability and Safety The most appropriate assessment of spectacles is whether pa- tients find them acceptable or not,10,11which is partly based onwhether they are symptom-free.12The participants provided in- formation regarding their preference (they ranked the spectaclesfrom 1st to 10th) and whether the spectacles were unacceptableand/or unsafe (Appendix A, avail able at http://links.lww.com/ OPX/A256).",Non-OADS,/arxiv_data1/oa_pdf/d6/67/opx-93-1196.PMC5049952.pdf
APPENDIX The two questionnaires given to participants in the study are available at http://links.lww.com/OPX/A256.,Non-OADS,/arxiv_data1/oa_pdf/d6/67/opx-93-1196.PMC5049952.pdf
Eligible pro- fessional Meaningful Use menu set: measures measure 1 of 6. https://www.cms.gov/Regulations-andGuidance/ Legislation/EHRIncentivePrograms/downloads/ Stage2 EPMenu 1SyndromicSurveillanceDataSub.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b6/88/jpump-22-s69.PMC5049954.pdf
https://www.healthit.gov/policy-researchers-implementers/ health-it-legislation.,Non-OADS,/arxiv_data1/oa_pdf/44/d9/jpump-22-s03.PMC5049957.pdf
"TABLE ●Free Online Courses, and Resources in Public Health Informaticsqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqqq Title Web Site Collaborative Requirements Development Methodology Processhttp://phii.org/crdm Resources and Toolkits http://phii.org/resources Health Informatics Fundamentals for Public Health Staff (10 wk/40-h course)https://www.healthit.gov/providers -professionals/implementation- resources/online-training-health -informatics-fundamentals Meaningful Use Basic Training for Public Health Professionalshttp://www.cdc.gov/ehrmeaningfuluse/ training.html Informatics Workforce Development and Traininghttps://www.cdph.ca.gov/data/ informatics/resource/Pages/default.",Non-OADS,/arxiv_data1/oa_pdf/2a/9e/jpump-22-s06.PMC5049959.pdf
aspx Health Informatics Forum Massive Open Online Course (MOOC)http://www.healthinformatics forum.com/MOOC,Non-OADS,/arxiv_data1/oa_pdf/2a/9e/jpump-22-s06.PMC5049959.pdf
"Washington, DC: National Academies Press; 2013. http://veterans.iom.edu/ ∼/media/Files/ Perspectives-Files/2013/Discussion-Papers/BPH-HiAP .",Non-OADS,/arxiv_data1/oa_pdf/2a/9e/jpump-22-s06.PMC5049959.pdf
http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/2a/9e/jpump-22-s06.PMC5049959.pdf
http://www.naccho.org/ uploads/downloadable-resources/Policy-and-Advocacy/ 11-05-LHD-Involvement-in-Meaningful-Use.pdf.,Non-OADS,/arxiv_data1/oa_pdf/43/fb/jpump-22-s18.PMC5049960.pdf
http://hab.hrsa.gov/manageyourgrant/ careware.html.,Non-OADS,/arxiv_data1/oa_pdf/43/fb/jpump-22-s18.PMC5049960.pdf
https://wwwn.cdc.gov/nndss/.,OADS,/arxiv_data1/oa_pdf/43/fb/jpump-22-s18.PMC5049960.pdf
http://www.resolv.org/site-healthleadershipforum /ﬁles/2014/03/Articulation-of-Foundational-Capabilities- and-Foundational-Areas-v1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d4/61/jpump-22-s58.PMC5049962.pdf
http://www.health.gov/phfunctions/ public.htm.,Non-OADS,/arxiv_data1/oa_pdf/d4/61/jpump-22-s58.PMC5049962.pdf
http://www.phii.org/academy.,Non-OADS,/arxiv_data1/oa_pdf/d4/61/jpump-22-s58.PMC5049962.pdf
http://www.astho.org/Press-Room/ ASTHO-and-de-Beaumont-Foundation-Commit-to-Improve -the-Public-Health-Workforce/12-12-15.,Non-OADS,/arxiv_data1/oa_pdf/d4/61/jpump-22-s58.PMC5049962.pdf
Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (http://www.JPHMP.com).,Non-OADS,/arxiv_data1/oa_pdf/19/bb/jpump-22-520.PMC5049964.pdf
The BCHC is a group of large LHDs from across the coun- try that together serve 51 million people in the United States (http://www.bigcitieshealth.org/).,Non-OADS,/arxiv_data1/oa_pdf/19/bb/jpump-22-520.PMC5049964.pdf
"Networks were composed of 8 organization types: coalitions, foundations, for-proﬁts, government agen- cies, schools/universities, hospitals/clinics, nonprof- its, and voluntary/advocacy organizations (see Sup- plemental Digital Content 1, available at: http://links.lww.com/JPHMP/A206, which shows the composi- tion of 89 BCHC local public health networks by or- ganization type).",OADS,/arxiv_data1/oa_pdf/19/bb/jpump-22-520.PMC5049964.pdf
"Supplemental Digital Content 2 (available at http://links.lww.com/JPHMP/A207) shows a net- work from each policy area that is near the mean on all metrics shown in the Table for the policy area indicated; note the noncentral location of the LHD and the lim- ited diversity in partner types for the core local fund- ing, with 13 of the 21 organizations in the network be- ing from the nonproﬁt (orange) and school/university",Non-OADS,/arxiv_data1/oa_pdf/19/bb/jpump-22-520.PMC5049964.pdf
Note the small size and centralized structure of the infant mortality network shown in Supplemental Digital Content 2 (available at: http://links.lww.com/JPHMP/A207).,Non-OADS,/arxiv_data1/oa_pdf/19/bb/jpump-22-520.PMC5049964.pdf
"This health department had the smallest networks overall and included a large proportion of partners that were coalitions, as shown in Supplemental Digital Con- tent 3 (available at: http://links.lww.com/JPHMP/ A208).●Discussion We identiﬁed and examined contact and working rela- tionships across 15 LHDs in large urban areas and their local partners working on public health policy.",OADS,/arxiv_data1/oa_pdf/19/bb/jpump-22-520.PMC5049964.pdf
http://www.cdc.gov/nphpsp/ essentialServices.html.,OADS,/arxiv_data1/oa_pdf/19/bb/jpump-22-520.PMC5049964.pdf
http://www.cdc.gov/stltpublichealth/ policy.,Non-OADS,/arxiv_data1/oa_pdf/19/bb/jpump-22-520.PMC5049964.pdf
http://www.astho.org/phwins/Promotional- Materials.,Non-OADS,/arxiv_data1/oa_pdf/19/bb/jpump-22-520.PMC5049964.pdf
This review was adapted from the Prescribe to Prevent online continuing medical education module created for prescribers and pharmacists (http://www.opioidprescri- bing.com/naloxone_module_1-landing).,Non-OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
"/C2232015 American Heart Association, Inc. (http://circ.ahajournals.org/content/ 132/18_suppl_2/S501.long).J Addict Med /C15Volume 10, Number 5, September/October 2016 Overdose Prevention and Naloxone Rescue Kits /C2232016 American Society of Addiction Medicine 303",Non-OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
Available at: http://www.ama-assn.org/ama/ama-wire/post/its- saving-lives-increasing-access-naloxone.,Non-OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
Available at: http://www.pharmacist.com/policy/controlled-sub- stances-and-other-medications-potential-abuse-and-use-opioid-reversal- agents-2.,Non-OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
Available at: http://www.asam.org/docs/default-source/publicy-policy- statements/1naloxone-rev-8-14.pdf.,Non-OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
Available at: http://www.mass.gov/eohhs/docs/ dph/substance-abuse/opioid/fy-15-oend-pilot-expansion-report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
Available at: http://www.samhsa.gov/data/sites/default/files/NSDUHNa- tionalFindingsResults2010-web/2k10ResultsRev/NSDUHresults- Rev2010.pdf.,OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
Available at: http://store.samh- sa.gov/shin/content//SMA14-4742/Overdose_Toolkit.pdf.,Non-OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
Available at: http://wonder.cdc.gov/mcd-icd10.html.,OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
Available at: http://www.cdc.gov/drugoverdose/data/overdo- se.html.,OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
Available at: http://www.ihs.gov/IHM/index.- cfm?module=dsp_ihm_sgm_main&sgm=ihm_sgm_9602.,OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
Available at: http://aspe.hhs.gov/sp/reports/2015/OpioidInitiative/ib_O- pioidInitiative.cfm.,Non-OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
Available at: https://www.federalregister.gov/articles/2014/ 09/09/2014-20926/disposal-of-controlled-substances.,OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
Avail- able at: http://www.deadiversion.usdoj.gov/drug_disposal/takeback/.,Non-OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm473505.htm.,Non-OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
Available at: http://www.fda.gov/Drugs/DrugSafety/ InformationbyDrugClass/ucm337852.htm.,Non-OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
Available at: http://www.unodc.org/documents/wdr2014/World_- Drug_Report_2014_web.pdf.,Non-OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
Available at: http://apps.who.int/iris/bitstream/ 10665/137462/1/9789241548816_eng.pdf?ua=1&ua=1.,Non-OADS,/arxiv_data1/oa_pdf/34/73/adm-10-300.PMC5049966.pdf
Available at http://www.cdc.gov/ vitalsigns/smokingandmentalillness/index.html.,Non-OADS,/arxiv_data1/oa_pdf/1f/77/adm-10-291.PMC5049967.pdf
Available at: https://www.cms.gov/Outreach- and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/ downloads/MM7133.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1f/77/adm-10-291.PMC5049967.pdf
Available at: http://c.ymcdn.com/sites/www.naquitline.org/resource/resmgr/Research/ March112015summary.pdf.,OADS,/arxiv_data1/oa_pdf/1f/77/adm-10-291.PMC5049967.pdf
Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/pccmjournal).,Non-OADS,/arxiv_data1/oa_pdf/c5/1d/pcc-17-957.PMC5049969.pdf
"Data were also collected on several neurodevelopmental care measures (for details, see ESM-1, Supplemental Digital Content 1, http://links.lww.com/PCC/A283).",OADS,/arxiv_data1/oa_pdf/c5/1d/pcc-17-957.PMC5049969.pdf
"We clas- sified units into three groups for these two indicators, with  group 1 having the lowest level of implementation and group 3  aiming for the highest level (supplemental file, Supplemental  Digital Content 1, http://links.lww.com/PCC/A283).",OADS,/arxiv_data1/oa_pdf/c5/1d/pcc-17-957.PMC5049969.pdf
Available at: http://www.efcni.org/index.php?id=1890.,Non-OADS,/arxiv_data1/oa_pdf/c5/1d/pcc-17-957.PMC5049969.pdf
Available at: http://www.unicef.org/crc/.,Non-OADS,/arxiv_data1/oa_pdf/c5/1d/pcc-17-957.PMC5049969.pdf
Availabe at: http://www.sante.gouv.fr/fichiers/bo/2004/04-52/a0523394.htm.,Non-OADS,/arxiv_data1/oa_pdf/c5/1d/pcc-17-957.PMC5049969.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: AspirinSystems pharmacogenomicsCardiovascular disease Colorectal cancer Gene expression pro ﬁling RUNX1 1.,Non-OADS,/arxiv_data1/oa_pdf/1d/53/main.PMC5049978.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.021 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/53/main.PMC5049978.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/53/main.PMC5049978.pdf
The coordinates of the peaks were convert- ed from hg18 to hg19 using liftOver ( https://genome.ucsc.edu/cgi-bin/ hgLiftOver ) and gene annotation was determined using Homer (http://homer.salk.edu/homer/ngs/index.html ).,OADS,/arxiv_data1/oa_pdf/1d/53/main.PMC5049978.pdf
All statistical analyses were conducted in R version 3.2 ( http://www.r-project.org /) using packages limma differential expression analysis and meta for meta-analyses.,OADS,/arxiv_data1/oa_pdf/1d/53/main.PMC5049978.pdf
"The present ﬁndings would seem to suggest that addictive behavior really lies behind genetic contributions to lung cancer, at least for this “lung cancer ”locus, although certainly more remains to be done to assess the nature of the wider genetic contributions to lung cancer risk.EBioMedicine 11 (2016) 19 –20 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.08.012 .",Non-OADS,/arxiv_data1/oa_pdf/65/56/main.PMC5049979.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.026 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/65/56/main.PMC5049979.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/56/main.PMC5049979.pdf
"If there were some, the hunt for mechanistic explanation will be on, etc.EBioMedicine 11 (2016) 25 –26 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.08.019 .",Non-OADS,/arxiv_data1/oa_pdf/54/df/main.PMC5049980.pdf
ﬁ. http://dx.doi.org/10.1016/j.ebiom.2016.08.032 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/54/df/main.PMC5049980.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/df/main.PMC5049980.pdf
This pro- vides one possible explanation for the contradictory ﬁndings regardingEBioMedicine 11 (2016) 27 –28 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.08.015 .,Non-OADS,/arxiv_data1/oa_pdf/bd/8d/main.PMC5049981.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.025 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/8d/main.PMC5049981.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/8d/main.PMC5049981.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.047 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/03/main.PMC5049982.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/03/main.PMC5049982.pdf
1http://www.approachproject.eu3 C.R.,Non-OADS,/arxiv_data1/oa_pdf/b7/03/main.PMC5049982.pdf
Particularly the latterEBioMedicine 11 (2016) 11 –12 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.07.031 .,Non-OADS,/arxiv_data1/oa_pdf/00/bf/main.PMC5049983.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.040 2352-3964/© 2016 Forschungsgesellschaft fur Arbeitsphysiologie und Arbe itschutz e.V.,Non-OADS,/arxiv_data1/oa_pdf/00/bf/main.PMC5049983.pdf
This is an open access article un der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/bf/main.PMC5049983.pdf
Nineteen of the 23 TPsequences from the ﬂies were identicalEBioMedicine 11 (2016) 9 –10 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.07.033 .,OADS,/arxiv_data1/oa_pdf/fd/a9/main.PMC5049984.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.028 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/fd/a9/main.PMC5049984.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/a9/main.PMC5049984.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Lung cancerSerum biomarkersRisk factors Early detection LDCT 1.,Non-OADS,/arxiv_data1/oa_pdf/bd/42/main.PMC5049985.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.018 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/42/main.PMC5049985.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/42/main.PMC5049985.pdf
"The biomarkers were measured as described above, and the blinded patients were predicted as cancer or non-cancer by the BRB-Array Tools package (version 3.6) available at http://linus.nci.nih.gov/BRB-ArrayTools.html .B r i e ﬂy, a predictor model was created using the 4-biomarker panel after adjustment for age, sex and smoking status in the training set, then subsequently tested in the validation cohort.",Non-OADS,/arxiv_data1/oa_pdf/bd/42/main.PMC5049985.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Ryanodine receptor Nitric oxide CalciumSeizuresNeurodegeneration 1.,Non-OADS,/arxiv_data1/oa_pdf/35/b7/main.PMC5049986.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.0202352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/35/b7/main.PMC5049986.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/b7/main.PMC5049986.pdf
"These results are perhaps not surprising, but their work emphasises that our appreciation of the condition is in- complete and highlight the need for further studies including use of SCT red cells for transfusion, especially in areas of greater prevalence of the genotype.EBioMedicine 11 (2016) 21 –22 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.08.006 .",Non-OADS,/arxiv_data1/oa_pdf/48/42/main.PMC5049987.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.023 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/42/main.PMC5049987.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/42/main.PMC5049987.pdf
"Notably, in a blinded test on patients with suspicious pulmonary nodules, the adjusted prediction model correctly discriminated patientsEBioMedicine 11 (2016) 17 –18 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.08.018 .",Non-OADS,/arxiv_data1/oa_pdf/19/12/main.PMC5049990.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.046 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/12/main.PMC5049990.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/12/main.PMC5049990.pdf
This is an open access article under the CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/37/main.PMC5049991.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.016  2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/37/main.PMC5049991.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/37/main.PMC5049991.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Circadian rhythmBipolar disordersPhase shiftCircadian dysregulation 1.,Non-OADS,/arxiv_data1/oa_pdf/cd/4e/main.PMC5049992.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.019 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/4e/main.PMC5049992.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cd/4e/main.PMC5049992.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Locally advanced and metastatic breast cancerNeoadjuvant systemic therapiesNeedle biopsiesThe RAS pathway activation in breast cancerSIAH E3 ligase Clinicopathological predictors And prognostic biomarkersEBioMedicine 11 (2016) 183 –198 Abbreviations: AUC, area under the curve; DRFS , distant recurrence-free survival; EGFR , epidermal growth factor receptor; ER, estrogen receptor; H&E , hematoxylin and eosin staining; HER2 , human epidermal growth factor receptor 2; IHC, immunohistochemistry; LN,l y m p hn o d e ; MRI,magnetic resonance imaging ;NRT, no residual tumor; NST, neoadjuvant systemic therapy; phospho-ERK , phosphorylated extracellular signal-regulated kinases; pCR, pathological complete response; pIR, pathological incomplete response; PH, proportional hazards; PR,progesterone receptor ;ROC, receiver operating characteristic; SIAH , human homologues of Drosophila Seven-In-Absentia (SINA); SOC,s t a n d a r do fc a r e ; sROC , survival receiver operating characteristic (sROC); TNBC , triple-negative breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/ad/08/main.PMC5049993.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.014 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/08/main.PMC5049993.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/08/main.PMC5049993.pdf
"Interestingly, relevant auto-antigens such as apolipoprotein B and heat shock proteins haveEBioMedicine 11 (2016) 15 –16 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.07.035 .",Non-OADS,/arxiv_data1/oa_pdf/0a/eb/main.PMC5049994.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.044 2352-3964/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/0a/eb/main.PMC5049994.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/eb/main.PMC5049994.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: TelomereTelomere lengthRaceSocioeconomic positionSingle nucleotide polymorphismPolygenic risk score 1.,Non-OADS,/arxiv_data1/oa_pdf/7a/fb/main.PMC5049995.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.015 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/fb/main.PMC5049995.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/fb/main.PMC5049995.pdf
EBioMedicine.EBioMedicine 11 (2016) 1 http://dx.doi.org/10.1016/j.ebiom.2016.09.009 2352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/73/b0/main.PMC5049996.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/b0/main.PMC5049996.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: AgingSenescenceExhaustion 1.,Non-OADS,/arxiv_data1/oa_pdf/c8/dd/main.PMC5049997.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.0292352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/dd/main.PMC5049997.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/dd/main.PMC5049997.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: RORα Subcutaneous adipose Obesity HepatomegalyFibrosisCollagen 1.,Non-OADS,/arxiv_data1/oa_pdf/75/87/main.PMC5049998.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.0272352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/75/87/main.PMC5049998.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/87/main.PMC5049998.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Key words: VaccineGrass pollenB cell-epitopeChallenge chamberImmunotherapy 1.,Non-OADS,/arxiv_data1/oa_pdf/33/38/main.PMC5049999.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.022 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/38/main.PMC5049999.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/38/main.PMC5049999.pdf
Thestudy has been registered at https://clinicaltrials.gov under the identi ﬁ- er: NCT01445002.,Non-OADS,/arxiv_data1/oa_pdf/33/38/main.PMC5049999.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Neurons Glia AstrocytesPsychedelicsGene expressionmPFCSerotoninImmuno ﬂuorescence FACS Neurocytometry 5-HT2A 1.,Non-OADS,/arxiv_data1/oa_pdf/af/42/main.PMC5050000.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.049 2352-3964/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/af/42/main.PMC5050000.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/42/main.PMC5050000.pdf
"Furthermore, long termEBioMedicine 11 (2016) 13 –14 DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.08.013 .",Non-OADS,/arxiv_data1/oa_pdf/64/1a/main.PMC5050010.pdf
http://dx.doi.org/10.1016/j.ebiom.2016.08.017 2352-3964/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/64/1a/main.PMC5050010.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/1a/main.PMC5050010.pdf
http://dx.doi.org/10.1038/nrg2504 .,Non-OADS,/arxiv_data1/oa_pdf/64/1a/main.PMC5050010.pdf
31867. http://dx.doi.org/10.1155/2007/ 31867 .,Non-OADS,/arxiv_data1/oa_pdf/64/1a/main.PMC5050010.pdf
http://dx.doi.org/10.1007/s00125- 014-3197-9 .,Non-OADS,/arxiv_data1/oa_pdf/64/1a/main.PMC5050010.pdf
"PLoSOne, 10:e0123987 http://dx.doi.org/10.1371/journal.pone.0123987 .",Non-OADS,/arxiv_data1/oa_pdf/64/1a/main.PMC5050010.pdf
"J. Neuroin ﬂammation 12, 141. http://dx.doi.org/10.1186/s12974-015-0368-7 .14 S. Chakrabarti / EBioMedicine 11 (2016) 13 –14",Non-OADS,/arxiv_data1/oa_pdf/64/1a/main.PMC5050010.pdf
PCR amplicon primers  were designed with Primer3Plus ( http://www.bioinformatics.nl/cgi-bin/primer3plus/ primer3plus.cgi/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/3d/nihms5404.PMC5050031.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/ba/nihms5160.PMC5050037.pdf
2012. http://dx.doi.org/10.1111/j.1740-8709.2012.00431.x  [Published online July 9] 17.,Non-OADS,/arxiv_data1/oa_pdf/40/ba/nihms5160.PMC5050037.pdf
2013. http://dx.doi.org/10.1111/ mcn.12053  [Published online June 18] 19.,Non-OADS,/arxiv_data1/oa_pdf/40/ba/nihms5160.PMC5050037.pdf
2013. http://dx.doi.org/10.1136/ archdischild-2013-304422  [Published online July 18] 37.,Non-OADS,/arxiv_data1/oa_pdf/40/ba/nihms5160.PMC5050037.pdf
2014. http://dx.doi.org/10.1038/jp.2014.8 43.,Non-OADS,/arxiv_data1/oa_pdf/40/ba/nihms5160.PMC5050037.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Supplementary Information accompanies this paper on International Journal of Obesity website (http://www.nature.com/ijo)Obesity and lymphatic function GD García Nores et al 1590 International Journal of Obesity (2016) 1582 –1590",Non-OADS,/arxiv_data1/oa_pdf/dd/17/ijo201696a.PMC5050064.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)SHP-2-upregulated ZEB1 mediates glioma EMT and invasion L Zhang et al 5652 Oncogene (2016) 5641 –5652 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/1c/53/onc2016100a.PMC5050071.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/89/c8/main.PMC5050256.pdf
E-mail address: Kunle.ashaye@hpft.nhs.uk http://dx.doi.org/10.1016/j.dadm.2016.03.003 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/89/c8/main.PMC5050256.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/c8/main.PMC5050256.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/91/main.PMC5050257.pdf
E-mail address: m.dauwan-3@umcutrecht.nl http://dx.doi.org/10.1016/j.dadm.2016.07.003 2352-8729/ /C2112016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/91/main.PMC5050257.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/91/main.PMC5050257.pdf
"Data were converted to American Standard Code for Information Interchange (ASCII) format, and 4 epochs of 4096 samples per subject (i.e., approximately 4!8 s EEG data per subject, sufﬁcient to perform qEEG an- alyses [25]) were loaded into the BrainWave software for further analysis (BrainWave version 0.9.152.2.17, C. J.Stam; available for download at http://home.kpn.nl/ stam7883/brainwave.html ).",OADS,/arxiv_data1/oa_pdf/5b/91/main.PMC5050257.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.dadm.2016.07.003 .,OADS,/arxiv_data1/oa_pdf/5b/91/main.PMC5050257.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/4e/main.PMC5050258.pdf
http://dx.doi.org/10.1016/j.dadm.2016.08.002 Fig.,OADS,/arxiv_data1/oa_pdf/86/4e/main.PMC5050258.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/21/main.PMC5050259.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.09.006 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/e0/21/main.PMC5050259.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Composite endpoint EliglustatGaucher disease type 1ImigluceraseNon-inferiority trialVelaglucerase alfa 1.,Non-OADS,/arxiv_data1/oa_pdf/2d/ee/main.PMC5050260.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.08.009 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/ee/main.PMC5050260.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2d/ee/main.PMC5050260.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/ba/main.PMC5050262.pdf
http://dx.doi.org/10.1016/j.eucr.2016.08.010Urology Case Reports 9 (2016) 51 e54,Non-OADS,/arxiv_data1/oa_pdf/b9/ba/main.PMC5050262.pdf
[6]http://www.umd.be/HSF3/ .,Non-OADS,/arxiv_data1/oa_pdf/12/8b/main.PMC5050266.pdf
[7]http://www.mutationtaster.org .,Non-OADS,/arxiv_data1/oa_pdf/12/8b/main.PMC5050266.pdf
16 September 2016 http://dx.doi.org/10.1016/j.ymgmr.2016.09.004 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/12/8b/main.PMC5050266.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/8b/main.PMC5050266.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by- nc-nd/4.0/ rThe Author(s) 2016 The Supplementary Information that accompanies this paper is available on t he Clinical and Translational Immuno logy website (http://www.nature.",Non-OADS,/arxiv_data1/oa_pdf/3b/53/cti201654a.PMC5050278.pdf
"Many helpful resources for participatory evaluation are available from the Community-CampusPartnerships for Health, https://ccph.memberclicks.",Non-OADS,/arxiv_data1/oa_pdf/35/4a/bmjqs-2015-004814.PMC5050280.pdf
"See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Shadish WR, Cook TD, Leviton LC.",Non-OADS,/arxiv_data1/oa_pdf/35/4a/bmjqs-2015-004814.PMC5050280.pdf
2004. http://www.eval.org/Publications/GuidingPrinciples.asp (accessed 15 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/35/4a/bmjqs-2015-004814.PMC5050280.pdf
"Princeton, NJ: Robert W ood Johnson Foundation, 2012. http://www.rwjf.org/content/dam/farm/reports/reports/2012/rwjf403010 (accessed 25 Nov 2014).Research and reporting methodology 806 Leviton LC, Melichar L. BMJ Qual Saf 2016; 25:803–807.",Non-OADS,/arxiv_data1/oa_pdf/35/4a/bmjqs-2015-004814.PMC5050280.pdf
"Princeton, NJ: Robert W ood Johnson Foundation, 2008. http://www.rwjf.org/content/dam/farm/reports/issue_ briefs/2008/rwjf35088 (accessed 13 Jan 2014).",Non-OADS,/arxiv_data1/oa_pdf/35/4a/bmjqs-2015-004814.PMC5050280.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 International Diabetes federation.,Non-OADS,/arxiv_data1/oa_pdf/d0/03/bjophthalmol-2015-307689.PMC5050285.pdf
"2013. http://www.idf.org/diabetesatlas2 Shaw JE, Sicree RA, Zimmet PZ.",Non-OADS,/arxiv_data1/oa_pdf/d0/03/bjophthalmol-2015-307689.PMC5050285.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/emermed-2015-205430).,Non-OADS,/arxiv_data1/oa_pdf/98/27/emermed-2015-205430.PMC5050286.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Quereshi N. Triage Systems: a review of the literature with reference to Saudia Arabia.,Non-OADS,/arxiv_data1/oa_pdf/98/27/emermed-2015-205430.PMC5050286.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ jclinpath-2015-203496).,OADS,/arxiv_data1/oa_pdf/e0/89/jclinpath-2015-203496.PMC5050288.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Wight TN.,Non-OADS,/arxiv_data1/oa_pdf/e0/89/jclinpath-2015-203496.PMC5050288.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/jclinpath-2016-203736).,Non-OADS,/arxiv_data1/oa_pdf/06/08/jclinpath-2016-203736.PMC5050289.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/archdischild-2015-309078).,Non-OADS,/arxiv_data1/oa_pdf/f3/d6/archdischild-2015-309078.PMC5050290.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Health and Social Care Information Centre.,Non-OADS,/arxiv_data1/oa_pdf/f3/d6/archdischild-2015-309078.PMC5050290.pdf
2014. http://www.nice.org.uk/guidance/cg176 (accessed 20 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/f3/d6/archdischild-2015-309078.PMC5050290.pdf
2012. http://www.nhs.uk/ NHSEngland/AboutNHSservices/Emergencyandurgentcareservices/Documents/2012/ map-of-major-trauma-centres-2012.pdf (accessed 20 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/f3/d6/archdischild-2015-309078.PMC5050290.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.06.010 2213-0071/ ©2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/7c/6f/main.PMC5050291.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 132 e134,Non-OADS,/arxiv_data1/oa_pdf/7c/6f/main.PMC5050291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: AtrophyCarotid occlusionCarotid diseaseCortical thicknessHigh-resolution MRIPrimary motor cortexPrimary visual cortex 1.,Non-OADS,/arxiv_data1/oa_pdf/4c/10/main.PMC5050292.pdf
http://dx.doi.org/10.1016/j.nicl.2016.09.013 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/10/main.PMC5050292.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/10/main.PMC5050292.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.04.003 2213-0071/ ©2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/d3/b4/main.PMC5050294.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 135 e136,Non-OADS,/arxiv_data1/oa_pdf/d3/b4/main.PMC5050294.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/4b/main.PMC5050295.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.c om/locate/ijpddr http://dx.doi.org/10.1016/j.ijpddr.2016.09.003 2211-3207/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/4b/main.PMC5050295.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experime ntal & Molecular Medicine website (http://www.nature.com/emm)Smad4 controls bone homeostasis YJ Moon et al 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/14/f4/emm201675a.PMC5050296.pdf
"The SDF ﬁles were then used by OMEGA 2.3.2 (OpenEye Scienti ﬁc Software, Santa Fe, NM, USA, http://www.eyesopen.com) which generates multiple conformers of each compound.",OADS,/arxiv_data1/oa_pdf/f6/1a/emm201678a.PMC5050297.pdf
"ROCS 2.4.1 (OpenEye Scienti ﬁc Software, http://www.eyesopen.com; command- line mode) software from Openeye using the RANKBY COMBO ﬂags which optimize both shape overlay and chemical (color) overlay.",Non-OADS,/arxiv_data1/oa_pdf/f6/1a/emm201678a.PMC5050297.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)Osteoactivin inhibition of osteoclasts is CD44 dependent GR Sondag et al 12 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/f6/1a/emm201678a.PMC5050297.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Phosphorylated BIS affects translocation of HSF1 HY Kim et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/fb/e7/emm201684a.PMC5050300.pdf
"1).7) pISSN 1975-4612 / eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.3.183 REVIEW J Cardiovasc Ultrasound  2016;24(3):183-190 •	Received: July 20, 2015  •	Revised: May 3, 2016  •	Accepted: July 26, 2016 •		Address for Correspondence: Asghar Ali, Department of Medicine, McGuire VA Medical Center, 1201 Broad Rock Boulevard, Richmond, VA 23249, USA     Tel: +1-804-675-6439, Fax: +1-804-675-5601, E-mail: mirasgharali@yahoo.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Anatomically, the RV consists of inflow tract, the apex and  infundibulum.5)8) There are three prominent bands present in  the RV of which the moderator band distinguishes RV from  LV.5)9) The ventriculoinfundibular fold is another important  structure that separates the tricuspid and pulmonary valves,  which is in contrast to the LV where the aortic and mitral  valves are in fibrous continuity.",Non-OADS,/arxiv_data1/oa_pdf/a3/e1/jcu-24-183.PMC5050302.pdf
"8) In patients with AS undergoing transcatheter aortic valve  implantation (TAVI), acute declines in Zva were reported.9)  Reductions in Zva observed 1 month after TAVI also were  shown to persist during a 2-year follow-up,10) suggesting that pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.3.191 early assessment of Zva may provide important intermediate- term prognostic information.",Non-OADS,/arxiv_data1/oa_pdf/4c/73/jcu-24-191.PMC5050303.pdf
"•	Received: August 22, 2016  •	Revised: August 25, 2016  •	Accepted: August 25, 2016 •		Address for Correspondence: Sung-Ji Park, Division of Cardiology, Department of Medicine, Cardiovascular Imaging Center, Heart Vascular Stroke Institute,  Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea  Tel: +82-2-3410-0887, Fax: +82-2-3410-3849, E-mail: tyche.park@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The Role of Index of Valvular-Arterial  Impedance and Systemic Arterial Compliance after Aortic   Valve Replacement Sung-Ji Park, MD, PhD Division of Cardiology, Department of Medicine, Cardiovascular Imaging Center, Heart Vascular Stroke Institute,  Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaEDITORIAL COMMENT J Cardiovasc Ultrasound  2016;24(3):191-192",Non-OADS,/arxiv_data1/oa_pdf/4c/73/jcu-24-191.PMC5050303.pdf
11)  that LV systolic dyssynchrony increased with worsening LV pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.3.193 ejection fraction in the remodeling group.,Non-OADS,/arxiv_data1/oa_pdf/36/a8/jcu-24-193.PMC5050304.pdf
"•	Received: August 19, 2016  •	Revised: September 5, 2016  •	Accepted: September 6, 2016 •		Address for Correspondence: Ju-Hee Lee, Division of Cardiology, Department of Internal Medicine, Chungbuk National University Hospital, 776 1sunhwan-ro,  Seowon-gu, Cheongju 28644, Korea   Tel: +82-43-269-6880, Fax: +82-43-273-3252, E-mail: juheelee@chungbuk.ac.kr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Left Ventricular Diastolic Dyssynchrony  in Post-Myocardial Infarction Patients: Does It Predict Future Left Ventricular  Remodeling?",Non-OADS,/arxiv_data1/oa_pdf/36/a8/jcu-24-193.PMC5050304.pdf
"More recently, technical advance in speckle tracking meth- od, which originally used for the measurement of ventricular pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.3.195 deformation, was applied to the evaluation of vascular stiff-ness.",Non-OADS,/arxiv_data1/oa_pdf/ec/45/jcu-24-195.PMC5050305.pdf
"•	Received: August 12, 2016  •	Revised: August 25, 2016  •	Accepted: August 25, 2016 •		Address for Correspondence: Jin-Oh Choi, Division of Cardiology, Department of Medicine, Heart Vascular Stroke Center, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea  Tel: +82-2-3410-3419, Fax: +82-2-3410-3849, E-mail: choijean5@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Speckle Tracking of Common Carotid  Artery: A New Method for the Evaluation of Mechanical Vascular Function  of Atherosclerosis Jin-Oh Choi, MD Division of Cardiology, Department of Medicine, Heart Vascular Stroke Center,  Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaEDITORIAL COMMENT J Cardiovasc Ultrasound  2016;24(3):195-196",Non-OADS,/arxiv_data1/oa_pdf/ec/45/jcu-24-195.PMC5050305.pdf
"In adult population, there is clear left ventricle twist because  of opposite rotational motional motion of base and apex, whereas in children both segments rotate in the same direction but for different amounts and with a longer deformational de-pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.3.197 lay compares with adults.4) During childhood, distinct pat- terns of apicobasal twisting was reported to be seen with matu- ration.5) Counterclockwise apical rotation was almost constant  during childhood, whereas the age-related increase in LV tor - sion during childhood resulted from a striking change in basal  rotation, initially counterclockwise in infancy to neutral in  early childhood and showing the adult clockwise pattern in  adolescence.",Non-OADS,/arxiv_data1/oa_pdf/76/08/jcu-24-197.PMC5050306.pdf
"•	Received: August 28, 2016  •	Revised: September 5, 2016  •	Accepted: September 6, 2016 •		Address for Correspondence: Soo-Jin Kim, Department of Pediatrics, Konkuk University School of Medicine, 120-1 Neungdong-ro, Gwangjin-gu, Seoul 05030,  Korea   Tel: +82-2-2030-7678, Fax: +82-2-2030-7748, E-mail: ksoojn@naver.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical Implication of Torsion and Strain  Using 2D Speckle Tracking Echocardiagraphy in Congenital and  Pediatric Population Soo-Jin Kim, MD, PhD Department of Pediatrics, Konkuk University School of Medicine, Seoul, KoreaEDITORIAL COMMENT J Cardiovasc Ultrasound  2016;24(3):197-198",Non-OADS,/arxiv_data1/oa_pdf/76/08/jcu-24-197.PMC5050306.pdf
"A strongpoint of this study is accurate and in detail  measurement of right heart dimension in different view, right heart systolic function with RV index of myocardial perfor - mance, tricuspid annular plane systolic excursion, S’ and frac- tional area change, right heart diastolic function using pulse pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.3.199 wave Doppler of the trans-tricuspid flow including the peak  early filing, the late diastolic filling, the ratio of E/A wave ve- locities and deceleration time and finally pulmonary artery he- modynamics with pulmonary artery acceleration time, pulmo-nary ejection time.",Non-OADS,/arxiv_data1/oa_pdf/e3/16/jcu-24-199.PMC5050307.pdf
"•	Received: August 26, 2016  •	Revised: September 5, 2016  •	Accepted: September 6, 2016 •		Address for Correspondence: Kyung-Hee Kim, Department of Cardiology, Sejong General Hospital, 28 Hohyeon-ro 489beon-gil, Sosa-gu, Bucheon 14754, Korea  Tel: +82-32-340-1443, Fax: +82-32-340-1180, E-mail: learnbyliving9@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Assessing Right Ventricular Function:  The Role of Echocardiography in a Murine Model of Pulmonary Hypertension Kyung-Hee Kim, MD, PhD Department of Cardiology, Sejong General Hospital, Bucheon, KoreaEDITORIAL COMMENT J Cardiovasc Ultrasound  2016;24(3):199-200",Non-OADS,/arxiv_data1/oa_pdf/e3/16/jcu-24-199.PMC5050307.pdf
"1-6) This supports the idea that degenerative AS pISSN 1975-4612 / eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.3.201 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2016;24(3):201-207 •	Received: March 29, 2016  •	Revised: August 17, 2016  •	Accepted: August 17, 2016 •		Address for Correspondence: Jae-Kwan Song, Cardiac Imaging Center, Asan Medical Center Heart Institute, University of Ulsan College of Medicine, 88  Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea   Tel: +82-2-3010-3155, Fax: +82-2-486-5918, E-mail: jksong@amc.seoul.kr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.should be considered as a potential manifestation of a systemic  process, rather than as a disease solely limited to the aortic valve.",Non-OADS,/arxiv_data1/oa_pdf/d3/8f/jcu-24-201.PMC5050308.pdf
"All statistical analyses were performed using the Statistical Package for the Social Sciences  (SPSS) version 18.0 for Windows (SPSS Inc., Chicago, IL,  USA) and R program version 3.1.1 (http://www.r-project.org).",OADS,/arxiv_data1/oa_pdf/d3/8f/jcu-24-201.PMC5050308.pdf
"208Introduction Diastolic dysfunction is known to develop after myocardial  damage.1)2) Deceleration time (DT) and mitral E wave to flow  propagation velocity ratio are examples shown to be associated  with adverse remodeling and/or poor prognosis after acute  myocardial infarction (AMI).3)4) While systolic dyssynchrony  was well studied and found to be associated with adverse re - modeling in patients with AMI, little attention has been paid  to diastolic dyssynchrony (DD) in those patients.5)6) This study pISSN 1975-4612 / eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.3.208 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2016;24(3):208-214 •	Received: April 2, 2016  •	Revised: July 18, 2016  •	Accepted: July 26, 2016 •		Address for Correspondence: Burak Turan, Cardiology Department, Kocaeli Derince Training and Research Hospital, Ibni Sina mah., Lojman sok., Derince,  Kocaeli 41900, Turkey   Tel: +90-262-317-8000, Fax: +90-262-233-5536, E-mail: drburakturan@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.was conducted to investigate the incidence of DD during acute  ST segment elevation myocardial infarction (STEMI) and its  impact on functional recovery of left ventricle (LV) thereafter.",Non-OADS,/arxiv_data1/oa_pdf/ec/b5/jcu-24-208.PMC5050309.pdf
"Carotid intima media  thickness (CIMT) as a surrogate marker of morphological pa - thology has frequently been employed for risk stratification of  CVD by use of carotid ultrasound (CUS).1) Prior studies have  documented both CIMT and parameters of arterial stiffness pISSN 1975-4612 / eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.3.215 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2016;24(3):215-222 •	Received: April 26, 2016  •	Revised: July 21, 2016  •	Accepted: July 26, 2016 •		Address for Correspondence: Hyuk-Jae Chang, Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro,  Seodaemun-gu, Seoul 03722, Korea   Tel: +82-2-2228-8454, Fax: +82-2-393-2041, E-mail: hjchang@yuhs.ac •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.are associated with hypertension (HTN) coronary atheroscle - rosis, stroke, and cardiovascular mortality.2-5) Further still,  CIMT is routinely recommended for evaluation of end organ  damage in patients with HTN based on current guidelines.6)  CIMT reflects the morphological changes of the arterial wall  which associated with atherosclerosis, while the parameters of  arterial stiffness tend to reflect the functional properties of the The Value of Elastic Modulus Index as   a Novel Surrogate Marker   for Cardiovascular Risk Stratification   by Dimensional Speckle-Tracking Carotid  Ultrasonography Ji Hyun Yoon, MD1,2, In-Jeong Cho, MD1,2, Hyuk-Jae Chang, MD, PhD1,2,3, Ji Min Sung, PhD2,  Jinyong Lee, MS4, Hojin Ryoo, MS4, Chi Young Shim, MD, PhD1,2, Geu-Ru Hong, MD, PhD1,2,  and Namsik Chung, MD, PhD1,2 1Division of Cardiology, Department of Internal Medicine, 2Cardiovascular Research Institute,   3Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea   4Infrastructure Technology Lab, Samsung Medison, Seoul, Korea Background: Carotid intima media thickness (CIMT) and the presence of carotid plaque have been used for risk stratification  of cardiovascular disease (CVD).",Non-OADS,/arxiv_data1/oa_pdf/ca/61/jcu-24-215.PMC5050310.pdf
"1)2) LV tor -pISSN 1975-4612 / eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.3.223 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2016;24(3):223-228 •	Received: May 3, 2016  •	Revised: August 17, 2016  •	Accepted: August 17, 2016 •		Address for Correspondence: Lucy Youngmin Eun, Division of Pediatric Cardiology, Department of Pediatrics, Yonsei University College of Medicine, 211 Eonju-ro,  Gangnam-gu, Seoul 06273, Korea   Tel: +82-2-2019-3350, Fax: +82-2-3461-9473, E-mail: lucyeun@yuhs.ac •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.sional deformation, based on helical myocardial fiber architec- ture, plays an important role with respect to LV ejection and filling performance.",Non-OADS,/arxiv_data1/oa_pdf/fe/f3/jcu-24-223.PMC5050311.pdf
"For the left ven - tricle (LV) assessment echocardiography has been proven to be  a versatile tool for evaluation of LV structure, systolic, diastolic, pISSN 1975-4612 / eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.3.229 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2016;24(3):229-238 •	Received: May 26, 2016  •	Revised: August 3, 2016  •	Accepted: August 3, 2016 •		Address for Correspondence: Andrew Kohut, Division of Cardiology, Department of Medicine, Drexel University College of Medicine, Mail Stop 470, 245 North  15th Street, Philadelphia, PA 19102-1192, USA   Tel: +1-215-762-3559, Fax: +1-215-762-1525, E-mail: andrew.kohut@drexelmed.edu •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.and vascular functions in mouse cardiomyopathy models.5)  However, the right ventricle (RV) and vascular functions associ - ated with it are not comprehensibly evaluated.",Non-OADS,/arxiv_data1/oa_pdf/25/8e/jcu-24-229.PMC5050312.pdf
http://dx.doi.org/10.1161/JAHA.115.002482.,Non-OADS,/arxiv_data1/oa_pdf/25/8e/jcu-24-229.PMC5050312.pdf
"He pISSN 1975-4612 / eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.3.239 CASE REPORT J Cardiovasc Ultrasound  2016;24(3):239-242 •	Received: June 22, 2015  •	Revised: July 21, 2016  •	Accepted: July 26, 2016 •		Address for Correspondence: Chul-Min Kim, Division of Cardiology, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic  University of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 16247, Korea   Tel: +82-31-249-7139, Fax: +82-31-247-7139, E-mail: anthleemd@naver.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.received an echocardiography examination, and he was diag - nosed with septal hypertrophied and non-obstructive HCMP  (EF, 72%; septal thickness, 19.7 mm; posterior wall LV thick - ness, 10 mm; LV end-diastolic/systolic volume, 42.7/13.4 mL).",Non-OADS,/arxiv_data1/oa_pdf/cc/b1/jcu-24-239.PMC5050313.pdf
"The anterior common pISSN 1975-4612 / eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.3.243 CASE REPORT J Cardiovasc Ultrasound  2016;24(3):243-246 •	Received: February 10, 2016  •	Revised: June 8, 2016  •	Accepted: July 26, 2016 •		Address for Correspondence: Jae Beom Lee, Division of Cardiology, Department of Internal Medicine, Anyang SAM Hospital, 9 Samdeok-ro, Manan-gu, Anyang  14030, Korea   Tel: +82-31-467-9106, Fax: +82-31-467-9198, E-mail: fa5754@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.leaflet appeared to be attached to the crest of the ventricular  septum by a chorda (Fig.",Non-OADS,/arxiv_data1/oa_pdf/88/77/jcu-24-243.PMC5050314.pdf
"Although we have only one re - ported case of an asymptomatic UAV in Korea,7) this case had  significant symptoms associated with severe aortic stenosis, and pISSN 1975-4612 / eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.3.247 CASE REPORT J Cardiovasc Ultrasound  2016;24(3):247-250 •	Received: April 2, 2016  •	Revised: May 16, 2016  •	Accepted: July 26, 2016 •		Address for Correspondence: Jae-Hyeong Park, Division of Cardiology, Department of Internal Medicine, School of Medicine, Chungnam National University,  Chungnam National University Hospital, 282 Munhwa-ro, Jung-gu, Daejeon 35015, Korea     Tel: +82-42-280-8237, Fax: +82-42-280-8238, E-mail: jaehpark@cnu.ac.kr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.unicommissural UAV was confirmed in the surgical specimen.",Non-OADS,/arxiv_data1/oa_pdf/92/35/jcu-24-247.PMC5050315.pdf
"At her 3 months  follow-up, she was still asymptomatic and a repeat TTE showed  •	Received: March 20, 2016  •	Revised: May 29, 2016  •	Accepted: July 26, 2016 •		Address for Correspondence: Amer Hawatmeh, Department of Cardiology, Saint Michael’s Medical Center, New York Medical College, 111 Central Avenue,  Newark, NJ 07102, USA   Tel: +1-973-877-5000, Fax: +1-973-877-5124, E-mail: amer_hawatmeh@hotmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.the migrated stent still in right atrium with no complications.",Non-OADS,/arxiv_data1/oa_pdf/c5/d1/jcu-24-251.PMC5050316.pdf
"Bagul NB, Moth P , Menon NJ, Myint F, Hamilton G.  Migration of pISSN 1975-4612 / eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.3.251 IMAGES IN CARDIOVASCULAR ULTRASOUND J Cardiovasc Ultrasound  2016;24(3):251-252 Migrated Subclavian Venous Stent into  the Right Atrium Ibrahim Khaddash, MD1, Amer Hawatmeh, MD2, Cynthia Dayrit-Demetillo, MA, M Ed1,   and Aiman Hamdan, MD1 1Department of Cardiology, Saint Joseph’s Regional Medical Center, New York Medical College, Paterson, NJ, USA   2Department of Cardiology, Saint Michael’s Medical Center, New York Medical College, Newark, NJ, USA KEY WORDS:  Subclavian stent  · Migration  · Right atrium.",Non-OADS,/arxiv_data1/oa_pdf/c5/d1/jcu-24-251.PMC5050316.pdf
"Three-pISSN 1975-4612 / eISSN 2005-9655  Copyright © 2016 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2016.24.3.253 •	Received: May 2, 2016  •	Revised: May 29, 2016  •	Accepted: July 26, 2016 •		Address for Correspondence: Kikuko Obase, Department of Cardiovascular Surgery, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan     Tel: +81-95-819-7307, Fax: +81-95-819-7311, E-mail: kobase@nagasaki-u.ac.jp •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.dimensional transthoracic echocardiography clearly visualized  double orifices (Fig.",Non-OADS,/arxiv_data1/oa_pdf/f6/1a/jcu-24-253.PMC5050317.pdf
"[http://dx.doi.org/10.1001/archpsyc.1965.01730060001001] [PMID: 5320621] [2] Schildkraut, J.J.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1176/ajp.122.5.509] [PMID: 5319766] [3] Elhwuegi, A.S. Central monoamines and their role in major depression.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.pnpbp.2003.11.018] [PMID: 15093950] [4] Trullas, R.; Skolnick, P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/0014-2999(90) 90204-J] [PMID: 2171955] [5] Hashimoto, K. Emerging role of glutamate in the pathophysiology of major depressive disorder.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1016/j.brainresrev.2009.05.,OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1007/s11064-007-9518-3] [PMID: 17960478] [8] Pariante, C.M.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.tins.2008.06.006] [PMID: 18675469] [9] Duman, R.S.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1385/NMM:5:1:011] [PMID: 15001809] [10] Mello, A.F.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1590/S1516-44462003000400010] [PMID: 15328550] [11] Maes, M. Evidence for an immune response in major depression: a review and hypothesis.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/0278-5846(94)00101-M] [PMID: 7708925] [12] Clark, J.A.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/ j.bbi.2009.09.009] [PMID: 19818725] [14] Kubera, M.; Obuchowicz, E.; Goehler, L.; Brzeszcz, J.; Maes,  M. In animal models, psychosocial stress-induced (neuro) inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.bbi.2010.02.006] [PMID: 20193757] [16] Bloch, M.H.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.jaac.2011.06.008] [PMID: 21961774] [17] Maes, M.; Bosmans, E.; Suy, E.; Vandervorst, C.; DeJonckheere, C.; Raus, J. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1111/j.1600-0447.1991.tb03163.x] [PMID: 1746291] [18] Maes, M.; Lambrechts, J.; Bosmans, E.; Jacobs, J.; Suy, E.; Vandervorst, C.; de Jonckheere, C.; Minner, B.; Raus, J.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1017/S0033291700032712] [PMID: 1574566] [19] Maes, M.; Stevens, W.; DeClerck, L.; Peeters, D.; Bridts, C.; Schotte, C.; Meltzer, H.; Scharpé, S.; Cosyns, P. Neutrophil chemotaxis, phagocytosis, and superoxide release in depressive illness.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1006/brbi.2000.0597] [PMID: 11566046] [21] Dowlati, Y.; Herrmann, N.; Swardfager, W.; Liu, H.; Sham, L.; Reim, E.K.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1034/j.1600-0447.2001.00162.x] [PMID: 11240580] [24] Song, C.; Halbreich, U.; Han, C.; Leonard, B.E.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1055/s-0029-1202263] [PMID: 19724980] [25] Brambilla, F.; Maggioni, M. Blood levels of cytokines in elderly patients with major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1111/j.1600-0447.1998.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1002/da.20876] [PMID: 21898706] [27] Kubera, M.; Curzytek, K.; Duda, W.; Leskiewicz, M.; Basta-Kaim, A.; Budziszewska, B.; Roman, A.; Zajicova, A.; Holan, V.; Szczesny, E.; Lason, W.; Maes, M. A new animal model of (chronic) depression induced by repeated and intermittent lipopolysaccharide administration for 4 months.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1016/j.bbi.2013.,OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.3389/fncel.2015.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.bbi.2012.11.013] [PMID: 23207108] [32] Xiu, L.J.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.neulet.2009.06.031] [PMID: 19539710] [33] Lam, R.W.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1177/ 0004867413488222] [PMID: 23652385] [34] Liu, R.P.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1186/1742-2094-11-47] [PMID: 24618100] [35] Su, F.; Y i ,  H .",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/ j.neuroscience.2015.02.028] [PMID: 25711936] [36] Strawbridge, R.; Arnone, D.; Danese, A.; Papadopoulos, A.; Herane Vives, A.; Cleare, A.J.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1016/j.psyneuen.2014.03.,OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/ j.bbi.2004.05.001] [PMID: 15581735] [40] Raison, C.L.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.4088/JCP.v66n0106] [PMID: 15669887] [41] Musselman, D.L.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1056/NEJM200103293441303] [PMID: 11274622] [42] Eugenin, E.A.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.jneuroim.2008.04.012] [PMID: 18538419] [44] Riek-Burchardt, M.; Kolodziej, A.; Henrich-Noack, P.; Reymann, K.G.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/ 10.1016/j.neuropharm.2009.07.032] [PMID: 19647005] [45] Pujol, F.; Kitabgi, P.; Boudin, H. The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1242/jcs.01694] [PMID: 15731012] [46] Kettenmann, H.; Kirchhoff, F.; Verkhratsky, A. Microglia: new roles for the synaptic stripper.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/ 10.1038/sj.jcbfm.9600229] [PMID: 16192992] [49] Ransohoff, R.M.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1016/j.immuni.2009.,OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/S1046-2023(02)00357-2] [PMID: 12725800] [52] Réaux-Le Goazigo, A.; Van Steenwinckel, J.; Rostène, W.;  Mélik Parsadaniantz, S. Current status of chemokines in the  adult CNS.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/ 10.1016/j.pneurobio.2013.02.001] [PMID: 23454481] [53] Adler, M. W.; Geller, E.B.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/ 10.1073/pnas.84.24.9233] [PMID: 3480540] [55] Murphy, P.M.; Baggiolini, M.; Charo, I.F.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/S1074-7613(00)80165-X] [PMID: 10714678] [57] Furutani, Y.; Nomura, H.; Notake, M.; Oyamada, Y.; Fukui, T.; Yamada, M.; Larsen, C.G.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/0006-291X(89)92430-3] [PMID: 2923622] [58] Mehrabian, M.; Sparkes, R.S.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/0888-7543(91)90239-B] [PMID: 2004761] [59] Fernandez, E.J.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1146/annurev.pharmtox.42.091901.115838] [PMID: 11807180] [60] Colobran, R.; Pujol-Borrell, R.; Armengol, M.P.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1111/ j.1365-2249.2007.03344.x] [PMID: 17437419] [61] Jones, B.A.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1124/mi.10.5.3] [PMID: 21045240] [62] Bazan, J.F.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1038/385640a0] [PMID: 9024663] [63] Matloubian, M.; David, A.; Engel, S.; Ryan, J.E.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/ 10.1038/79738] [PMID: 11017100] [64] Hundhausen, C.; Misztela, D.; Berkhout, T.A.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1182/blood-2002-12-3775] [PMID: 12714508] [65] Allen, S.J.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1146/annurev.immunol.24.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/ S1471-4892(01)00122-9] [PMID: 11786310] [69] Murphy, P.M. International Union of Pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1124/pr.54.2.227] [PMID: 12037138] [70] Rajagopal, S.; Bassoni, D.L.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1074/jbc.M113.479113] [PMID: 24145037] [71] Knall, C.; Young, S.; Nick, J.A.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1074/ jbc.271.5.2832] [PMID: 8576262] [72] Curnock, A.P.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1046/j.1365-2567.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1111/nyas.12855] [PMID: 26251227] [74] Che, X.; Ye, W.; Panga, L.; Wu, D.C.; Yang, G.Y.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/S0006-8993(01)02328-9] [PMID: 11384610] [75] Mantovani, A. Chemokines.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1159/000058734] [PMID: 10550926] [76] Mélik-Parsadaniantz, S.; Rostène, W. Chemokines and neuromodulation.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/ 10.1002/cne.21780] [PMID: 18615560] [81] Tran, P.B.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1002/cne.21229] [PMID: 17183554] [82] Lu, M.; Grove, E.A.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/ 10.1523/JNEUROSCI.1728-06.2006] [PMID: 16793890] [84] Stumm, R.; Höllt, V. CXC chemokine receptor 4 regulates neuronal migration and axonal pathfinding in the developing nervous system: implications for neuronal regeneration in the adult brain.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/ 10.1677/JME-06-0032] [PMID: 17339400] [85] Stumm, R.; Kolodziej, A.; Schulz, S.; Kohtz, J.D.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1002/cne.21336] [PMID: 17366607],Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.4651-07.2008] [PMID: 18272682] [87] Li, G.; Adesnik, H.; Li, J.; Long, J.; Nicoll, R.A.; Rubenstein, J.L.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.psyneuen.2012.03.019] [PMID: 22525700] [89] Stuart, M.J.; Corrigan, F.; Baune, B.T.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1186/1742-2094-11-31] [PMID: 24528805] [90] Banisadr, G.; Bhattacharyya, B.J.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1126/science.1202529] [PMID: 21778362] [93] Paolicelli, R.C.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/ 10.1016/j.neuroscience.2009.08.075] [PMID: 19748551] [96] Banisadr, G.; Gosselin, R.D.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/ 10.1002/cne.20729] [PMID: 16196033] [97] Gao, Y.J.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.3623-08.2009] [PMID: 19339605] [98] Musante, V.; Longordo, F.; Neri, E.; Pedrazzi, M.; Kalfas, F.; Severi, P.; Raiteri, M.; Pittaluga, A. RANTES modulates the release of glutamate in human neocortex.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1523/JNEUROSCI.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.neuropharm.2013.07.037] [PMID: 23958452] [100] Guyon, A.; Skrzydelsi, D.; Rovère, C.; Rostène, W.; Parsadaniantz, S.M.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1111/j.1471-4159.2006.03659.x] [PMID: 16476083] [101] Gerard, C.; Rollins, B.J.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1038/84209] [PMID: 11175802] [102] Hinojosa, A.E.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1016/j.neubiorev.2014.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1038/jcbfm.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1007/s11302-011-9288-x] [PMID: 22222817] [106] Ishizuka, K.; Kimura, T.; Igata-yi, R.; Katsuragi, S.; Takamatsu, J.; Miyakawa, T. Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer’s disease.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1182/blood-2007-12-129122] [PMID: 18802011] [108] Gu, L.; Tseng, S.; Horner, R.M.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1038/35006097] [PMID: 10746730] [109] Zhou, Y.; Tang, H.; Liu, J.; Dong, J.; Xiong, H. Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1111/j.1471-4159.2010.07121.x] [PMID: 21105875] [110] Kalehua, A.N.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/ j.yexcr.2004.02.031] [PMID: 15194436] [111] Harrison, E.L.; Jaehne, E.J.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1016/j.bbr.2014.01.,OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1159/000123834] [PMID: 18391506] [113] Bachstetter, A.D.; Morganti, J.M.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/ 10.1016/j.neurobiolaging.2009.11.022] [PMID: 20018408] [114] Suzumura, A. Neuron-microglia interaction in neuroinflammation.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1111/j.1471-4159.2009.06253.x] [PMID: 19627440] [117] Stephan, A.H.; Barres, B.A.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.brainres.2014.11.032] [PMID: 25463024] [119] Pagani, F.; Paolicelli, R.C.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1038/nn1715] [PMID: 16732273] [121] Rosito, M.; Lauro, C.; Chece, G.; Porzia, A.; Monaco, L.; Mainiero, F.; Catalano, M.; Limatola, C.; Trettel, F. Trasmembrane chemokines CX3CL1 and CXCL16 drive interplay between neurons, m i c r o g l i a  a n d  a s t r o c y t e s  t o  c o u n t e r a c t  p M C A O  a n d  excitotoxic neuronal death.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1677/JME-06-0035] [PMID: 17339398] [123] Licinio, J.; Wong, M.L.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/ 10.1097/00001756-199209000-00008] [PMID: 1421131] [124] Toba, Y.; Tiong, J.D.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/ 10.1002/dneu.20594] [PMID: 18188864] [125] Schwarting, G.A.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1126/ science.2646711] [PMID: 2646711] [130] Miñano, F.J.; Sancibrian, M.; Vizcaino, M.; Paez, X.; Davatelis, G.; Fahey, T.; Sherry, B.; Cerami, A.; Myers, R.D.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1007/s11064-010-0367-0] [PMID: 21184279] [135] Girotti, M.; Donegan, J.J.; Morilak, D.A.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/ 10.1016/j.psyneuen.2011.02.008] [PMID: 21411230] [136] Jaehne, E.J.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.bbr.2013.12.006] [PMID: 24333375] [137] Campbell, S.J.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.bbi.2010.01.011] [PMID: 20138139] [138] Corona, A.W.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1186/1742-2094-7-93] [PMID: 21167054] [139] Corona, A.W.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.bbi.2012.08.008] [PMID: 22926082] [140] Hoyo-Becerra, C.; Liu, Z.; Yao, J.; Kaltwasser, B.; Gerken, G.; Hermann, D.M.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1007/s12035-014-8861-z] [PMID: 25159480] [141] Ogłodek, E.; Szota, A.; Just, M.; Moś, D.; Araszkiewicz, A.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1016/j.euroneuro.2007.06.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.3109/ 15622970802573246] [PMID: 19921973] [145] Lehto, S.M.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.psyneuen.2009.06.007] [PMID: 19592174] [146] Black, C.; Miller, B.J.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.bbi.2009.04.008] [PMID: 19406226] [148] Grassi-Oliveira, R.; Brieztke, E.; Teixeira, A.; Pezzi, J.C.; Zanini, M.; Lopes, R.P.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1590/ S1516-44462012000100013] [PMID: 22392392] [149] Isung, J.; Mobarrez, F.; Nordström, P.; Åsberg, M.; Jokinen, J.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.3109/15622975.2011.624549] [PMID: 22098148] [150] Drexhage, R.C.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1016/j.bbi.,OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1159/000258696] [PMID: 19923858] [152] Pae, C.U.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1159/000076718] [PMID: 15034225] [153] Roh, M.S.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.neulet.2007.04.038] [PMID: 17928143] [154] Padmos, R.C.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1001/archpsyc.65.4.395] [PMID: 18391128] [155] Young, J.J.; Bruno, D.; Pomara, N. A r e v i e w  o f  t h e  r e l a t i o n s h i p  between proinflammatory cytokines and major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/ j.jad.2014.07.032] [PMID: 25128861] [156] Merendino, R.A.; Di Pasquale, G.; De Luca, F.; Di Pasquale, L.; Ferlazzo, E.; Martino, G.; Palumbo, M.C.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1080/ 09511920410001713484] [PMID: 15223613] [157] Nakatani, N.; Hattori, E.; Ohnishi, T.; Dean, B.; Iwayama, Y.; Matsumoto, I.; Kato, T.; Osumi, N.; Higuchi, T.; Niwa, S.; Yoshikawa, T. Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1093/hmg/ddl118] [PMID: 16687443] [158] Fontenelle, L.F.; Barbosa, I.G.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.comppsych.2011.12.007] [PMID: 22300901] [159] Janelidze, S.; Ventorp, F.; Erhardt, S.; Hansson, O.; Minthon,  L.; Flax, J.; Samuelsson, M.; Traskman-Bendz, L.; Brundin, L. Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/j.psyneuen.2012.09.010] [PMID: 23062672] [160] Barbosa, I.G.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1007/s00406-012-0327-6] [PMID: 22584806] [161] Lindqvist, D.; Janelidze, S.; Hagell, P.; Erhardt, S.; Samuelsson, M.; Minthon, L.; Hansson, O.; Björkqvist, M.; Träskman-Bendz, L.; Brundin, L. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1016/ j.biopsych.2009.01.030] [PMID: 19268915] [162] Eller, T.; Vasar, V.; Shlik, J.; Maron, E.J.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1176/ajp.155.1.4] [PMID: 9433332] [164] Wong, M.L.",Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/10.1038/ mp.2008.59] [PMID: 18504423] [165] van Zuiden, M.; Heijnen, C.J.",OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
[http://dx.doi.org/10.1016/j.pharep.2014.06.001] [PMID: 25150002],OADS,/arxiv_data1/oa_pdf/1e/42/CN-14-705.PMC5050392.pdf
"[http://dx.doi.org/ 10.1146/annurev.neuro.26.041002.131128] [PMID: 15217338] [3] Pereda, A.E.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1038/nrn3708] [PMID: 24619342] [4] Willecke, K.; Eiberger, J.; Degen, J.; Eckardt, D.; Romualdi, A.; Güldenagel, M.; Deutsch, U.; Söhl, G. Structural and functional diversity of connexin genes in the mouse and human genome.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.1515/BC.,Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/ 10.1016/j.cardiores.2003.11.013] [PMID: 15094343] [6] Nagy, J.I.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/S0306-4522(98)00191-2] [PMID: 10197766] [7] Mansour, H.; McColm, J.R.; Cole, L.; Weible, M., II; Korlimbinis, A.; Chan-Ling, T. Connexin 30 e x p r e s s i o n  a n d  f r e q u e n c y  o f  connexin heterogeneity in astrocyte gap junction plaques increase with age in the rat retina.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/j.neulet.2013.04.013] [PMID: 23618652] [9] Pannasch, U.; Freche, D.; Dallérac, G.; Ghézali, G.; Escartin, C.; Ezan, P.; Cohen-Salmon, M.; Benchenane, K.; Abudara, V.; Dufour, A.; Lübke, J.H.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1038/nn.3662] [PMID: 24584052] [10] Nagy, J.I.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.1002/glia.,Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/j.nbd.2011.03.003] [PMID: 21396451] [12] Cotrina, M.L.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/j.brainres.2012.07.003] [PMID: 22789906] [13] Condorelli, D.F.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1046/j.1460-9568.1998.00163.x] [PMID: 9753189] [14] Belluardo, N.; Mudò, G.; Trovato-Salinaro, A.; Le Gurun, S.; Charollais, A.; Serre-Beinier, V.; Amato, G.; Haefliger, J.A.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/ S0306-4522(03)00077-0] [PMID: 12809690] [16] Chapman, R.J.; Lall, V.K.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1007/s00429-012-0426-1] [PMID: 22638825] [17] Posłuszny, A.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/ 10.1523/JNEUROSCI.6216-11.2012] [PMID: 22457486] [19] Mylvaganam, S.; Ramani, M.; Krawczyk, M.; Carlen, P.L.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.3389/fphys.2014.00172] [PMID: 24847276],Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1007/s12264-011-1944-1] [PMID: 22108816] [21] Gutierrez, G.J.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/ 10.1523/JNEUROSCI.0937-13.2013] [PMID: 23926276] [22] Hormuzdi, S.G.; Pais, I.; LeBeau, F.E.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/ 10.1016/S0896-6273(01)00387-7] [PMID: 11516404] [23] Jiruska, P.; de Curtis, M.; Jefferys, J.G.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1113/jphysiol.2012.239590] [PMID: 23184516] [24] Akbarpour, B.; Sayyah, M.; Babapour, V.; Mahdian, R.; Beheshti, S.; Kamyab, A.R.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/ 10.1007/s12264-012-1279-6] [PMID: 23149765] [25] Beheshti, S.; Sayyah, M.; Golkar, M.; Sepehri, H.; Babaie, J.; Vaziri, B.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/j.pnpbp.2010.02.006] [PMID: 20153799] [26] Gajda, Z.; Gyengési, E.; Hermesz, E.; Ali, K.S.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1111/j.0013-9580.2003.25803.x] [PMID: 14636335] [27] Zappalà, A.; Cicero, D.; Serapide, M.F.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/ j.neuroscience.2006.03.053] [PMID: 16690210] [28] Fonseca, C.G.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/S0006-8993(01) 03289-9] [PMID: 11852037] [29] Collignon, F.; Wetjen, N.M.; Cohen-Gadol, A.A.; Cascino, G.D.; Parisi, J.; Meyer, F.B.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.3171/jns.2006.105.1.77] [PMID: 16874892] [30] Abbaci, M.; B a r b e r i-Heyob, M.; Blondel, W.; Guillemin, F.; Didelon, J.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.2144/000112810] [PMID: 18611167] [31] Juszczak, G.R.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/ j.pnpbp.2008.12.014] [PMID: 19162118] [32] Pinder, R.M.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.2165/ 00003495-197611040-00002] [PMID: 780088] [33] Souness, G.W.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/ 10.1210/endo-129-5-2451] [PMID: 1657575] [34] Davidson, J.S.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1007/s12264-013-1342-y] [PMID: 23650049] [37] Stoletov, K.; Strnadel, J.; Zardouzian, E.; Momiyama, M.; Park, F.D.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1242/jcs.112748] [PMID: 23321642] [38] Ross, F.M.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/ S0306-4522(01)00222-6] [PMID: 11516825] [40] Kraglund, N.; Andreasen, M.; Nedergaard, S. Differential influence of non-synaptic mechanisms in two in vitro m o d e l s  o f  e p i l e p t i c  field bursts.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.1016/j.brainres.2013.05.,OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1186/1471-2210-3-3] [PMID: 12720572] [44] Sefil, F.; Bagirici, F.; Acar, M.D.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.1016/j.neuropharm.,OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.1111/j.1528-1167.2006.,Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/ j.brainres.2007.10.040] [PMID: 18031716] [51] Sayyah, M.; Rezaie, M.; Haghighi, S.; Amanzadeh, A. Intra-amygdala all-trans retinoic acid inhibits amygdala-kindled seizures",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1111/j.1460-9568.2005.04558.x] [PMID: 16420455] [53] Franco-Pérez, J.; Ballesteros-Zebadúa, P.; Manjarrez-Marmolejo, J.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/ 10.1016/j.neulet.2015.06.037] [PMID: 26141611] [54] da Silva, A.F.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1017/ mdh.2013.69] [PMID: 24331212] [55] Achan, J.; Talisuna, A.O.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1186/1475-2875-10-144] [PMID: 21609473] [56] Noubiap, J.J.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/ 10.1016/0304-3940(81)90258-5] [PMID: 7322448] [58] Cherubini, E.; North, R.A.; Surprenant, A. Quinine blocks a calcium-activated potassium conductance in mammalian enteric neurones.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/ 10.1111/j.1476-5381.1984.tb10112.x] [PMID: 6091826] [59] Malchow, R.P.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1085/jgp.104.6.1039] [PMID: 7535344] [60] White, T.W.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1046/ j.1460-9568.1999.00607.x] [PMID: 10336656] [61] Srinivas, M.; Hopperstad, M.G.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1007/BF00583380] [PMID: 3714453] [63] Uusisaari, M.; Smirnov, S.; Voipio, J.; Kaila, K. Spontaneous epileptiform activity mediated by GABA(A) receptors and gap junctions in the rat hippocampal slice following long-term exposure to GABA(B) antagonists.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/S0028-3908(02)00156-9] [PMID: 12367602] [64] Gigout, S.; Louvel, J.; Kawasaki, H.; D’Antuono, M.; Armand, V.; Kurcewicz, I.; Olivier, A.; Laschet, J.; Turak, B.; Devaux, B.; Pumain, R.; Avoli, M. Effects of gap junction blockers on human neocortical synchronization.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/j.nbd.2005.12.011] [PMID: 16478664] [65] Voss, L.J.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1111/j.1528-1167.2009.02087.x] [PMID: 19486358] [66] Wambebe, C.; Sokomba, E.; Amabeoku, G. Effect of quinine on electroshock and pentylenetetrazol-induced seizures in mice.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/0278-5846(90)90070-W] [PMID: 2300677] [67] Nassiri-Asl, M.; Zamansoltani, F.; Torabinejad, B. Antiepileptic effects of quinine in the pentylenetetrazole model of seizure.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/ j.seizure.2008.08.002] [PMID: 18786839] [68] Bostanci, M.O.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.1016/j.seizure.2006.,OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/j.pnpbp.2008.05.007] [PMID: 18556104] [70] Gajda, Z.; Szupera, Z.; Blazsó, G.; Szente, M. Quinine, a blocker of neuronal cx36 channels, suppresses seizure activity in rat neocortex in vivo.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/ 10.1111/j.1528-1167.2005.00254.x] [PMID: 16190928] [71] Medina-Ceja, L.; Ventura-Mejía, C. Differential effects of trimethylamine and quinine on seizures induced by 4-aminopyridine a d m i n i s t r a t i o n  i n  t h e  e n t o r h i n a l  c o r t e x  o f  v i g i l a n t  rats.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1155/2014/282490] [PMID: 25276773] [73] Nevin, R.L.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1155/2010/310753] [PMID: 22937225] [77] Franco-Pérez, J.; Ballesteros-Zebadúa, P.; Manjarrez-Marmolejo, J. Anticonvulsant effects of mefloquine on generalized tonic-clonic seizures induced by two acute models in rats.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1186/s12868-015-0145-7] [PMID: 25886955] [78] Dow, G.; Bauman, R.; Caridha, D.; Cabezas, M.; Du, F.; Gomez-Lobo, R.; Park, M.; Smith, K.; Cannard, K. Mefloquine induces dose-related neurological effects in a rat model.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1128/ AAC.50.3.1045-1053.2006] [PMID: 16495267] [79] Wenckebach, K. Cinchona derivatives in the treatment of heart disorders.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.1001/ jama.1923.02650060042012] [80] Center for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"Treatment of malaria: Guidelines for clinicians (United States) Available from: http://www.cdc.gov/malaria/diagnosis_treatment/clinicians3.html, 2013, 1-8.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1085/jgp.83.6.919] [PMID: 6330283] [83] Malchow, R.P.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1085/jgp.104.6.1039] [PMID: 7535344] [84] Steriade, M.; Stoica, E. On the anticonvulsive effect of quinidine.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/ j.drudis.2008.02.006] [PMID: 18598910] [86] Lambert, D.M.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1021/ jm058183t] [PMID: 16078824] [87] Lo, Y.K.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/S0006-2952(01)00772-9] [PMID: 11709196] [88] Zhang, Y.; Xie, H.; Lei, G.; Li, F.; Pan, J.; Liu, C.; Liu, Z.; Liu, L.; Cao, X.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.4103/1673-5374.131607] [PMID: 25206906] [89] Venance, L.; Piomelli, D.; Glowinski, J.; Giaume, C. Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1038/376590a0] [PMID: 7637807] [90] Guan, X.; Cravatt, B.F.; Ehring, G.R.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1083/jcb.139.7.1785] [PMID: 9412472] [91] Lambert, D.M.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1046/j.1528-1157.2001.41499.x] [PMID: 11442148] [92] Wallace, M.J.; Martin, B.R.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/S0014-2999(02)02331-2] [PMID: 12359270] [93] Karanian, D.A.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1124/jpet.107.120147] [PMID: 17545313] [94] Naidoo, V.; Nikas, S.P.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.1016/j.eplepsyres.,OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/j.neuropharm.2012.11.017] [PMID: 23206503] [97] Wu, C.F.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/ 10.1211/0022357021431] [PMID: 12956907] [98] Solomonia, R.; Nozadze, M.; Mikautadze, E.; Kuchiashvili, N.; Kiguradze, T.; Abkhazava, D.; Pkhakadze, V.; Mamulaishvili, I.; Mikeladze, E.; Avaliani, N. Effect of oleamide on pentylenetetrazole-induced seizures in rats.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1007/s10517-008-0056-z] [PMID: 19023975] [99] Davidson, J.S.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/ j.ejphar.2013.02.004] [PMID: 23420003] [102] Weingart, R.; Bukauskas, F.F.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1007/s004240050517] [PMID: 9382947] [103] Marandykina, A.; Palacios-Prado, N.; Rimkutė, L.; Skeberdis, V.A.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1113/jphysiol.2013.250910] [PMID: 23420660] [104] Zhang, D.Q.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1017/S0952523807070472] [PMID: 17711600] [106] Wallenstein, M.C.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1159/ 000137996] [PMID: 6433367] [107] Nilsen, K.E.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1152/jn.00972.2003] [PMID: 15277598] [109] Jahromi, S.S.; Wentlandt, K.; Piran, S.; Carlen, P.L.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
[http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1002/ptr.2362] [PMID: 18446848] [114] de Curtis, M.; Manfridi, A.; Biella, G. Activity-dependent pH shifts and periodic recurrence of spontaneous interictal spikes in a model of focal epileptogenesis.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.3109/ 02713681003770746] [PMID: 20673043] [117] Moore, L.K.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1111/j.1469-7793.1999.0679u.x] [PMID: 10200417] [119] Wang, J.; Ma, M.; Locovei, S.; Keane, R.W.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1152/ajpcell.00097.2007] [PMID: 17652431] [120] Evans, W.H.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1080/ 15419060801891034] [PMID: 18392994] [121] Evans, W.H.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1042/ bst0290606] [PMID: 11498037] [122] Samoilova, M.; Wentlandt, K.; Adamchik, Y.; Velumian, A.A.; Carlen, P.L.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/ j.expneurol.2008.01.005] [PMID: 18284929] [123] Yoon, J.J.; Green, C.R.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/ j.eplepsyres.2010.08.014] [PMID: 20851574] [124] Maier, N.; Güldenagel, M.; Söhl, G.; Siegmund, H.; Willecke, K.; Draguhn, A.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1113/jphysiol.2002.017624] [PMID: 12042356] [125] Verkhratsky, A.; Nedergaard, M.; Hertz, L. Why are astrocytes important?",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/ 10.1016/j.neuron.2008.04.002] [PMID: 18439402] [127] Wu, X.L.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1007/s00221-015-4226-8] [PMID: 25690864] [128] Stout, C.E.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1074/jbc.M109902200] [PMID: 11790776] [129] Takahashi, D.K.",Non-OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/j.nbd.2010.07.018] [PMID: 20691786] [130] Montero, T.D.",OADS,/arxiv_data1/oa_pdf/03/79/CN-14-759.PMC5050393.pdf
"[http://dx.doi.org/10.1016/0306-9877(91)90272-Z] [PMID: 1943879] [2] Howren, M.B.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1097/ PSY.0b013e3181907c1b] [PMID: 19188531] [3] Müller, N.; Schwarz, M.J.; Dehning, S.; Douhe, A.; Cerovecki, A.; Goldstein-Müller, B.; Spellmann, I.; Hetzel, G.; Maino, K.; Kleindienst, N.; Möller, H.J.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1038/sj.mp.4001805] [PMID: 16491133] [4] Tyring, S.; Gottlieb, A.; Papp, K.; Gordon, K.; Leonardi, C.; Wang, A.; Lalla, D.; Woolley, M.; Jahreis, A.; Zitnik, R.; Cella, D.; Krishnan, R. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1016/S0140-6736(05)67763-X] [PMID: 16399150] [5] Akhondzadeh, S.; Jafari, S.; Raisi, F.; Nasehi, A.A.; Ghoreishi, A.; Salehi, B.; Mohebbi-Rasa, S.; Raznahan, M.; Kamalipour, A.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1002/ da.20589] [PMID: 19496103] [6] Abbasi, S.H.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1001/ jamapsychiatry.2014.1611] [PMID: 25322082] [8] Na, K.S.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
[http://dx.doi.org/10.1016/j.pnpbp.,OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1101/cshperspect.a016303] [PMID: 25635046] [11] Anthony, D.C.; Couch, Y.; Losey, P.; Evans, M.C.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1016/j.bbi.2011.10.011] [PMID: 22085588] [12] Jiang, Z.; Jiang, J.X.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
[http://dx.doi.org/10.1016/j.imlet.2014.,OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1038/nrn2038] [PMID: 17180163] [15] Louveau, A.; Smirnov, I.; Keyes, T.J.; Eccles, J.D.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1038/nature14432] [PMID: 26030524] [16] Engelhardt, B.; Sorokin, L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1007/ s00281-009-0177-0] [PMID: 19779720] [17] Dantzer, R.; O’Connor, J.C.; Freund, G.G.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1038/nrn2297] [PMID: 18073775] [18] Banks, W.A.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1159/000097202] [PMID: 8963753] [19] Quan, N.; Whiteside, M.; Herkenham, M. Time course and localization patterns of interleukin-1beta messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1016/ j.clinthera.2015.04.002] [PMID: 26046241] [21] Korczak, D.J.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1007/s00125-011-2240-3] [PMID: 21789690] [22] Dickens, C.; McGowan, L.; Clark-Carter, D.; Creed, F. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/ 10.1002/hup.912] [PMID: 18172906] [27] Friebe, A.; Horn, M.; Schmidt, F.; Janssen, G.; Schmid-Wendtner, M.H.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
[http://dx.doi.org/10.1016/j.psyneuen.2014.03.,OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1016/j.jad.2011.08.003] [PMID: 21872339] [30] Valkanova, V.; Ebmeier, K.P.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1016/ j.bbi.2013.08.014] [PMID: 24016864] [33] Setiawan, E.; Wilson, A.A.; Mizrahi, R.; Rusjan, P.M.; Miler, L.; Rajkowska, G.; Suridjan, I.; Kennedy, J.L.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1001/ jamapsychiatry.2014.2427] [PMID: 25629589] [34] Eggermont, A.M.; Suciu, S.; Santinami, M.; Testori, A.; Kruit, W.H.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1016/S0140-6736(08)61033-8] [PMID: 18620949] [35] Reichenberg, A.; Gorman, J.M.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1097/01.aids.0000192087.64432.ae] [PMID: 16251815] [36] Sarkar, S.; Schaefer, M. Antidepressant pretreatment for the prevention of interferon alfa-associated depression: a systematic review and meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1016/j.psym.2013.06.015] [PMID: 24012293] [37] Iyengar, R.L.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1161/ CIRCULATIONAHA.110.004671] [PMID: 21555710] [42] Toussi, S.S.; Pan, N.; Walters, H.M.; Walsh, T.J.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1093/cid/cit489] [PMID: 23899685] [43] Fields, C.; Drye, L.; Vaidya, V.; Lyketsos, C. Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1056/ NEJMoa050493] [PMID: 15713943] [45] Solomon, S.D.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1056/NEJMoa050405] [PMID: 15713944] [46] Solomon, D.H.; Avorn, J.; Stürmer, T.; Glynn, R.J.; Mogun, H.; Schneeweiss, S. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1002/art.21887] [PMID: 16645966] [47] Solomon, S.D.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1161/ CIRCULATIONAHA.108.764530] [PMID: 18378608] [48] Mendlewicz, J.; Kriwin, P.; Oswald, P.; Souery, D.; Alboni, S.; Brunello, N. Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1097/00004850-200607000-00005] [PMID: 16687994] [49] Menter, A.; Augustin, M.; Signorovitch, J.; Yu, A.P.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1016/j.jaad.2009.07.022] [PMID: 20219265] [50] Langley, R.G.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
[http://dx.doi.org/10.1016/j.jaad.2009.09.,OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1038/89058] [PMID: 11385505] [53] Bloch, M.H.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1038/mp.2011.100] [PMID: 21931319] [54] Della-Morte, D.; Palmirotta, R.; Rehni, A.K.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.2217/pgs.14.162] [PMID: 25521362] [55] Miyaoka, T.; Wake, R.; Furuya, M.; Liaury, K.; Ieda, M.; Kawakami, K.; Tsuchie, K.; Taki, M.; Ishihara, K.; Araki, T.; Horiguchi, J. Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/ 10.3390/molecules170910446] [PMID: 22945025] [57] Ghanizadeh, A.; Hedayati, A. Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1002/da.22195] [PMID: 24115188] [58] Gougol, A.; Zareh-Mohammadi, N.; Raheb, S.; Farokhnia, M.; Salimi, S.; Iranpour, N.; Yekehtaz, H.; Akhondzadeh, S. Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1177/0269881115578160] [PMID: 25827645] [59] Martins, J.G.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1038/mp.2012.25] [PMID: 22488258] [60] Sepanjnia, K.; Modabbernia, A.; Ashrafi, M.; Modabbernia, M.J.; Akhondzadeh, S. Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1038/npp.2012.58] [PMID: 22549115] [61] Kashani, L.; Omidvar, T.; Farazmand, B.; Modabbernia, A.; Ramzanzadeh, F.; Tehraninejad, E.S.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
[http://dx.doi.org/10.1016/j.psyneuen.2012.,OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1176/ajp.152.2.265] [PMID: 7840362] [63] DeBattista, C.; Posener, J.A.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
[http://dx.doi.org/10.1016/j.nbd.2004.01.,OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1016/j.bbr.2012.07.026] [PMID: 22963995] [66] Dean, O.M.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.9758/cpn.2014.12.3.180] [PMID: 25598820] [67] Abolfazli, R.; Hosseini, M.; Ghanizadeh, A.; Ghaleiha, A.; Tabrizi, M.; Raznahan, M.; Golalizadeh, M.; Akhondzadeh, S. Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1002/da.20801] [PMID: 21456039] [68] Goss, A.J.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1016/j.pnpbp.2014.10.003] [PMID: 25455584] [71] Anderson, G.; Berk, M.; Dean, O.; Moylan, S.; Maes, M. Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: Therapeutic implications.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1007/s12035-014-8705-x] [PMID: 24752591] [73] Köhler, O; Gasse, C; Petersen, L; Nierenberg, A; Mors, O; Østergaard, S The effect of concomitant treatment with selective serotonin reuptake inhibitors and statins: A population-based study.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1007/ s00228-014-1666-1] [PMID: 24643636] [76] Müller, N.; Riedel, M.; Schwarz, M.J.; Engel, R.R.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1016/j.bbr.2015.05.062] [PMID: 26112756] [78] Wingerchuk, D.M.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1212/01.WNL.0000156803.23698.9A] [PMID: 15824361] [79] Sumowski, J.F.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1016/j.apmr.2014.02.004] [PMID: 24561056] [80] Solomon, D.H.; Avorn, J.; Stürmer, T.; Glynn, R.J.; Mogun, H.; Schneeweiss, S. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.",OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"[http://dx.doi.org/10.1002/art.21887] [PMID: 16645966] [81] Kayser, M.S.",Non-OADS,/arxiv_data1/oa_pdf/ed/bc/CN-14-732.PMC5050394.pdf
"Facts sheep No 369 Depression http://www.who.int/ mediacentre/factsheets/fs369/en/, 2012 October; [Accessed August 15, 2015]; [2] Kupfer, D.J.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/S0140-6736(11)60602-8] [PMID: 22189047] [3] Greenberg, P.E.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.4088/JCP.14m09298] [PMID: 25742202] [4] Rush, A.J.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1176/ajp.2006.163.11.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1001/archgenpsychiatry.2011.2044] [PMID: 22393205] [6] Haapakoski, R.; Mathieu, J.; Ebmeier, K.P.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/j.bbi.2015.06.001] [PMID: 26065825] [7] Dowlati, Y.; Herrmann, N.; Swardfager, W.; Liu, H.; Sham, L.; Reim, E.K.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1016/j.pnpbp.2007.09.,OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1186/1741-7015-11-200] [PMID: 24228900] [11] Felger, J.C.; Lotrich, F.E.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/ j.neuroscience.2013.04.060] [PMID: 23644052] [12] Lotrich, F.E.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1016/j.brainres.,OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1038/sj.mp.4002148] [PMID: 18195714] [16] Malynn, S.; Campos-Torres, A.; Moynagh, P.; Haase, J.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1007/s11064-012-0967-y] [PMID: 23338678] [17] Ferrés-Coy, A.; Galofré, M.; Pilar-Cuéllar, F.; Vidal, R.; Paz, V.; Ruiz-Bronchal, E.; Campa, L.; Pazos, Á.; Caso, J.R.; Leza, J.C.; Alvarado, G.; Montefeltro, A.; Valdizán, E.M.; Artigas, F.; Bortolozzi, A.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1038/mp.2015.80] [PMID: 26100539] [18] Dunn, A.J.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1111/j.1749-6632.2000.tb05426.x] [PMID: 11268389] [19] Zunszain, P.A.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1016/j.pnpbp.2010.04.,OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1155/ 2015/898393] [PMID: 26078821] [23] Eyre, H.; Baune, B.T.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/j.psyneuen.2012.03.019] [PMID: 22525700] [24] Frodl, T.; Amico, F. Is there an association between peripheral immune markers and structural/functional neuroimaging findings?",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/j.pnpbp.2012.12.013] [PMID: 23313563] [25] Haas, C.E.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1007/s00228-005-0971-0] [PMID: 16041547] [26] Hiemke, C.; Baumann, P.; Bergemann, N.; Conca, A.; Dietmaier, O.; Egberts, K.; Fric, M.; Gerlach, M.; Greiner, C.; Gründer, G.; Haen, E.; Havemann-Reinecke, U.; Jaquenoud Sirot, E.; Kirchherr, H.; Laux, G.; Lutz, U.C.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.1054/jcaf.2002.127773] [PMID: 12411982] [30] Aitken, A.E.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.2165/ 11319980-000000000-00000] [PMID: 20384392] [32] Furlanut, M.; Soardo, G.; Donnini, D.; Sechi, L.; Franceschi, L. Fluoxetine disposition in patients with chronic hepatitis C treated with interferon-α.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.2165/11534720-000000000-00000] [PMID: 20923249] [33] Hefner, G.; Shams, M.E.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.1002/ajmg.b.32309] [PMID: 25847751] [38] Liptrott, N.J.; Penny, M.; Bray, P.G.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.1159/000110445] [PMID: 17982267] [40] Poller, B.; Drewe, J.; Krähenbühl, S.; Huwyler, J.; Gutmann, H. Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a  mod el of th e h uman  bloo d-brain barrier.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1007/s10571-009-9431-1] [PMID: 19629677],Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1124/mol.106.029512] [PMID: 17132686] [42] von Wedel-Parlow, M.; Wölte, P.; Galla, H.J.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1016/j.psyneuen.2014.03.,OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1016/j.euroneuro.2007.06.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/ j.jpsychires.2005.11.003] [PMID: 16375926] [47] Asnis, G.M.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1097/01.mcg.0000210099.36500.fe] [PMID: 16633105] [48] Strawbridge, R.; Arnone, D.; Danese, A.; Papadopoulos, A.; Herane Vives, A.; Cleare, A.J.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1038/npp.2011.132] [PMID: 21796103] [50] Himmerich, H.; Milenović, S.; Fulda, S.; Plümäkers, B.; Sheldrick, A.J.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.1016/j.pharep.2013.08.002] [PMID: 24905304] [52] Liu, R.P.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1186/1742-2094-11-47] [PMID: 24618100] [53] Vismari, L.; Alves, G.J.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.3109/08923973.2011.638305] [PMID: 22208160] [54] Manikowska, K.; Mikołajczyk, M.; Mikołajczak, P.Ł.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1093/ijnp/pyu076] [PMID: 25522414] [56] Munzer, A.; Sack, U.; Mergl, R.; Schönherr, J.; Petersein, C.; Bartsch, S.; Kirkby, K.C.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.3390/toxins5112227] [PMID: 24257035] [57] Petersein, C.; Sack, U.; Mergl, R.; Schönherr, J.; Schmidt, F.M.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1007/s00702-014-1328-6] [PMID: 25377522] [58] Maes, M.; Song, C.; Lin, A.H.; Bonaccorso, S.; Kenis, G.; De Jongh, R.; Bosmans, E.; Scharpé, S. Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/S0893-133X(98) 00088-8] [PMID: 10088138] [59] Thomas, A.J.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.1176/appi.ajp.162.1.175] [PMID: 15625217] [60] Steptoe, A.; Kunz-Ebrecht, S.R.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1017/ S0033291702007250] [PMID: 12785468] [61] Eller, T.; Aluoja, A.; Maron, E.; Vasar, V. Soluble interleukin-2 receptor and tumor necrosis factor levels in depressed patients in Estonia.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/ j.biopsych.2014.10.014] [PMID: 25541493] [63] Serafini, G.; Pompili, M.; Elena Seretti, M.; Stefani, H.; Palermo, M.; Coryell, W.; Girardi, P. The role of inflammatory cytokines in suicidal behavior: a systematic review.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/ j.euroneuro.2013.06.002] [PMID: 23896009] [64] Zheng, L.S.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.3389/fncel.2015.00005] [PMID: 25674053] [65] Krügel, U.; Fischer, J.; Bauer, K.; Sack, U.; Himmerich, H. The impact of social isolation on immunological parameters in rats.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1186/1741-7015-10-66] [PMID: 22747645] [67] Janssen, D.G.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1002/hup.1103] [PMID: 20373471] [68] Uher, R.; Tansey, K.E.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/j.pnpbp.2009.03.020] [PMID: 19332097] [70] Lanquillon, S.; Krieg, J.C.; Bening-Abu-Shach, U.; Vedder, H. Cytokine production and treatment response in major depressive disorder.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1006/cyto.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1001/ jamapsychiatry.2014.1611] [PMID: 25322082] [75] Eyre, H.A.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/j.pnpbp.2014.10.003] [PMID: 25455584] [76] Fields, C.; Drye, L.; Vaidya, V.; Lyketsos, C. Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1007/s11011-012-9326-6] [PMID: 22773310] [79] Köhler, O.; Petersen, L.; Mors, O.; Gasse, C. Inflammation and depression: combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1002/brb3.338] [PMID: 26357585] [80] Berk, M.; Dean, O.; D r e x h a g e ,  H .",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1186/ 1741-7015-11-74] [81] Perez-G, M.; Melo, M.; Keegan, A.D.; Zamorano, J. Aspirin and salicylates inhibit the IL-4- a n d  I L-13-induced activation of STAT6.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.4049/jimmunol.168.3.1428] [PMID: 11801685] [82] Brunello, N.; Alboni, S.; Capone, G.; Benatti, C.; Blom, J.M.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1097/00004850-200607000-00004] [PMID: 16687993] [83] Yang, J.M.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.1016/j.neuroscience.2014.06.016] [PMID: 24952332] [84] Toussi, S.S.; Pan, N.; Walters, H.M.; Walsh, T.J.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1093/cid/cit489] [PMID: 23899685] [85] Tyring, S.; Gottlieb, A.; Papp, K.; Gordon, K.; Leonardi, C.; Wang, A.; Lalla, D.; Woolley, M.; Jahreis, A.; Zitnik, R.; Cella, D.; Krishnan, R. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.1016/S0140-6736(05)67763-X] [PMID: 16399150] [86] Krügel, U.; Fischer, J.; Radicke, S.; Sack, U.; Himmerich, H. Antidepressant effects of TNF-α blockade in an animal model of depression.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1016/j.bbi.2014.,OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1111/bcpt.12037] [PMID: 23167806] [92] Menter, A .",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/j.jaad.2009.07.022] [PMID: 20219265] [93] Langley, R.G.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1016/j.jaad.2009.09.,OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.1177/2040622315579059] [PMID: 25954495] [96] Taniguchi, T.; Kanakura, H.; Takemoto, Y.; Yamamoto, K. The antiinflammatory effects of ketamine in endotoxemic rats during moderate and mild hypothermia.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1213/01.ANE.0000100740.07331.A2] [PMID: 15041609] [97] Helmer, K.S.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1097/01.shk.0000065766.72937.cf] [PMID: 12813371] [98] Wang, N.; Yu, H.Y.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1097/TA.0000000000000588] [PMID: 25807407] [100] Yang, J.J.; Wang, N.; Yang, C.; Shi, J.Y.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.1016/j.neulet.2015.05.022] [PMID: 25980993] [103] Schmidt, F.M.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1371/journal.pone.0121971] [104] Lin, P.Y.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/ j.biopsych.2010.03.018] [PMID: 20452573] [105] Martins, J.G.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1038/mp.2012.25] [PMID: 22488258] [106] Bloch, M.H.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1038/ mp.2011.100] [PMID: 21931319] [107] Lin, P.Y.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.1038/mp.2012.111] [PMID: 22824812] [108] Fond, G.; Hamdani, N.; Kapczinski, F.; Boukouaci, W.; Drancourt, N.; Dargel, A.; Oliveira, J.; Le Guen, E.; Marlinge, E.; Tamouza, R.; Leboyer, M. Effectiveness and tolerance of anti-inflammatory drugs’ add-on therapy in major mental disorders: a systematic qualitative review.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1111/acps.12211] [PMID: 24215721] [109] Sublette, M.E.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1038/npp.2010.98] [PMID: 20668435] [112] Calder, P.C.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1017/S0029665113001031] [PMID: 23668691] [113] Lee, J.Y.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1194/jlr.M200361-JLR200] [PMID: 12562875] [114] Gougol, A.; Zareh-Mohammadi, N.; Raheb, S.; Farokhnia, M.; Salimi, S.; Iranpour, N.; Yekehtaz, H.; Akhondzadeh, S. Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1177/0269881115578160] [PMID: 25827645] [115] Ghanizadeh, A.; Hedayati, A. Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1002/da.22195] [PMID: 24115188] [116] Glaus, J.; Vandeleur, C.L.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1016/j.jad.2015.03.,OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.1517/14656566.2013.803067] [PMID: 23767773] [118] Macedo, A.F.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1186/ 1741-7015-12-51] [119] Rosenson, R.S.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/S0140-6736(98) 05917-0] [PMID: 10459915] [120] Ferro, D.; Parrotto, S.; Basili, S.; Alessandri, C.; Violi, F. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/S0735-1097(00)00771-3] [PMID: 10933353] [121] Bustos, C.; Hernández-Presa, M.A.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/S0735-1097(98)00487-2] [PMID: 9857893] [122] Antonopoulos, A.S.; Margaritis, M.; Lee, R.; Channon, K.; Antoniades, C. Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1007/978-0-387-46401-5_3] [PMID: 17569207] [125] Abe, Y.; Hashimoto, S.; Horie, T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1006/phrs.1998.0404] [PMID: 10051376] [126] Buhrmann, C.; Mobasheri, A.; Busch, F.; Aldinger, C.; Stahlmann, R.; Montaseri, A.; Shakibaei, M. Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.3390/molecules191220864] [PMID: 25514226] [129] Lopresti, A.L.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1002/ ptr.5025] [PMID: 23832433] [131] Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/S0140-6736(03) 12705-5] [PMID: 12642045] [132] Lehtimäki, K.; Keränen, T.; Huuhka, M.; Palmio, J.; Hurme, M.; Leinonen, E.; Peltola, J.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.1097/YCT.0b013e3181571abb] [PMID: 18379341] [133] Stelzhammer, V.; Guest, P.C.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/ j.euroneuro.2012.10.012] [PMID: 23183131] [134] Fluitman, S.B.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/j.jad.2010.11.035] [PMID: 21183225] [135] Hestad, K.A.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1097/00124509-200312000-00002] [PMID: 14657769] [136] Zhu, X.; Li, P.; Hao, X.; Wei, K.; Min, S.; Luo, J.; Xie, F.; Jin, J. Ketamine-mediated alleviation of electroconvulsive shock-induced memory impairment is associated with the regulation of neuroinflammation and soluble amyloid-beta peptide in depressive-like rats.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1038/tp.2015.100] [PMID: 26218851] [138] Dougherty, D.D.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1177/0004867415599845] [PMID: 26276049] [140] Calleja-Castillo, J.M.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.1155/2013/698634] [PMID: 24235973] [141] Perez-Caballero, L.; Pérez-Egea, R.; Romero-Grimaldi, C.; Puigdemont, D.; Molet, J.; Caso, J.R.; Mico, J.A.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1038/ mp.2013.63] [PMID: 23711979] [142] Dunn, A.L.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/ j.amepre.2004.09.003] [PMID: 15626549] [143] Rethorst, C.D.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.2165/00007256-200939060-00004] [PMID: 19453207] [144] Trivedi, M.H.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.4088/JCP.10m06743] [PMID: 21658349] [145] Bergman, D. The endocrinology of exercise.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1007/s11739-013-0921-2] [PMID: 23475807] [146] Rethorst, C.D.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.1038/mp.2012.125] [PMID: 22925832] [147] Kapsimalis, F.; Basta, M.; Varouchakis, G.; Gourgoulianis, K.; Vgontzas, A.; Kryger, M. Cytokines and pathological sleep.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1016/j.sleep.2007.,OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1111/j.1749-6632.2009.05300.x] [PMID: 20398008] [149] Lange, T.; Dimitrov, S.; Fehm, H.L.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1001/ archinte.166.16.1695] [PMID: 16983046] [150] Himmerich, H.; Beitinger, P.A.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.1001/archinte.166.16.1739] [PMID: 16983052] [151] Axelsson, J.; Rehman, J.U.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1176/appi.neuropsych.11060142] [PMID: 23037650] [154] Benedetti, F.; Lucca, A.; Brambilla, F.; Colombo, C.; Smeraldi, E. Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/S0278-5846(02)00255-5] [PMID: 12452541] [155] Pandey, G.N.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1016/j.jpsychires.,OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/j.bbi.2015.02.015] [PMID: 25712260] [157] Gárate, I.; García-Bueno, B.; Madrigal, J.L.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/ 10.1186/1742-2094-11-8] [PMID: 24410883] [158] Li, J.; Csakai, A.; Jin, J.; Zhang, F.; Yin, H. Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuro- inflammation.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1002/cmdc.201500188] [159] Li, X.; Jope, R.S.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1038/npp.2010.105] [PMID: 20668436] [160] Martin, M.; Rehani, K.; Jope, R.S.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1038/ni1221] [PMID: 16007092] [161] Yuskaitis, C.J.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1007/s10787-011-0111-7] [PMID: 22271002] [163] Fajemiroye, J.O.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1038/srep11582] [PMID: 26199018] [164] Yi, L.T.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1177/ 0269881112467090] [PMID: 23151611] [165] Lee, S.; Kim, D.H.; Lee, C.H.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/j.jep.2010.07.015] [PMID: 20637276] [166] O’Connor, J.C.; Lawson, M.A.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1038/sj.mp.4002148] [PMID: 18195714] [167] Liu, Y.N.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.1016/j.pnpbp.2012.02.002] [PMID: 22349578] [169] Dean, O.M.",OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
"[http://dx.doi.org/10.3109/09540261.2013.813442] [PMID: 24151804] [171] Abbasi, S.H.",Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/b3/CN-14-674.PMC5050395.pdf
[http://dx.doi.org/10.1038/475027a] [PMID: 21734685]   Abhay Sharma,Non-OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1001/archpsyc.62.6.617] [PMID: 15939839] [3] Miller, G. Is pharma running out of brainy ideas?",Non-OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1126/science.329.5991.502] [PMID: 20671165] [4] Hyman, S.E.",OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1126/scitranslmed.3003142] [PMID: 23052291] [5] Insel, T.R.",OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1038/483269a] [PMID: 22422245] [6] Hyman, S.E.",OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1038/npp.2013.181] [PMID: 24317307] [7] Trivedi, M.H.",OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1176/appi.ajp.163.1.28] [PMID: 16390886] [8] Berman, R.M.",Non-OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1016/S0006-3223(99)00230-9] [PMID: 10686270] [9] Price, R.B.",OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1176/appi.ajp.2013.13030392] [PMID: 23982301] [11] Ballard, E.D.",OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1016/j.jpsychires.2014.07.027] [PMID: 25169854] [12] Krishnan, V.; Nestler, E.J.",OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1038/nature07455] [PMID: 18923511] [13] Dolgin, E. Rapid antidepressant effects of ketamine ignite drug discovery.",Non-OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
[http://dx.doi.org/10.1038/nm0113-8] [PMID: 23295995] [14] Editorial.,Non-OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1038/517121a] [15] Reardon, S. Rave drug tested against depression.",Non-OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1038/517130a] [PMID: 25567262] [16] Sanacora, G.; Schatzberg, A.F.",OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1038/npp.2014.261] [PMID: 25257213] [17] Nutt, D. Help luck along to find psychiatric medicines.",Non-OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1038/515165a] [PMID: 25391924] [18] Kafkafi, N.; Mayo, C.L.",Non-OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1007/s00213-013-3230-6] [PMID: 23958942] [19] Sun, J.; Huang, L.C.",Non-OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1155/2014/258784] [20] Liang, C.; Sun, J.; Tao, C. Semantic Web Ontology and Data Integration: a Case Study in Aiding Psychiatric Drug Repurposing.",OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1517/14656566.2015.1032248] [PMID: 25866122] [22] McCoy, T.H., Jr; Perlis, R.H. A tool to utilize adverse effect profiles to identify brain-active medications for repurposing.",Non-OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1093/ijnp/pyu078] [PMID: 25673184] [23] Sarter, M.; Tricklebank, M. Revitalizing psychiatric drug discovery.",Non-OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1038/nrd3755] [PMID: 22653200] [24] Monteggia, L.M.",OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1038/ 515200a] [PMID: 25391955] [25] Hyman, S. Mental health: depression needs large human-genetics studies.",Non-OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1038/515189a] [PMID: 25391945] [26] Renault, P.F.",Non-OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1001/archinte.1987.00370090055011] [PMID: 3307672] [27] Maes, M.; Van der Planken, M.; Stevens, W.J.",Non-OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1016/0022-3956(92)90004-8] [PMID: 1613679] [28] Maes, M.; Meltzer, H.Y.",OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/ 10.1016/0165-0327(95)00028-L] [PMID: 8550956] [29] Haapakoski, R.; Ebmeier, K.P.",OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1016/ j.pnpbp.2015.11.012] [PMID: 26631274] [30] Miller, A.H.; Raison, C.L.",OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1038/nri.2015.5] [PMID: 26711676] [31] Hodes, G.E.",OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"[http://dx.doi.org/10.1038/nn.4113] [PMID: 26404713]   Abhay Sharma (Guest Editor) CSIR-Institute of Genomics and Integrative Biology Council of Scientific and Industrial Research Sukhdev Vihar, Mathura Road New Delhi 110025 E-mail: abhaysharma@igib.res.in",Non-OADS,/arxiv_data1/oa_pdf/f0/f2/CN-14-663.PMC5050396.pdf
"Psychiatry, 2015, 6, 13. http://dx.doi.org/10.3389/fpsyt.2015.00013 [3] DSM-V-TR: Diagnostic and Statistical Manual of Mental Disorders Fifth Edition Text Revision.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Bull., 2009, 35(2), 383-402. http://dx.doi.org/10.1093/schbul/sbn135 [5] Doherty, J.L.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Genome Med., 2014, 6(4), 29. http://dx.doi.org/ 10.1186/gm546 [6] Brown, A.S. and Derkits, E.J.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"J. Psychiatry, 2010, 167(3), 261-80. http://dx.doi.org/10.1176/appi.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Rev., 2002, 8(1), 51-7. http://dx.doi.org/10.1002/mrdd.10004 [8] Mednick, S.A., Machon, R.A., H u t t u n e n ,  M .",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Gen. Psychiatry, 1988, 45(2), 189-92. http://dx.doi.org/10.1001/archpsyc.1988.01800260109013 [9] Brown, A.S., M.D.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Gen. Psychiatry, 2004, 61(8), 774-80. http://dx.doi.org/10.1001/ archpsyc.61.8.774 [10] Meyer, U., Feldon, J. and Fatemi, S.H.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Rev., 2009, 33(7), 1061-79. http://dx.doi.org/10.1016/j.neubiorev.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"http://dx.doi.org/10.1038/tp.2012.6 [12] Harvey, L. and Boksa, P. Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"D e v. N e ur ob io l., 2012, 72(10), 1335-48. http://dx.doi.org/ 10.1002/dneu.22043 [13] Meyer, U. Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neurobiol., 2010, 90(3), 285-326. http://dx.doi.org/10.1016/j.pneurobio.2009.10.018 [15] Machon, R.A., Mednick, S.A., and Huttunen, M.O.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Gen. Psychiatry, 1997, 54(4), 322-8. http://dx.doi.org/ 10.1001/archpsyc.1997.01830160040006 [16] Mino, Y., Oshima, I., and Okagami, K. Mood disorders and influenza epidemics in Japan.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neurosci., 2000, 54(1), 59-65. http://dx.doi.org/10.1046/j.1440-1819.2000.00638.x [17] Pang, D., Syed, S., Fine, P., and Jones, P.B.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"J. Psychiatry, 1996, 168(3), 368-71. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Gen. Psychiatry, 2003, 60(12), 1187-92. http://dx.doi.org/10.1001/ archpsyc.60.12.1187 [20] Sullivan, P.F., Neale, M.C., and Kendler, K.S.Genetic epidemiology of major depression: review a nd m eta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"J. Psychiatry, 2000, 157(10), 1552-62. http://dx.doi.org/10.1176/ appi.ajp.157.10.1552 [21] Wray, N.R., Pergadia, M.L., Blackwood, D.H., Penninx, B.W., Gordon, S.D., Nyholt, D.R., Ripke, S., MacIntyre, D.J., McGhee, K.A., Maclean, A.W., Smit, J.H., Hottenga, J.J., Willemsen, G., Middeldorp, C.M., de Geus E.J., Lewis, C.M., McGuffin, P., Hickie, I.B., van den Oord, E.J., Liu, J.Z., Macgregor, S., McEvoy, B.P., Byrne, E.M., Medland, S.E., Statham, D.J., Henders, A.K., Heath, A.C., Montgomery, G.W., Martin, N.G., Boomsma, D.I., Madden, P.A., and Sullivan, P.F.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Psychiatry, 2012, 17(1), 36-48. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"http://dx.doi.org/10.1038/tp.2013.132 [23] Babri, S., Doosti, M.H., and Salari, A.A.Strain-dependent effects of prenatal maternal immune activation on anxiety- a n d  d e p r e s s i o n-like behaviors in offspring.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Immun., 2014, 37, 164-76. http://dx.doi.org/10.1016/j.bbi.2013.12.003 [24] Majidi-Zolbanin, J., Doosti, M.H., Kosari-Nasab, M., and Salari, A.A. Prenatal maternal immune activation increases anxiety- a n d  depressive-like behaviors in offspring with experimental autoimmune encephalomyelitis.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neuroscience, 2015, 294, 69-81. http://dx.doi.org/10.1016/j.neuroscience.2015.03.016 [25] Lin, Y.L.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Brain Res., 2014, 259, 24-34. http://dx.doi.org/10.1016/j.bbr.2013.10.034 [26] Zhang, Z. and van Praag, H. Maternal immune activation differentially impacts mature and adult-born hippocampal neurons in male mice.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"45, 60-70. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neuroscience, 2015, 299, 56-65. http://dx.doi.org/10.1016/j.neuroscience.2015.04.065 [28] Meyer, U., Knuesel, I., Nyffeler, M., and Feldon, J.Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Psychopharmacology (Berl), 2010, 208(4), 531-43. http://dx.doi.org/10.1007/s00213-009-1754-6 [29] Meyer, U., Nyffeler, M., Engler, A., Urwyler, A., Schedlowski, M., Knuesel, I., Yee, B.K., and Feldon, J.The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neurosci., 2006, 26(18), 4752-62. http://dx.doi.org/10.1523/JNEUROSCI.0099-06.2006 [30] Graciarena, M., Depino, A.M., and Pitossi, F.J. Prenatal inflammation impairs adult neurogenesis and memory related behavior through persistent hippocampal TGFbeta1 downregulation.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Immun., 2010, 24(8), 1301-9. http://dx.doi.org/10.1016/j.bbi.2010.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Ther., 2015, 149, 213-26. http://dx.doi.org/10.1016/j.pharmthera.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neurosci., 2013, 7, 217. http://dx.doi.org/10.3389/fnbeh.2013.00217 [33] Pollak, D.D., Rey, C.E., and Monje, F.J. Rodent models in depression research: classical strategies and new directions.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"42(4), 252-64. http://dx.doi.org/10.3109/ 07853891003769957",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Med., 1997, 27(3), 539-47. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Gen. Psychiatry, 1995, 52(5), 374-83. http://dx.doi.org/10.1001/archpsyc.1995.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Psychiatry, 2015, 6, 68. http://dx.doi.org/10.3389/fpsyt.2015.00068 [37] Pittenger, C. and Duman, R.S.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"33(1), 88-109. http://dx.doi.org/10.1038/sj.npp.1301574 [38] Stepanichev, M., .",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Int., 2014, 932757. http://dx.doi.org/10.1155/2014/932757 [39] Nestler, E.J.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neurosci., 2010, 13(10), 1161-9. http://dx.doi.org/ 10.1038/nn.2647 [40] McEwen, B.S.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"R e v .,  2003, 9(3), 149-54. http://dx.doi.org/10.1002/mrdd.10074 [41] Brown, A.S., Susser, E.S., Lin, S.P., Neugebauer, R., and Gorman, J.M.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"J. Psychiatry, 1995, 166(5), 601-6. http://dx.doi.org/10.1192/ bjp.166.5.601 [42] Brown, A.S., van Os., J. Driessens, C., Hoek, H.W., and Susser, E.S.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"P s y c hiatry, 2000, 157(2), 190-5. http://dx.doi.org/10.1176/appi.ajp.157.2.190 [43] Stein, A.D., Pierik, F.H., Verrips G.H., Susser, E.S., and Lumey, L.H.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Epidemiology, 2009, 20(6), 909-15. http://dx.doi.org/ 10.1097/EDE.0b013e3181b5f227 [44] Rice, F., Jones, I. and Thapar, A.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
The impact of gestational stress and prenatal growth on emotional problems in offs http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Med., 2010, 40(2), 335-45. http://dx.doi.org/10.1017/S0033291709005911 [46] Dunkel, S, C., and Tanner, L. Anxiety, depression and stress in pregnancy: implications for mothers, children, research, and practice.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Psychiatry, 2012, 25(2), 141-8. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Rev., 2015, 48, 70-91. http://dx.doi.org/10.1016/j.neubiorev.2014.11.013 [48] Graignic-Philippe, R., Dayan, J., Chokron, S., Jacquet, A.Y., and Tordjman, S. Effects of prenatal stress on fetal and child development: a critical literature review.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Rev., 2014, 43, 137-62. http://dx.doi.org/10.1016/j.neubiorev.2014.03.022 [49] Markham, J.A.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Psychopharmacology (Berl), 2011, 214(1), 89-106. http://dx.doi.org/10.1007/s00213-010-2035-0 [50] Weinstock, M.  The potential influence of maternal stress hormones on development and mental health of the offspring.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Immun., 2005, 19(4), 296-308. http://dx.doi.org/10.1016/j.bbi.2004.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Rev., 2008, 32(6), 1073-86. http://dx.doi.org/10.1016/j.neubiorev.2008.03.002 [52] Brunton, P.J.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neuroendocrinol., 2010, 22(4):, 258-71. http://dx.doi.org/10.1111/j.1365-2826.2010.01969.x [53] Cratty, M.S., Ward, H.E., Johnson, E.A., Azzaro, A.J.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Brain Res., 1995, 675(1-2), 297-302. http://dx.doi.org/10.1016/0006-8993(95)00087-7 [54] Zuena, A.R., Mairesse, J., Casolini, P., Cinque, C., Alema, G.S., Morley-Fletcher, S., Chiodi, V., Spagnoli, L.G., Gradini, R., Catalani, A. Nicoletti, F., and Maccari, S. Prenatal restraint stress generates two distinct behavioral and neurochemical profiles in male and female rats.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Endocrinology, 2005, 146(7), 3202-10. http://dx.doi.org/10.1210/en.2004-1458 [56] Walf, A.A. and Frye, C.A.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Stress, 2007, 10(3), 251-60. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Res., 2007, 32(10), 1730-40. http://dx.doi.org/10.1007/s11064-007-9339-4 [58] Lee, M.M., Reif, A., and Schmitt, A.G. Major depression: a role for hippocampal neurogenesis?",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neurosci., 2013, 14, 153-79. http://dx.doi.org/10.1007/7854_2012_226 [59] Mednick, S.A., Huttunen, M.O., and Machon, R.A.Prenatal influenza infections and adult schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Schizophr Bull., 1994, 20(2), 263-7. http://dx.doi.org/10.1093/schbul/20.2.263 [60] Fatemi, S .",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Synapse, 1998, 29(1), 84-8. http://dx.doi.org/10.1002/(SICI)1098-2396(199805)29:1<84::AID-SYN8>3.0.CO;2-7 [61] Fatemi, S.H., Emamian, E.S., Kist, D., Sidwell, R.W., Nakajima, K., Akhter, P., Shier, A., Sheikh, S., and Bailey, K. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally i n f e c t e d  n e o n a t a l  m i c e .",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Psychiatry, 1999, 4(2), 145-54. http://dx.doi.org/10.1038/sj.mp.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neuroreport, 2000, 11(7), 1493-6. http://dx.doi.org/10.1097/00001756-200005150-00026 [63] Fatemi, S.H., Emamian, E.S., Sidwell, R.W., Kist, D.A., Stary, J.M., Earle, J.A., and Thuras, P. Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Psychiatry, 2002, 7(6), 633-40. http://dx.doi.org/10.1038/sj.mp.4001046 [64] Shi, L., Fatemi, S.H., Sidwell, R.W., and Patterson, P.H.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neurobiol., 2002, 22(1), 25-33. http://dx.doi.org/10.1023/A: 1015337611258 [66] Fatemi, S.H., Araghi-Niknam, M., Laurence, J.A., Stary, J.M., Sidwell, R.W., and Lee, S. Glial fibrillary acidic protein and glutamic acid decarboxylase 65 and 67 kDa proteins are increased in brains of neonatal BALB/c mice following viral infection  in utero.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Res., 2004, 69(1), 121-3. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Res., 2008, 99(1-3), 56-70. http://dx.doi.org/10.1016/j.schres.2007.11.018 [68] Meyer, U., and Feldon, J. Neural basis of psychosis-related behaviour in the infection model of schizophrenia.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"7    701 Res., 2009, 204(2), 322-34. http://dx.doi.org/10.1016/j.bbr.2008.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Immun., 2007, 21(4), 490-502. http://dx.doi.org/10.1016/j.bbi.2006.12.007 [70] Meyer, U., Feldon, J., Schedlowski, M., and Yee, B.K.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Rev., 2005, 29(6), 913-47. http://dx.doi.org/10.1016/j.neubiorev.2004.10.012 [71] Borrell, J., Vela, J.M., Arevalo-Martin, A., Molina-Holgado, E., and Guaza, C.Prenatal immune challenge disrupts sensorimotor gating in adult rats.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neuropsychopharmacology, 2002, 26(2), 204-15. http://dx.doi.org/10.1016/S0893-133X(01)00360-8 [72] Meyer, U., Feldon, J., Schedlowski, M., and Yee, B.K.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Immun., 2006, 20(4), 378-88. http://dx.doi.org/10.1016/j.bbi.2005.11.003 [73] Zuckerman, L., Rehavi, M., Nachman, R. andWeiner, I.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neuro- psychopharmacology, 2003, 28(10), 1778-89. http://dx.doi.org/ 10.1038/sj.npp.1300248 [74] Zuckerman, L. and Weiner, I. Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Psycho- pharmacology (Berl), 2003, 169(3-4), 308-13. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Immun., 2008, 22(4), 469-86. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Res., 2004, 38(3), 335-45. http://dx.doi.org/ 10.1016/j.jpsychires.2003.10.001 [78] Meyer, U., Yee, B.K.and Feldon, J.The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neuroscientist, 2007, 13(3), 241-56. http://dx.doi.org/ 10.1177/1073858406296401 [79] Schmidt, H.D.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Pharmacol., 2007, 18(5-6), 391-418. http://dx.doi.org/10.1097/FBP.0b013e3282ee2aa8 [80] Ozawa, K., Hashimoto, K., Kishimoto, T., Shimizu, E., Ishikura, H., and Iyo, M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Psychiatry, 2006, 59(6), 546-54. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Placenta, 2002, 23(4), 257-73. http://dx.doi.org/10.1053/plac.2001.0782 [84] Babulas, V., Factor-Litvak, P., Goetz, R., Schaefer, C.A., and Brown A.S. Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"J. Psychiatry, 2006, 163(5), 927-9. http://dx.doi.org/10.1176/ajp.2006.163.5.927 [85] Li, Q., Cheung, C. Wei, R., Hui, E.S., Feldon, J., Meyer, U., Chung, S., Chua, S.E., Sham, P.C., Wu, E.X.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"http://dx.doi.org/ 10.1371/journal.pone.0006354 [86] Bilbo, S.D.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neuroendocrinol., 2012, 33(3), 267-86. http://dx.doi.org/10.1016/ j.yfrne.2012.08.006 [87] Robinson, D.P.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Behav., 2012, 62(3), 263-71. http://dx.doi.org/ 10.1016/j.yhbeh.2012.02.023 [88] Holsapple, M.P., West, L.J., and Landreth, K.S.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Reprod.Toxicol., 2003, 68(4), 321-34. http://dx.doi.org/10.1002/bdrb.10035 [89] Klosterkotter, J., Schultze-Lutter, F., Bechdolf, A., and Ruhrmann, S. Prediction and prevention of schizophrenia: what has been achieved and where to go next?",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"World Psychiatry, 2011, 10(3), 165-74. http://dx.doi.org/10.1002/j.2051-5545.2011.tb00044.x [90] Tandon, R., Nasrallah, H.A., and Keshavan, M.S.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Res., 2010, 122(1-3), 1-23. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"http://dx.doi.org/ 10.1093/schbul/sbr083 [92] Raison, C.L., Capuron, L., and Miller, A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Trends Immunol., 2006, 27(1), 24-31. http://dx.doi.org/10.1016/j.it.2005.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Psychiatry, 2008, 64(4), 266-72. http://dx.doi.org/ 10.1016/j.biopsych.2008.03.017 [94] Capuron, L., Fornwalt, F.B., Knight, B.T., Harvey, P.D., Ninan, P.T.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Disord., 2009, 119(1-3), 181-5. http://dx.doi.org/10.1016/ j.jad.2009.02.017 [95] Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., and Kelley, K.W.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neurosci., 2008, 9(1), 46-56. http://dx.doi.org/10.1038/nrn2297  [96] Reimer, T., Brcic, M., Schweizer, M., and Jungi, T.W.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Biol., 2008, 83(5), 1249-57. http://dx.doi.org/10.1189/jlb.0607412 [97] Dammann, O. and Leviton, A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Res., 1997, 42(1), 1-8. http://dx.doi.org/10.1203/00006450-199707000-00001 [98] Howerton, C.L.",Non-OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Behav., 2012, 62(3), 237-42. http://dx.doi.org/10.1016/j.yhbeh.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
"Neuroscience, 2013, 246, 199-229. http://dx.doi.org/ 10.1016/j.neuroscience.2013.04.060 [100] Arck, P.C.",OADS,/arxiv_data1/oa_pdf/eb/df/CN-14-688.PMC5050397.pdf
